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 i 
ABSTRACT 
 
 
Structural and functional studies of XvPrx2, a type II peroxiredoxin from the 
resurrection plant Xerophyta viscosa 
 
E. J. Onyemata, Department of Biotechnology, Faculty of Natural Sciences, University 
of the Western Cape 
 
XvPrx2 is a 1-Cys-containing member of the Prx5 subfamily of peroxiredoxins isolated 
from the resurrection plant Xerophyta viscosa. It is reported to be up-regulated during 
periods of desiccation and to protect nucleic acids and cellular proteins from oxidative 
damage through scavenging of reactive oxygen species, suggesting that it may play a 
role the desiccation tolerance of X. viscosa (Govender, 2006). Members of the Prx5 
subfamily have previously been reported to occur as non-covalent homodimers 
associating across an A-type interface. PrxD from Populus tremula, a close homologue 
of XvPrx2, forms disulphide bonds with glutathione (glutathionylation) resulting in the 
unfolding of the Cp-loop and α2-helix and disruption of the homodimer, on the basis of 
which glutathionylation has been proposed as a physiological mechanism for 
regeneration of all members of the Prx5 subfamily (Noguera-Mazon, et al., 2006b). 
 
Chapter 3 of this thesis describes the development of procedures for expression and 
purification of large quantities of unlabeled and 15N- and 13C-enriched samples of 
XvPrx2 using a bacterial expression system. Protein crystals were grown for X-ray 
diffraction studies, but they diffracted to insufficient resolution for structure 
determination.  
 
 ii 
Chapter 4 describes the investigation of the oligomeric state of XvPrx2 using size 
exclusion chromatography, non-denaturing mass spectrometry and nuclear magnetic 
resonance spectroscopy (NMR). Consistent with previous reports XvPrx2 was found to 
form non-covalent homodimers; the oligomeric state was found to be highly pH-
dependent, being monomeric below pH 6 and homodimeric above. Both states were 
present in the vicinity of pH 6, exchanging slowly on the NMR time scale but rapidly 
on the time scale of size exclusion chromatography. This is the first report of pH-
dependent oligomerization in Prx5 subfamily members. 
 
Over 90% of the backbone resonances of the homodimeric form were successfully 
assigned at pH 7.2, but attempts to use chemical shift perturbation analysis to map the 
dimerization interface were frustrated by the poor stability of the protein at pH 5 which 
did not allow for assignment of the monomeric form. Attempts to assign side-chain 
resonances of the homodimeric form at pH 7.2 were also unsuccessful, due to poor 
coherence transfer resulting from the large effective molecular weight of the complex 
(36 kDa), but a highly downshifted resonance at -0.53 ppm, which is a useful marker 
for the homodimeric state, was successfully assigned to Ile42. Structures of other Prx5 
subfamily members have highlighted the presence of a network of hydrogen bonds 
stabilizing the α2-helix, which are likely to also affect the stability of the homodimer; 
the pH-dependence of the homodimerisation was found to be consistent with a model 
in which a single ionisable group with a pKa of 6.0 can accept a hydrogen bond when 
ionized, thereby stabilizing the homodimer, but cannot accept the hydrogen bond when 
protonated. 
 
 iii 
Chapter 5 reports on the effect of mutating two ionisable residues potentially playing a 
role in the stability of the α2-helix. Replacing His55 by alanine extended the stability of 
the monomer up to pH 8, indicating that the hydrogen bond accepted by His55 from 
Arg129 is important in stabilizing the homodimer in the wild type protein above pH 6. 
At pH 6 the H55A mutant was found to be monomeric and stable at 25 °C for a 
number of weeks and may therefore provide a means of investigating the structure and 
function of the monomeric form of the protein. Contrary to expectation replacing 
Cys51 by serine stabilized the homodimer at lower pH values than the wild type.  
 
Oxidation of XvPrx2 with a range of concentrations of H2O2 yielded only the over-
oxidized sulphinic acid (-SOOH) form. This is consistent with multiple reports that the 
sulphenic acid (-SOH) form is unstable and readily oxidized to higher oxidation states. 
Despite the disappearance of the downfield-shifted resonance at -0.52 ppm, which had 
been found to be diagnostic of the homodimer, analysis of the effect of oxidation on 
the 15N-HSQC spectrum, combined with results from size exclusion chromatography, 
suggests that oxidation does not abolish the homodimer. A possible explanation is that 
the α2-helix is disrupted by oxidation, but not sufficiently to destabilize the 
homodimer. 
 
Consistent with reports of its effect on PtPrxD, glutathionylation completely disrupted 
the XvPrx2 homodimer. Glutathionylation was achieved both by incubation of oxidized 
glutathione (GSSG) with reduced XvPrx2, and by incubation of reduced glutathione 
(GSH) with oxidized XvPrx2. Complete glutathionylation was achieved despite the fact 
that the protein was over-oxidised to the sulphinic acid (-SOOH) form. 
 
 iv 
Following glutathionylation, XvPrx2 could be completely regenerated by addition of 
DTT, yielding a 15N-HSQC spectrum indistinguishable from that prior to oxidation. 
The implication of this result is that glutathionylation combined with DTT should 
provide an effective way of regenerating XvPrx2 following oxidation by H2O2. 
Kinetics assays are proposed using both DTT and the physiologically appropriate 
electron donor glutaredoxin to investigate the activities of wild type XvPrx2 and the 
H55A mutant reported in this thesis. 
 
Key words: peroxiredoxin, structure, monomer, non-covalent dimer, NMR, 
electrospray ionization mass spectrometry (ESI-MS), size exclusion chromatography 
(SEC), oligomeric state, pH, X-ray crystallization 
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Chapter 1: literature review 
1.1 Introduction  
Plant water deficit occurs when the rate of transpiration exceeds the rate of water 
uptake, leading to desiccation (Bray, 1997). Response to desiccation by plants takes the 
form of stomata closure, a process that results in the transfer of high-energy electrons 
to oxygen and nitrogen species, leading to the formation of reactive oxygen and 
nitrogen radicals (ROS and RNS). Partially reduced or activated ROS and RNS, 
produced by photosynthetic organisms as by-products of normal cellular metabolism 
during steady state functioning at the levels of mitochondrial and chloroplastic electron 
transfer chains are highly reactive and toxic and can lead to cell destruction (Takahashi 
& Asada, 1988). In vitro studies conducted by several groups have demonstrated that 
ROS and RNS participate in many physiological processes such as signal transduction, 
modulation of transcription factors and cell differentiation (Finkel, 1998; Kang, et al., 
1998; Sundaresan, et al., 1995). The dual roles of ROS and RNS in the regulation of 
important processes as well as in toxicity implies a tight regulation of the their 
concentrations. Cells have developed many enzymatic and non-enzymatic anti-
oxidative systems for regulation of these molecules, including glutathione-dependent 
peroxidases (Apxs, GPxs), thioredoxin peroxidases (TPxs), and the recently 
characterized peroxiredoxins (Prxs) (Noguera-Mazon, et al., 2006a), which are the 
subject of this review.  
 
Peroxiredoxins (Prxs), previously named thiol-specific antioxidants (TSA), thioredoxin 
peroxidases (TPx) or Peroxidoxins, are multi-functional thiol-dependent anti-oxidant 
peroxidases, which are ubiquitously expressed in many organisms and in many cellular 
compartments (Dietz, 2003; Kim, et al., 1988). They are heme-free abundant low 
 2 
efficiency peroxidases, which achieve the reduction of various peroxides including 
alkyl-hydroperoxides, hydrogen peroxides and peroxinitrates, using a conserved 
catalytic cysteine residue and thiol-containing proteins as reductants (Rouhier & 
Jacquot, 2005). Peroxiredoxins were first identified through studies involving the 
regulation of glutamine synthase (GS) in yeast where it was found to confer protection 
against oxidative inactivation of the GS (Kim, et al., 1985). Purified GS suffered a 
gradual loss in activity when stored in a thiol-containing buffer but retained activity 
when stored in the same buffer containing extracts from Saccharomyces cereviseae, 
which suggested the presence of an anti-oxidant molecule within the extract. A 25 kDa 
protein was subsequently isolated from the yeast extract and shown to protect GS from 
oxidative inactivation by ROS in the presence of a number of thiol-containing 
compounds including dithiothreitol (DTT), mercaptoethanol, thiolglycerol, gluthione 
and dyhroliporic acid (Kim, et al., 1985). 
 
The first cDNA clone encoding a plant peroxiredoxin (pBS128) was reported by 
Goldmark and co-workers (Goldmark, et al., 1992). Northern hybridization methods 
using pBS128 revealed that Prx genes are expressed predominantly in parts of the plant 
which survive desiccation, such as the seed, suggesting a role for them in abiotic stress 
response (Rhee, et al., 1994).  
 
A number of functions have been proposed for Prxs including roles in the maintenance 
of seed dormancy, in growth and development, in ROS-and RNS-dependent signalling, 
in pathogen defence and in the protection of cellular organelles including the 
mitochondrial DNA against oxidative degradation (Banmeyer, et al., 2005; Dietz, et 
al., 2006; Rouhier, et al., 2004).  
 3 
A group of plants commonly known as resurrection plants posses a unique and 
effective mechanism of coping with drought stress by being desiccation tolerant (Scott, 
2000). Xerophyta viscosa (X. viscosa), a desiccation-tolerant plant, survives 
dehydration to 5% relative water content and achieves complete rehydration reaching 
full physiological activity within 3 days following rehydration (Sherwin & Farrant, 
1998). Resurrection plants can be used as model systems to gain insight into drought 
tolerance serving as potential source of genes that could provide tolerance to abiotic 
stress. An increased expression of a number of several antioxidant enzymes has been 
noted in response to drought in resurrection plants (Smirnoff, 1993). XvPrx2, a novel 
antioxidant enzyme, was isolated and characterized from X. viscosa (Govender, 2006; 
Mowla, et al., 2002).  
 
XvPrx2 is a 1-Cys containing peroxiredoxin shown to be present in multiple 
homologues in X. viscosa (Govender, 2006). XvPrx2 was identified as one of the genes 
up-regulated during desiccation periods of X. viscosa. Previous studies have shown that 
XvPrx2 protects nucleic acids and other cellular proteins from oxidative damage 
through the scavenging of ROS suggesting a role for it in the tolerance of desiccation 
by X. viscosa (Govender, 2006). 
 
XvPrx2 is a potential candidate for the transformation of maize which experiences loss 
of about 70 % of maximum achievable crop yields in comparison to optimal crop 
yields (Neumann, 1995) as a result of dessication. Thus efforts to improve the drought 
tolerance of maize achievable by transforming it with stress response genes such as 
XvPrx2 will require a full understanding of the structural properties and function of this 
gene and how this contributes to the regulation of ROS and RNS during desiccation. 
 4 
This project is aimed at understanding the structural and functional properties of 
XvPrx2 and in particular how its structural property is affected by ROS and other 
factors such as pH. 
1.2 Catalytic cycle of peroxiredoxins 
All Prxs have in common a catalytic cycle that uses a conserved active site cysteine 
(Cp) to reduce peroxides. The catalytic cycle of Prxs involves three chemical steps: (1) 
peroxidation, in which the peroxide is reduced (ROOH→ROH) with corresponding 
oxidation of the catalytic thiol (Prx-SP- → Prx-SP-OH), (2) resolution, in which another 
thiol (SR-) attacks the sulphenic (SOH) group, forming a disulphide Prx-SP-SR-R’, and 
(3) recycling, in which the disulphide is reduced by another thiol (R”-SH), 
regenerating both SP and SR (Prx-SPH and R’-SRH). The resolving thiol forms part of a 
cysteine which either forms part of the same Prx molecule, which is then called a 2-
Cys Prx, or an independent molecule, in which case the Prx is known as a 1-Cys Prx. 
Resolution of 2-Cys Prx’s may take place by the formation of head-to-tail homodimers 
(typical 2-Cys) or by conformational changes within a single molecule bringing the CP 
and CR into proximity (atypical 2-Cys). Step 1 occurs whilst the protein is in the fully 
folded (FF) conformation while steps 2 and 3 lead to a change in protein conformation 
from FF to locally unfolded (LU) and back to FF (FF→LU→FF) (Hall, et al., 2011; 
Noguera-Mazon, et al., 2006a). A schematic representation of the catalytic reaction of 
Prx is shown in Fig 1.1. 
 
Step 1 
Peroxidation is a nucleophilic bimolecular substitution reaction (SN2 reaction) whereby  
 
 5 
 
 
 
 
Fig 1.1: Prx catalytic cycle. The catalytic cycle of Prx involves three main chemical steps including (1) 
peroxidation, (2) resolution, and (3) recycling. Prx undergoes two distinct conformational changes 
during the catalytic cycle: FF (fully folded, active-site intact) and LU (locally unfolded, disulfide 
between the CP and the CR). The formation of disulphide bonds in step 2 requires that a local unfolding 
event occur following which a local refolding event needs to occur to reform the peroxide-binding active 
site following disulphide reduction in step 3. Inactivation of sensitive eukaryotic 2-Cys Prxs allows for 
temporary build up of H2O2, which plays signalling function. The inactivated form can be rescued 
through an ATP-dependent reaction catalyzed by sulfiredoxin (Srx) (step 5). Prxs have a 1-Cys or 2-Cys 
reaction mechanism. For the 1-Cys Prx, the resolving cysteine comes either from a small molecule or 
another protein while for the 2-Cys the resolving cysteine comes from within the protein (the same 
subunit or a different sub-unit). The generic Prx is represented as a monomer, with SP designating the 
sulfur atom of the CP while the CR (from R” with SR designates the sulfur atom). Different proteins, 
including Trx and AhpF, have been identified as R” in step 3. The figure was taken from (Hall, et al., 
2011). 
 
 
 6 
 
a nucleophile (SP-O-) attacks an electrophile (ROBOAH) resulting in the formation of 
SpOAH (a nucleophile-electrophile bonded product) and displacement of one of the 
peroxide’s oxygen atoms (OB), following the breaking of the bond between OA and OB. 
The formation of a new bond between the nucleophile and one of the substrate’s 
oxygen atoms (SpOAH) results in products such as alcohol (or water) and nitrate (Hall, 
et al., 2010).  
 
In addition to the conserved cysteine (CP) the active site contains a trio of conserved 
residues: proline, threonine (occasionally serine) and arginine (Fig 1.2). Three of the 
four conserved residues are found close together in the sequence in the configuration 
PXXXTXXCP, which is known as the CP loop (Fig 1.3). The conserved arginine occurs 
later in the amino acid sequence but is in close proximity to the CP loop in the folded 
structure (Fig 1.2). A fifth conserved residue, which is most frequently glutamic acid, 
glutamine or histidine, occurs 3 or 4 residues after CP and is positioned close to the 
conserved arginine in the folded structure (Fig 1.2). 
 
The active site environment of the CP contributes to the lowering of the pKa of the CP, 
from 8.5 in solution thiols to somewhere in the range of 5 - 6 (Nelson, et al., 2008; 
Ogusucu, et al., 2007). However calculations have shown that lowering of the pKa of 
CP only accounts for 106-fold rate increase in the reactivity of Prxs (Hall, et al., 2010).  
The rest of the activity comes from interactions within the active site of the protein, 
which enables the stabilization and activation of the transition state of substrates (see 
Section 1.5). 
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Fig 1.2: Prx active site hydrogen-bonding interactions. Thick broken lines represent the hydrogen-
bonding interactions by active site residues of Prx. A number of hydrogen-bonding interactions stabilize 
the CP, allowing it to activate and react with substrates. The image was generated from the structure of 
Peroxiredoxin from Populus tremula (PDB 1TP9) and has been visualized using the PYMOL Molecular 
Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.3: Sequence alignment of representative members of Prx subfamilies. N-terminal extensions 
can be seen for the Tpx subfamily while C-terminal extensions are seen for the Prx1 and Prx6 
subfamilies. A number of insertions appear in a subfamily-specific manner at different locations within 
the alignment. These insertions have implication for the structural features of individual subfamilies 
(Section 1.5). Residues of the CP-loop motif and the conserved arginine that are involved in extensive 
hydrogen-bonding interactions within the active site of Prxs (Fig 1.2) have been indicated. The 
alignment was created using MUSCLE (Edgar, 2004). 
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    XvPrx2 PSFIEKAEELKAKGVDEFLVISVNDPFVMKAWSKTYPE--------NKHVKFLAD--GSGKYTQALGVELDLSEKGL--G   124
AaTPx KKFNEIMAGM--EGVD-VTVVSMDLPFAQKRFCESFN---------IQNVTVASD--FRYRDMEKYGVLIGEGALKG---   130
 BsTPx RR N EAAKL---GDVNVYTISADLPFAQARWCGANG-------- ID VETLSDH RDMSFGEAFGVYIKE R----  125
 SpTPx RR N ELAGL---DNTVVLTVSMDLPFAQKRWCGAEG-------- LDNAIMLSDY FDHSFGRDYALLINEWH----  123
Mt hpE1 DQLRDHLPEFENDDSA-ALAISVGPPPTHKIWATQS--------- GFTFPLLSDFWPHGAVSQAYGVFNEQA ----  1 2
MtAhpE2 DQLRDHLPEFENDDSA-ALAISVGPPPTHKIWATQS--------- GFTFPLLSDFWPHGAVSQAYGVFNEQAG-  1 9
HsPrxII IA SNRAEDFRKLGCE-VLGVSVDSQFTHLAWINTPRKEGGLG-- P NIPLLAD--VTRRLSEDYGV KTD G-  12
 RnPrx IAFS RAEEFKKLNCQ-VIGASVDSHFSHLAWINTPKKQGGLG-- PMNIPLVSD--PKRTIAQDYGVLKADEG-  124
 HpAhpC IAFDKRVKDFHEKGFN-VIGVSIDSEQVHFAWKNTPVEKGGIG-- QVSFPMVAD--ITKSISRDYDVL E A--  120
 Pv2Cys LDKALDAFHERNVE-LLGCSVDSKYTHLAWKKTPLAKGGIG-- NIKHTL SD- ITKSISKDYNVLFDDS--  139
PyTp I LDKALDSFKERNVE-LLGCSVDSKFTHLAWKKTPLSQGGIG-- NIKHTLISD- IS SIARSYDVLFNES--  135
 ApT x VS AR YEDFQRLGVD-LIGLSVDSVFSHIKWKEWIERHIGV--- RIPFPIIAD- PQGTVAR LGLLHA S T 12
y1 AE G MHEDFLKLNCK-LIGFSCNSKESHDKWIEDIKYYGKLN-- KWEIPIVCD- ESRELAN LKIMDEQEKDITGLP 125
Hs rxVI1 GRAA LAPEFAKRNVK-LIALSIDSVEDHLAWSKDINAYNSEEPTEKLPFPIIDD- RNRELAILLGMLDPA KDEKGMP 128
ruler ........90.......100.......110.......120.......130.......140.......150.......160
              *   ..     :                                                                 
    PtPrxD TRSRRFALLVDDLKVKAANIEGG---GEFTVSSAEDILKDL---------------------------------------   162
    XvPrx2 LRSRRFAILVDDLKVKVANVEEG---GAFTISGADEILKAV---------------------------------------   162
AaTPx ILARAVFIIDKEGKVAYVQLVPE-ITEEPNYDEVVNKVKELI--------------------------------------   171
 BsTPx LLA SVFVLDENGKVVYAEYVSE-ATNHPNYEKPIEAAKALVK--  167
 SpTPx LA AVFVLDTDNTIRYVEYVDN-INSEPNFEAAIAAAKAL----  163
Mt hpE1 AN GTFVVDRSGIIRFAEMKQ---PGE-VRDQRL---------- W  144
MtAhpE2 IAN GTFVVDRSGIIRFAEMKQ---PGE-VRDQRL---------- W  151
HsPrxII IAY GLFIIDGKGVLRQITVNDL-PVGR-SVDEALRLVQAFQYTDEH GEVCPAGWKP GSDTI  182
 RnPrx SF LFIIDDKGILRQITINDL-PVGR-SVDEILRLVQAFQFTDKH GEVCPAGWKP GSDTI  18
 HpAhpC L AFLIDKNMKVRHAVINDL-PLGR-NADEMLRMVDALLHFEEH GEVCPAGWRKGDKGM  180
    Pv2Cys VSLRAFVLIDMNGIVQHLLVNNL-AIGR-SVDEILRIIDAIQHHEKY-GDVCPANWQKGKVSM-----------------   199
    PyTpxI VALRAFVLIDKQGVVQHLLVNNL-ALGR-SVDEILRLIDALQHHEKY-GDVCPANWQK----GKESM-------------   195
     ApTpx HTVRGVFIVDARGVIRTMLYYPM-ELGR-LVDEILRIVKALKLGDSL-KRAVPADWPNNEIIGEGLIVPPPTTEDQARAR   199
    Py1Cys LTCRCLFFISPEKKIKATVLYPA-TTGR-NAHEILRVLKSLQLTYTT-PVATPVNWNE----GDKCCVIPTLQDDEISKH   198
  HsPrxVI1 VTARVVFVFGPDKKLKLSILYPA-TTGR-NFDEILRVVISLQLTAEK-RVATPVDWKD----GDSVMVLPTIPEEEAKKL   201
     ruler .......170.......180.......190.......200.......210.......220.......230.......240
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Step 2 
Resolution occurs when the resolving thiol (SRH), present within the protein (2-Cys 
mechanism) or from an external source (1-Cys mechanism), attacks the sulphenic acid 
group (SpOH) to release a water molecule and form a disulphide (Prx-Sp-SR-R’). Prior 
to the attack on the SpOH group by the SRH, the SpOH group is in a FF protected active 
site with the result that there is a need to expose this group, a requirement that is met 
by conformational changes that involves unfolding of the active site to the locally 
unfolded (LU) conformation (FF→ LU) (see Fig 1.1) (Hall, et al., 2011). Both states 
(the FF and LU) are thought to exist in a dynamic equilibrium following oxidation 
until the protein becomes locked in a LU state, following the formation of the 
disulphide bridge (Hall, et al., 2011). 
 
Step 3 
Recycling occurs when the disulphide is reduced by a thiol-containing protein or small 
molecule regenerating the free thiols SpH and SRH. A number of thiol-containing 
proteins or small molecules including glutathione, thioredoxins, glutaredoxins, 
cyclophilins, NADPH-dependent thioredoxin reductase C and ascorbate have been 
found to fulfill this role (Rhee, et al., 2005). The reduction of the disulphide allows the 
FF active site to refold preparing the Prx for another round of catalysis. 
 
The resolving step is in competition with additional peroxide substrates which further 
oxidize the sulphenic acid intermediate to higher oxidation states sulfinic acid (SpO2H) 
and or sulphonic (SpO3H), often called “over-oxidation”. Over-oxidation is widely 
reported to be resistant to resolution and recycling, leading to the inactivation of the 
enzyme. The structure of the CP of Plasmodium falciparium Prx and two other Prxs 
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revealed that the geometry of the active site plays a role in determining the state of 
oxidation of the SpH. Sarma and co-workers showed that once oxidized oxygen atoms 
attached to the Cp can occupy three possible sites (Oδ1, Oδ2 and Oδ3) and that the state 
of oxidation is dependent on which of the positions is occupied by the attached oxygen 
(Sarma, et al., 2005). The authors suggest that the SpOH intermediate is formed when 
the peroxide substrate binds to the active site pocket in such a way that one of its 
oxygen atoms occupies the Oδ1 position whereas the SpO2H intermediate is formed 
when the attached oxygen atom occupies positions Oδ1 and Oδ2, while the SpO3H 
intermediate is formed when the attached oxygen atom occupies positions Oδ2 and Oδ3. 
Following the occupation of the Oδ1 site the binding of further peroxide substrate 
requires that the attached oxygen be rotated out of this and into the next site. The 
formation of the over-oxidised Prx states (SpO2H and SpO3H) is therefore dependent 
not only on the thermodynamics of the unfolding of the active site but also the ease 
with which the structure can accommodate oxygen atoms into the Oδ2 and Oδ3 positions 
(Sarma, et al., 2005). 
 
Although over-oxidation leads to inactivation of the enzyme, it appears that in some 
eukaryotes build-up of over-oxidised Prxs may serve a signalling function, alerting the 
cells to high levels of reactive oxygen species. Biteau and co-workers have identified 
sulfiredoxin (Srx) as able to reduce doubly oxidised peroxiredoxins (Biteau, et al., 
2003). Although the activity of Srx has only been reported for some of the Prx 
subgroups, it has been suggested that in instances where Srx is functional the rate at 
which the Prxs become hyperoxidised far exceeds the rate of reduction of its sulfinic 
acid forms (Biteau, et al., 2003). 
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1.3 Tertiary structure of Prxs 
The core structure of peroxiredoxins consists of a seven-stranded β-sheet (β2-β1-β5-β4-
β3-β6-β7) surrounded by five helices (α1 to α5) (Echalier, et al., 2005). The β-sheet is 
twisted in such a way that a central sheet made up of strands β5-β4-β3-β6-β7 is covered 
on one face by β1, β2, α1 and α4 and on the opposite face by helices α2, α3 and α5 (Fig 
1.4) (Hall, et al., 2011). The α1 helix is a 310-helix in approximately half of the 
elucidated structures while the length of the α5 varies from 2 to 5 turns in different sub-
family members, although it starts in the same position across all the sub-family (Hall, 
et al., 2011). Additional secondary structural elements such as insertions within the N- 
or C-termini or between loops of the protein occur in a sub-family specific manner (see 
Section 1.5 for details).  
 
The α2-helix contains the conserved active site cysteine residue CP; in the words of 
Hall and co-workers helix α2 is packed as a “baby lying in a cradle” relative to the rest 
of the structure where the bed of the cradle is formed by strands β3 and β4 and the 
walls by α3 and α5 (Fig 1.4A) (Hall, et al., 2009b). The α2-helix has been implicated in 
catalysis as local unfolding of the helix takes place during the catalytic cycle of the 
protein. The cradle that is formed around α2 has been recognized to be important for 
stabilizing the fully folded and locally unfolded conformations of the protein and in 
facilitating a switch between the two conformations (Hall, et al., 2011). 
 
The FF conformation is required for productive binding of Prxs to substrates and is 
characterized by a number of features such as a fully folded active site pocket and Cp-
loop. The Cp is found in the first turn of the conserved α2 helix, while the resolving 
cysteine CR may be buried as far away as 12 to 14 Å from the Cp in the FF  
 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.4: Core secondary structural elements of Prxs. (A) Shows the conserved core structure 
displayed such that the arrangement of the β-strands (2-1-5-4-3-6-7) and α helices (1 and 4) is visible. 
Rotation of the image (A) by 180 degrees around the y-axis such that helix α2 appears in the words of 
Hall and co-workers  “like a baby placed in cradle” with the sides of the cradle are formed by α5 and α3 
and the base by β3 and β4 (Hall, et al., 2011) as shown in (B). The Cp (displayed in sticks, yellow) is 
located within the first turn of the α2 helix. The figure was generated based on the structure of ScnTPx 
(PDB entry 2A4V) and has been visualized using the PYMOL Molecular Graphics System (2003) 
Delano Scientific, San Carlos, CA, USA. 
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conformation. The active site pocket contains a conserved catalytic CP residue at the 
base of the pocket as well as three other residues: arginine, proline and threonine 
(replaced by serine in a few instances). The Cp-loop is a contiguous segment of 
conserved sequence motif (PXXXTXXCp) containing three of the conserved residues 
found in the loop preceding the α2-helix and shown to undergo conformational changes 
during the catalytic cycle (Wood, et al., 2002). The FF structures show little variation 
within the Cp-loop conformation (Hall, et al., 2010).  
 
The locally unfolded conformation is characterized by the unfolding of the first turn of 
the α2-helix and the Cp-loop allowing the Cp to move out of the protected site and 
becoming exposed and close to the SRH so as to form a disulphide bridge. Prxs which 
react with the 2-Cys mechanism also experience the unfolding of the C-terminal end 
which allows the resolving cysteine to move closer in the exposed CP to form 
disulphide with it (Wood, et al., 2003b).  
 
The role of active site residues in the reactivity of Prxs 
The roles of the active site residues in the reactivity of Prxs have recently been 
characterized based on insights gleaned from enzyme-complex structures. Specific 
hydrogen bonding interactions between some backbone and side chain residues within 
the active site as well as some residues of the Cp-loop, α2-helix and main chain 
backbone have been recognized to stabilize and activate not only the Cp but also the 
transition state of the substrate. H2O2-bound Prx structures show that the H2O2 
molecule is well positioned in the active site to allow for a peroxidatic in-line SN2 
displacement reaction (Hall, et al., 2010). In SN2 displacement reactions, the 
nucleophile is expected to be within the length of a hydrogen bond away and 
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positioned about 180 degrees in the direction of the center of the electrophile. The 
presence of a partially formed bond at approximately 3.4 Å between the Cp 
(nucleophile) and OA (electrophilic center) as well as the positioning of the Cp at about 
172 degrees from the OA contributes to the formation of the transition state (Fig 1.5). 
In addition to the positioning of the Cp, specific hydrogen bonding interactions 
involving residues of the active site play a role in the stabilising the transition state 
complex (Fig 1.5). For example, the active site proline residue shields the Cp from 
unwanted reactions while positioning the following two residues for hydrogen 
bonding. The threonine positions and activates the OA atom of the peroxide while the 
arginine positions and activates the OA atom and the Cp (Fig 1.5). The conserved 
arginine is stabilized by further interactions involving either a glutamine, glutamic acid 
or histidine residue, which is one turn away from the Cp with additional interactions 
occurring with backbone carbonyl groups in the β7-α5 loop (Hall, et al., 2010) (Fig 1.5 
and 1.2 ). 
1.4 Quaternary structures of Prxs 
Prxs structures have been reported to exist in a number of oligomeric states including 
monomers, dimers and decamers (Echalier, et al., 2005; Hall, et al., 2009b). The 
presence of higher order oligomeric states suggests that the monomer units interact 
with each other in an organized manner.  
 
1.4.1 Prx-Prx structural interfaces  
Two types of dimer interfaces have been recognized in Prxs referred to as the B-type 
(parallel) and A-type (perpendicular) (Sarma, et al., 2005). The B-type interface is 
formed through the interaction of the β-sheets of the respective monomer units along  
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Fig 1.5: Interactions in the Prx active site Michaelis complex. The diagram shows the schematic 
drawing of the peroxide bound active site with emphasis on hydrogen-bonding interactions. The in-line 
geometry for SP allowing it to attack OA for the peroxidatic SN2 reaction (bold broken line) and key 
hydrogen-bonding interactions (pale broken, dotted, and continuous lines have been indicated. This 
diagram complements the image shown in Fig 1.2. Backbone atoms in the CP-loop are identified by their 
sequence position relative to CP based on the Cp-loop motif (PXXXTXXCp) (Fig 1.2). The negative 
charge on the CP-thiolate has been indicated. The image has been directly taken from Hall, et al., 2010. 
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strand β7 (numbering based on the conserved secondary structural elements), resulting 
in a 10-stranded β-sheets (β5-β4-β3-β6-β7-β7-β6-β3-β4-β5) (Fig 1.6). The 2-fold axis of 
symmetry is oriented perpendicularly to the 10-stranded sheet, passing through (β7-β7) 
interface. B-type dimers are considered to be strong and stable and not prone to 
dissociation possibly due to extensive interaction of C-terminal extensions across the 
two fold axis of the respective monomer units (Hall, et al., 2011). All Prxs which 
display B-type dimer interacting interfaces also show A type dimer interfaces, where 
the A-type interface is involved in the interaction of dimers (dimer-dimer interface), 
which results in the formation of higher ordered oligomers of four, five or six dimers 
(Fig 1.7) (Echalier, et al., 2005).  
 
The A-type (perpendicular dimer) interfaces result from the interaction of equivalent 
parts of the protein in four different regions including region 1 (β3-α2), region II (β4-
α3), region III (β5-α4) and region IV (α4-β8) (Fig 1.8) (Echalier, et al., 2005). The 
central β-sheet of each monomer is perpendicular to the interface unlike in the B-type 
where it is parallel to the interface (Fig 1.7) (Dietz, 2011). The A-type interface is 
prone to dissociation possibly due to the absence of C-terminal extensions, which 
provide stability in B-type interfaces (Echalier, et al., 2005). The dissociation of the A-
type interface has been reported for some Prxs resulting in the transition of the 
oligomeric states from higher ordered oligomers to dimers or dimers to monomers 
suggesting that the A-type interface plays a role in the formation of higher ordered 
oligomeric state of some Prxs (Echalier, et al., 2005; Noguera-Mazon, et al., 2006b). 
Poole and co-workers have shown furthermore that the catalytic activity of Prxs is 
reduced when they transition from decamers to dimers on the basis that the decamer  
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Fig 1.6: Cartoon representation of the B-type dimer interface. The B-type interface has been 
displayed such that the C-terminus of the structure is visible in (A) while the N-terminus is visible in 
(B). The 2-fold axis is represented by a dot. Both images were generated based on the structure of 
RnPrx1 (PDB entry 1QQ2) and the figure has been visualized using the PYMOL Molecular Graphics 
System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.7: B-type and A-type dimer interfaces displayed in a higher order Prx oligomers. The B-type 
interface is represented using the (II) symbol and enables two monomer units to interact while the A-
type interface is represented using ⊥ symbol and allows two B-type dimer units to interact. The figure 
was generated based on the structure of Salmonella typhimuruim AhpC (PDB entry 1N8J) and has been 
visualized using the PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, 
USA. 
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Fig 1.8: A-type dimer interface. Cartoon representation of the A-type dimer interface is shown in (A) 
while (B) and (C) show both sides of the surface representation of the A-type dimer interface. The 2-fold 
axis is represented by a dot shown in (A). The image shown in (B) and (C) have been colour coded to 
illustrate the four different interacting regions: 1 (β3-α2, red), II (β4-α3, blue), III (β5-α4, yellow) and 
IV (α4-β8, cyan) that make up the A-type interface (Echalier, et al., 2005). The figure was generated 
based on the structure of PfAOP (PDB entry 1XIY) and has been visualized using the PYMOL 
Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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contributes to the stability of the folded conformation of the active site (Parsonage, et 
al., 2005). 
1.4.2 Factors affecting the quaternary structure of Prxs 
A range of factors including the oxidation state of the catalytic cysteine (Cp) (Wood, et 
al., 2002), ionic strength (Chauhan & Mande, 2001), low pH (Kristensen, et al., 1999), 
high magnesium or calcium concentrations (Plishker, et al., 1992), reduction of redox 
active disulphide center (Schröder, et al., 2000) and over oxidation of the peroxidatic 
cysteine (Wood, et al., 2002), have been reported to play a role in the stability of the 
quaternary structures of Prxs.  
 
1.4.2.1 Oxidation and quaternary structure Prxs 
The state of oxidation of Prxs has been reported to lead to changes to their quaternary 
structures (Barranco-Medina, et al., 2009). Prx structures containing A-and B-type 
dimer interfaces (Prx1) appear as decamers in the FF conformation and as dimers in 
the LU conformation (Wood, et al., 2002). The first turn of the α2-helix containing the 
Cp unwinds following the formation of disulphide bridges (LU), shifting the residues 
preceding the Cp forward resulting in the disruption of the perpendicular interface and 
the dissociation of the decamer into dimers (Wood, et al., 2002). It was further 
observed that the quaternary structure of the protein was a decamer when overly-
oxidised although the decamer associated with the overly-oxidised form is poorly 
recycled by reducing agents like thioredoxins while the dimeric form display low 
peroxidase activity (Wood, et al., 2002).  
 
The decamer to dimer transition on oxidation has been noted particularly for the Prx1 
subfamily. However in a recent study Cao and co-workers showed that the reduced and 
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oxidised forms of a Prx1 subfamily member existed as decamers despite the fact that 
the Cp-loop adopted the LU conformation following oxidation (Cao, et al., 2011). In 
this example the increased stability of the decamer in the oxidised form appeared to be 
a consequence of the replacement of proline at position 260 with phenylalanine (Cao, 
et al., 2011).  
 
Members of the Prx5 subfamily of peroxiredoxins have been reported to occur as non-
covalent homodimers (Echalier, et al., 2005; Evrard, et al., 2004; Trivelli, et al., 
2003a). Kim and co-workers showed using analytical ultracentrifugation, light 
scattering and size exclusion experiments that the oligomerization state of human Prx5 
is independent of its redox state (Kim, et al., 2003). The oxidised and reduced forms of 
human Prx5 eluted at the same volume in size exclusion analysis, although the 
oxidised form of the protein did display features such as the unfolding of the α2-helix, 
consistent with structural changes observed for the LU conformation.  
 
A change in the oligomeric state of a Prx5 member has been reported following 
glutathionylation. Glutathionylation is a reversable covalent modification of protein 
cysteine thiols through the formation of mixed disulphides between the oxidised form 
of the protein and glutathione, a tri-peptide consisting of glycine, cysteine and glutamic 
acid. Cellular levels of glutathione are raised under elevated stress and glutathione 
plays an important role in preventing protein cysteine thiols from undergoing 
irreversible oxidation (Gallogly & Mieyal, 2007). Reversible glutathionylation 
modulates the activities of diverse protein substrates in situ, with effects on multiple 
physiological events (Gallogly & Mieyal, 2007).  
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Glutathionylation can occur either directly as observed for the 1-Cys “D” type Prxs 
(Prx5) or indirectly as in the case of the 1-Cys “B” type Prxs (Prx6 subfamily) 
(Manevich, et al., 2004; Noguera-Mazon, et al., 2006b). In indirect glutathionylation, 
the GSH is not able to access the CP of the oxidised protein. However this barrier is 
broken following the formation of a heterodimeric complex between the oxidised 
protein and πGST. It appears that both in the case of direct and indirect 
glutathionylation the protein needs be oxidised prior to the attachment of glutathione. 
Whilst glutathionylation strictly refers to the attachment of the GSH molecule to 
proteins, the prior requirement that the protein be first oxidised has resulted in some 
researchers referring to glutathionylation as a redox reaction.  
 
Noguera-Mazon and co-workers showed that the glutathionylation of Prx from 
Populus tremula led to unfolding of the α2-helix, leading to the disruption of the dimer 
interface and the dissociation of the non-covalent homodimer to monomers (Noguera-
Mazon, et al., 2006b). They demonstrated furthermore that glutathionylation can be 
reversed by addition of DTT at 10-fold excess oxidised glutathione (GSSG) to protein 
concentration. However, at 20-fold excess GSSG the DTT dependent reversal was 
incomplete suggesting that the dimer-monomer transition was based on non-covalent 
interactions between GSSG and the protein.  
 
The transition of the Prx5 subfamily (dimer to monomer) observed following 
glutathionylation has been likened to the decamer to dimer switch in the Prx1 proteins 
(Noguera-Mazon, et al., 2006b).  
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1.4.2.2 The effect of pH on the oligomeric state of Prxs 
A role for pH in determining the oligomeric state of Prxs was suggested through the 
study of calpromotin, a Prx1 subfamily member. Using gel filtration analysis over a 
range of pH from 5 to 8.5 Kristensen and co-workers showed that calpromotin was 
present as a large aggregate of about 300 kDa at pH 5.4 and a dimer of about 50 kDa at 
pH 8.53 (Kristensen, et al., 1999). This result led the authors to propose that an 
ionisable group (not identified) that titrates between pH 7 and 8 was responsible for the 
effect. This represents the only report suggesting a role for pH in the oligomeric state 
of the Prxs. However, the effect of pH on the oligomeric state of Prxs has not been 
rigorously investigated. A role for pH in the oligomeric state of XvPrx2 has been 
examined in this thesis and the findings presented in Chapter 4 of this work. 
1.5 Classification of Prxs 
Prxs have been classified into six distinct groups named Prx1, Prx6, Prx5, TPx, BCP 
and AhpE based on the structural alignment of conserved residues found within the 
vicinity of the active site as well as other residues found within a distance of 10Å to 
key conserved residues (Hofmann, et al., 2002; Nelson, et al., 2011; Noguera-Mazon, 
et al., 2006a; Trivelli, et al., 2003b). Phylogenic analysis of Prx sequences using 
representative members from all subfamilies is shown in Fig 1.9.  
1.5.1 Prx1 subfamily 
The Prx1 subfamily, previously referred to as the “A” group, are highly expressed 
peroxiredoxins that are found in various organisms. Representative members include 
yeast TSA proteins, bacterial AhpC proteins, several plant proteins and human Prxs 
numbered I to IV (Baier & Dietz, 1997; Dietz, et al., 2002; Hofmann, et al., 2002; 
Rhee, et al., 2001; Trivelli, et al., 2003b; Wood, et al., 2002; Zhou, et al., 1997). 
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Fig 1.9: Family tree of representative members from all Prx subfamilies. The tree shows that Prxs 
can be classified into six subfamilies (Prx1, Prx6, AhpE, BCP, Prx5 and Tpx). XvPrx2 (the sequence of 
this study, boxed in red) falls into the Prx5 subfamily and is closest with Prx-pop (Populus tremula Prx, 
PDB entry 1TP9). The tree was visualized using TreeView X (Page, 1996). 
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In addition to their roles as anti-oxidants, other roles including signalling and 
chaperone activity have been proposed for the Prx1 subfamily of peroxiredoxins (Hall, 
et al., 2009a). Hall and co-workers have reported that proteins of the Prx1 subfamily 
can assume signalling roles through disulphide exchanges with other down-stream 
sensor proteins, following exposure to high concentrations of H2O2. They also noted 
that the exposure of members of the Prx1 subfamily to high concentrations of H2O2 
results in the formation of higher ordered oligomers that have chaperoning activity. In 
both instances the exposure of members of the Prx1 subfamily to high concentrations 
of H2O2 results in their temporarily inactivation enabling a local build up of H2O2 
which ensures that peroxides serve a signalling role (Hall, et al., 2009a).  
 
A number of structures of Prx1 members have been determined either in the FF or LU 
conformations (Fig 1.10). Comparison with the conserved common-core structure 
reveals the presence of two additional secondary structural elements in the form of 
helices α4 and α7 (Fig 1.11). Prx1 structures contain a longer loop between helices α6 
and α7, as well as a 40 - 50 amino acid extension in the C-terminus following α7 (Figs. 
1.9 and 1.11). Members of the Prx1 subfamily are 2-Cys Peroxiredoxins. The Cp of 
Prx1 is located in the first turn of α2-helix in the FF conformational while the resolving 
cysteine (CR) is located at the C-terminus of the protein, in a conserved position with 
reference to the primary representative structure of this sub-family of proteins (Hall, et 
al., 2011). 
 
The CR is buried within the C-terminal extension at approximately 14 Å away from the 
Cp in the FF conformation. Poole and co-workers have reported that the Cp-loop forms 
a helix (α2), positioning the peroxidatic cysteine (CP) in the active site in  
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Fig 1.10: Core secondary structural elements of representative Prx1 structure. (A) FF Prx1 
structure showing the presence of the Cp (displayed as sticks, yellow) within the first turn of α2-helix 
while the CR is located in a loop between helices α7 and α8. The image was generated based on the 
structure of RnPrx1 (PDB entry 2Z9S). (B) LU Prx1 structure showing an exposed Cp (displayed as 
sticks, yellow) following the unfolding of the α2-helix and the C-terminus of the protein. The CR 
(displayed as sticks, brown) is located in a loop after α6. A close contact can be seen between the Cp and 
CR after the unfolding event, which allows the two residues to be disulphide bonded and thereby locking 
the structure in the LU conformation. The red dot indicates the position of the dimer interface and the 
dimer involves β-strand 7 from both monomer units. The image was generated based on the structure of 
RnPrx1 (PDB entry 1QQ2). The figure has been visualized using the PYMOL Molecular Graphics 
System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.11: Overlay of Prx1 and the conserved Prx core structure. The overlay shows that Prx1 (red) 
has an extended C-terminal end, which gives rise to α7 helix (Prx1 numbering). An additional α4 helix 
(Prx1 numbering) is present in the structure of Prx1 but not in the conserved Prx core structure (green). 
The C-terminal extension is consistent with sequence alignment shown in Fig 1.4, suggesting a sequence 
to structural relation with implications for function. The conserved core structure of Prxs was generated 
based on the structure of SnTPx (PDB entry 2A4V) while the structure of Prx1 (red) was based on the 
structure of HsPrx1 (PDB entry 3HY2). The figure has been visualized using the PYMOL Molecular 
Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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the reduced state. Peroxide decomposition results in the oxidation of the CP to 
sulphenic acid resulting in the burying of the sulphur by the sulphenic acid oxygen 
(Wood, et al., 2003b). A local unfolding event occurs at the active site resulting in the 
conversion of the Cp-loop into a solvent-exposed loop and thereby exposing the 
sulphenic sulphur for disulphide bond formation. Disulphide bond formation requires 
the C-terminal end of the protein to undergo unfolding resulting in positioning of the 
CP and CR at a distance that will allow disulphide bond to be formed between the CP 
and CR. This change results in the dissociation of the oligomeric state of the Prx1 from 
decamer to dimers (Wood, et al., 2003b). The regeneration of the protein requires the 
presence of a reducing agent that can break the disulphide bonds and restore the fold of 
the Cp-loop. 
 
Structures of Prx1 members have revealed that they dimerise along a B-type interface 
(Fig 1.12), with the C-terminal extension reaching across the dimer and making 
extensive contacts with the other subunit (Hall, et al., 2011). Higher order oligomeric 
states of B-type homodimers interacting through the inter-dimer A-type ⊥ interfaces 
occur in the Prx1 subfamily (Section 1.4.1, Fig 1.7). A link between the oxidation and 
the oligomerization state has been reported in which the protein is a decamer when Cp 
is in the SpH, SpOH, SpO2H or SpO3H oxidative states and as a dimer when Cp is 
disulphide bonded with the CR (LU) (Wood, et al., 2003b). 
 
The decamer to dimer transition occurs in part due to the unfolding of the Cp-loop, 
which disrupts the A-type interface. The decamer to dimer dissociation in turn affects 
the catalytic activity of the Prx1 subfamily because the decamer contributes to the 
stability of the folded conformation of the active site (Parsonage, et al., 2005). 
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Fig 1.12: Cartoon representation of the B-type dimer interface. The B-type interface has been 
displayed such that the C-terminus of the structure is visible in (A) while the N-terminus is visible in 
(B). The 2-fold axis is represented by a dot. Both images were generated based on the structure of 
RnPrx1 (PDB entry 1QQ2) and the figure has been visualized using the PYMOL Molecular Graphics 
System (2003) Delano Scientific, San Carlos, CA, USA. 
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The Prx1 subfamily can be further divided into two groups based on the robustness or 
sensitivity of the proteins to over-oxidation by peroxides (Wood, et al., 2003a). 
Members sensitive to over-oxidation contain a YF-motif in the C-terminal extension, 
which packs against the CP-loop stabilising the α2-helix and blocking access to the CP. 
This prevents formation of the disulphide bridge between the Cp and CR, creating the 
opportunity for further oxidation of the SpOH side chain to higher oxidation states 
(Wood, et al., 2003a). Over-oxidised forms of Prx1 can no longer be regenerated by 
the normal catalytic mechanism (Section 1.2 Fig 1.2). However special repair enzymes 
known as sulfiredoxins (Srx) act in conjunction with ATP, Mg2+ and a thiol-containing 
reductant to regenerate the sulphenic acid forms of Prx1 to active Prx (Jonsson & 
Lowther, 2007). 
1.5.2 Prx6 subfamily 
The Prx6 subfamily was previously referred to as the “B”, the “1-Cys” or the ORF6 
group. The name is taken from human PrxVI, which was the first structure from the 
family to be elucidated (Choi, et al., 1998). Prx6 have been found in all kingdoms of 
life (Baier & Dietz, 1997; Dietz, et al., 2002; Hofmann, et al., 2002; Noguera-Mazon, 
et al., 2006b; Rhee, et al., 2001; Stacy, et al., 1999; Trivelli, et al., 2003b; Wood, et 
al., 2002; Zhou, et al., 1997). Prx6 is predominantly made up of 1-Cys peroxiredoxins, 
although a number of 2-Cys Prxs have also been reported (Barranco-Medina, et al., 
2009; Hall, et al., 2011). Reactivating reducing agents identified for recycling of Prx6 
members include glutathione S-transferase, thioredoxin and ascorbate (Manevich, et 
al., 2004; Monteiro, et al., 2007; Pedrajas, et al., 2000; Ralat, et al., 2005). 
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Prx6 members form homodimers in solution, associating across a B-type interface. 
(Section.1.4.1). Each monomer is composed of two domains: a large N-terminal 
domain containing a thioredoxin-fold similar to the core Prx structure and a smaller C-
terminal domain (Fig 1.13). The N-terminal domains dimerise through the anti-parallel 
interaction of their β9-strands, stabilized by folding of the C-terminal domain of one 
monomer over the N-terminal domain of another monomer (Fig 1.14). It has been 
proposed that the C-terminal domain binds in the vicinity of the active site and 
contributes to substrate specificity by narrowing the entrance of the active site 
(Echalier, et al., 2005).  
 
A hallmark of Prx6 family is the C-terminal domain which, unlike in the case of the 
Prx1 family, is structured, incorporating up to 4 β-strands (β10, β11, β12, β13) and an α 
helix (α6). Prx6 members also contain an insertion comprising β-strands β6 and β7. An 
overlay of a representative Prx6 structure and the core Prx structure is shown in Fig 
1.15. 
 
Prx6 peroxiredoxins have been reported in a number of oligomeric states, including 
monomers, dimers and tetramers (Bystrova, et al., 2007; Choi, et al., 1998; Smeets, et 
al., 2008). However, unlike Prx1, Prx6 subfamily members do not appear to form 
decamers. This is due to the presence of the loop between α4 and β6 (Fig 1.16), which 
disrupts the A-type interface responsible for higher order associations in the Prx1 
member proteins. The inability of Prx6 to form higher order structures (teroid-shaped- 
decamer) suggests that they will not have chaperone activity but more likely serve as 
peroxidases. 
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Fig 1.13: Cartoon representation of secondary structural elements of Prx6. A representative FF 
Prx6 structure with the Cp (represented as sticks, yellow) shown within the first turn of the α2 helix. The 
diagram shows that Prx6 has 13 β-strands and 6α-helices (Prx6 numbering). The diagram was generated 
based on the structure of AmPRDX6 (PDB entry 2V2G) and the figure has been visualized using the 
PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.14: Cartoon representation of the B-type dimer interface of Prx6. The B-type interface has 
been displayed such that the C-terminus of the structure is visible in (A) and the N-terminus in (B). The 
2-fold axis is represented by a dot. Both images were generated based on the structure of AmPRDX6 
(PDB entry 2V2G) and the figure has been visualized using the PYMOL Molecular Graphics System 
(2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.15: Overlay of core Prx, Prx1 and Prx6 structures. (A) Shows overlay of Prx core structure 
(PDB entry 2A4V, green) and Prx6 structure (PDB entry 2V2G, red) while (B) shows overlay of Prx1 
(PDB entry 3HY2, blue) and Prx6 (PDB entry 2V2G, red). (A) shows that Prx6 has C-terminal 
extension which gives rise to a number of secondary structural elements including β-strand (β10, β11, β12, 
β13) and helix α6. Prx6 incorporates a β-hairpin (β6 and β7) which is not present in the core Prx structure 
while both Prx1 and Prx6 have C-terminal extensions as shown in (B). The figure has been visualized 
using the PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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1.5.3 TPx subfamily 
The TPx subfamily (previously referred to as the “E” group) are predominantly found 
in Gram-positive and Gram-negative eubacteria (Baier & Dietz, 1997; Dietz, et al., 
2002; Hofmann, et al., 2002; Noguera-Mazon, et al., 2006b; Rhee, et al., 2001; Stacy, 
et al., 1999; Trivelli, et al., 2003b; Wood, et al., 2002; Zhou, et al., 1997). TPxs are 
cytoplasmic proteins released during osmotic shock that serve as main agents for the 
removal of hydrogen peroxides resulting from oxidative stress in bacteria (Tao, 2008). 
Most Tpx members use the 2-Cys reaction mechanism with the CR positioned within its 
α3 helix (Fig 1.17) although a small number of 1-Cys Tpx’s have been reported (Hall, 
et al., 2011).  
 
 
The representative FF structure of Tpx peroxiredoxins contains 6 α-helices and 9 β-
strands (Fig 1.17). Tpxs contain an extended N-terminus incorporating a β-hairpin 
comprised of β-strands β1 and β2, which appears to play a role in substrate specificity 
(Hall, et al., 2011). Compared to the common-core structure of peroxiredoxins, an 
extra α helix (α5), which folds toward the N-terminus, is present in Tpx structures (Fig 
1.18). Tpxs form homodimers across an A-type interface although its dimer interface 
does not dissociate with a change in oxidative state (Baker & Poole, 2003). Analysis of 
representative Tpx structures both in the FF and LU states reveal that the reaction cycle 
requires the unfolding of the N and C-terminus of the α2-helix. It appears the unfolding 
of the N-terminal end of the α2-helix results in changes in the packing interaction of the 
α2 and α3, leading to the destabilization of the C-terminal end of α3, allowing the 
exposed Cp and CR (now in close proximity) to form disulphide bridges between the 
SPOH and SRH (Fig 1.19A). The change in conformation of Tpxs from FF to LU 
during their reaction cycle results in massive structural changes especially at the α2 and  
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Fig 1.16: Overlay of regions corresponding to α4 and β6 of Prx1 and Prx6 structures. The image 
shows the presence of two β-strands in the loop between α4 and β6 in Prx6 but not Prx1 (PDB entry 
3HY2, red). Prx1 contains A-type dimer interface through which it forms higher ordered structures 
(teroid-shaped decamer). The loop between α4 and β6 is one of the sites used to form the A-type 
interacting interface (Smeets, et al., 2008). The loop between α4 and β6 of Prx6 (PDB entry 2V2G, blue) 
contains two β-strand insertions which crowd out this region ensuring that it is not available for the 
formation of the A-type dimer interface (Smeets, et al., 2008). All Prx6 have been classified as B-type 
dimers and although some Prx6 structures have been shown to be tetramers, the interaction that allows 
for higher oligomers to form is not based on the A-type interface. The figure has been visualized using 
PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.17: Cartoon representation of structural elements of Tpx. The diagram shows that Tpxs have 6 
α-helices and 9 β-strands. The Cp (displayed as sticks, yellow) is found within the first turn of α2-helix 
while the CR (displayed as sticks, brown) is located within α3 helix with Cp and CR separated by a 
distance of 15 Å (Choi, et al., 2003). The image was generated based on the structure of MtTpx (PDB 
entry 1Y25) and the figure has been visualized using PYMOL Molecular Graphics System (2003) 
Delano Scientific, San Carlos, CA, USA. 
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Fig 1.18: Overlay of the common core Prx structure with Tpx. The image shows that Tpxs (red) have 
an extended N-terminal end which gives rise to three additional secondary structural elements including 
2 β-strands (a β-hairpin consisting of β-strands 1 and 2 (Tpx numbering) and an α helix (α5) compared 
to the conserved common-core structure (green) of Prxs. The N-terminus β-hairpin of Tpxs are involved 
in the formation of a hydrophobic collar that likely tailors substrate specificity to alkyl peroxidases 
(Hall, et al., 2011). The image was generated based on structures of MtTpx (PDB entry 1Y25, red) and 
the conserved core Prxs structure was generated based on PDB entry 2A4V (green). The figure has been 
visualized using the PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, 
USA. 
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α3 helices (Fig 1.19B). 
1.5.4 AhpE  
The AhpE subfamily are homologues of AhpC from Mycobacterium tuberculosis and 
closely related bacteria (Cole & Barrell, 1998; Li, et al., 2005; Soito, et al., 2010). 
AhpE shares approximately 34 and 25 % sequence identity with AhpC and BCP 
respectively (Hall, et al., 2011; Li, et al., 2005). There is no conserved CR, on the basis 
of which AhpE is classified as a 1-Cys peroxiredoxin. As yet no physiologically 
relevant reductant has been identified (Soito, et al., 2010).  
 
Structures of AhpE members have been determined in reduced and oxidised states (Li, 
et al., 2005) and they crystallize as homodimers with A-type interfaces (Fig 1.20). 
Each of the monomers consists of nine 9 β-strands and 5 α-helices (Fig 1.20). Size 
exclusion chromatography suggests that MtAhpE may form octamers in solution (Li, et 
al., 2005). A unique feature of AhpE is an extended N-terminal loop parallel to strand 
β9 (Fig 1.20A) that makes hydrogen-bonding interactions with it and ensures that β9 
cannot participate in a B-type interface of the kind seen in Prx1 and Prx6 (Li, et al., 
2005).  The C-terminal end of AhpE lacks a C-terminal extension like those found in 
Prx1 and Prx6 subfamilies. AhpE includes a β-hairpin insertion comprising of strands 
β6 and β7 between helix α4 and strand β6 and a longer loop between β7 and α5 as 
compared to the core Prx structure (Hall, et al., 2011) (Fig 1.21). 
 
Comparison of the oxidised and reduced forms of the AhpE structures reveals that in 
the sulphenic acid state (SpOH) the arginine and threonine, which together stabilize the 
thiolate Cp, swing away allowing the loop between β7 and α5 to shift in position, 
resulting in opening up of the active site (Li, et al., 2005). 
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Fig 1.19: Cartoon representation of Tpx structure. (A) Shows the structure of TPX in fully folded 
(FF) conformation while (B) shows an overlay of FF (red) and the LU (blue) TPx. The FF Tpx structure 
shows that the catalytic cysteine (Cp) (green sticks) is located within the 1st turn of helix α2 but become 
exposed in the LU conformation (yellow sticks) due to unfolding of the N terminus of α2 helix. The CR 
is located in helix α3 in the FF conformation (cyan sticks) but becomes exposed in the LU conformation 
(pink sticks). The Cp and CR become aligned and come into close proximity to form a disulphide bond 
and lock the structure in the LU conformation following structural changes associated from the 
unfolding of the N and C termini of α2 and α3 helices respectively. The FF Tpx structure was generated 
based on the structure of MtTpx (PDB entry 1Y25) while the LU Tpx structure was generated based on 
the structure of MtTpx (PDB entry 1XVQ). The figure has been visualized using the PYMOL Molecular 
Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.20: Cartoon representation of the structure of a representative member of AhpE. The A-type 
dimer interface is shown in (A) while the monomer structure containing 5 α-helices and 9 β-strands is 
shown in (B). The Cp is found within the first turn of α2-helix and is preceded by the Cp-loop. The 
oxidation of the catalytic thiolate to SOH is accompanied re-arrangement of the loop joining β9 and helix 
α5. The image was generated based on the structure of MtAhpE (PDB entry 1XXU) and the figure has 
been visualized using the PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, 
CA, USA. 
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Fig 1.21: Overlay of the conserved core Prxs and AhpE structures. (A) Shows the overlay of both 
structures (core Prx structure has been coloured green, while AhpE structure has been coloured red) 
while an expanded view of regions between α4 and β6 and α5 and β7 (core Prx structure numbering) can 
be seen in (B1) and (B2). The region between α4 and β6 in AhpE has a β-hairpin insertion (β6 and β7, 
AhpE numbering), which is absent in the conserved core structure while the region between α5 and β7 
show an extended loop in AhpE (∞) compared to the same region in the core structure (⌘). The re-
arrangement of the extended loop between α5 and β7 is associated with the oxidation of the catalytic 
thiolate to SOH. These images where generated based on the core structure (PDB entry 2A4V, green) 
and AhpE (PDB entry 1XXU, red) respectively and have been visualized using the PYMOL Molecular 
Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
 
!
7 
!
6 
A 
B1 
B2 
!7 
"
5 
!
7 
!
6 
!
!
!
6 
"
4 
 43 
This re-arrangement of the structure is thought to represent the first stage of the 
resolution of the 1-Cys Prx. Subsequent conformational changes are expected to occur 
involving helix α2, which should expose and position the Cp for a reaction with a 
partner protein or small molecule (Hall, et al., 2011).  
1.5.5 BCP 
Bacterioferritin comigratory protein (BCP) is representative of a subfamily of Prxs 
which were previously commonly referred to as the “C” group (Hofmann, et al., 2002). 
They were originally identified largely in pathogenic bacteria but have been 
subsequently been shown to be widely distributed in fungi and plants (PrxQ) (Jeong, et 
al., 2000; Kong, et al., 2000; Rouhier, et al., 2004). BCPs are divided into two main 
groups consisting of 2-Cys and 1-Cys members respectively (D'Ambrosio, et al., 
2009). The 2-Cys group has been further divided into the PrxQα and PrxQβ members 
based on the position of the CR (Wakita, et al., 2007). Hall and co-workers have 
recently suggested that this method of classification may not suffice for all members of 
the BCP subfamily in Prxs (Hall, et al., 2011). 
 
BCP structures have been reported to exist both as monomers and dimers (A-type 
interface) (Fig 1.22) (Hall, et al., 2011) with the β-hairpin (β6 and β7) insertion 
suggested to play some role in preventing the formation of stabilising hydrogen bonds 
that can affect the oligomeric state of the protein as well in the regulation of the 
accessibility of the substrate channel (Echalier, et al., 2005). 
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Fig: 1.22: Cartoon representation of the structure of ApBCP. (A) The FF BCP structure with the Cp 
(yellow sticks) and CR (brown sticks) located on the α2-helix is shown in (A). The Cp and CR are at about 
10 Å apart in the FF conformation (D'Ambrosio, et al., 2009) while the dimeric structure (A-type 
interface) of BCP is shown in (B). Image shown in (A) was generated based on the structure of ApBCP 
(PDB entry 2CX4) and while image (B) was generated based on the structure of ApBCP (PDB entry 
2CX4). The figure has been visualized using the PYMOL Molecular Graphics System (2003) Delano 
Scientific, San Carlos, CA, USA. 
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1.5.6 Prx5 subfamily 
The Prx5 subfamily (previously referred to as the “D” group) has been identified in 
mammals, fungi, bacteria and higher plants (Dietz, 2011; Knoops, et al., 1999; Seo, et 
al., 2000; Soito, et al., 2010; Zhou, et al., 1997). It is named after the Human PRDX5, 
the first structure belonging to this subfamily to be elucidated (Declercq, et al., 2001). 
Human PRDX5 is present in a number of compartments including the mitochondria, 
peroxisomes, nucleus and cystosol (Declercq, et al., 2001; Seo, et al., 2000; Zhou, et 
al., 1997). 83 % of Prx5 proteins use the 1-Cys mechanism, but 17 % use the 2-Cys, 
with the CR located in the loop preceding helix α5. A number of agents including 
glutaredoxin and thioredoxins have been shown to function as proton donors (Hall, et 
al., 2011; Rouhier, et al., 2001; Soito, et al., 2010). 
 
Structures of a number of Prx5 members have been resolved in both the FF and the  
LU conformations. The FF human Prx5 structure is made up of 6 α-helices and 7 β-
strands (Fig 1.23A). A number of structural changes have been observed upon the 
oxidation of the human Prx5 structure including the unfolding of the N-terminus of the 
α2-helix and the swinging away of the α6 helix which leads to the exposure and 
positioning of the Cp and CR for disulphide bridge formation (Fig 1.23B). 
 
A feature of the Prx5 subfamily is the presence of an extra residue immediately after 
the Cp within its α2-helix, which results in a bulging of the C-terminal end of the α2-
helix or “α-aneurysm” (Sarma, et al., 2005). Prx5 proteins have a much shorter α5 
helix compared to the core Prx structure (Fig 1.24).  
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Fig 1.23: Cartoon representation of HsPrxV structure. (A) HsPrxV (FF) structure (PDB entry 1HD2) 
with the CP (yellow sticks) and CR (brown sticks). The CP and CR are at a distance of about 13 Å in the 
FF structure and cannot therefore form disulphide bridges (Evrard, et al., 2004) (B) LU structure of 
HsPrxV (PDB entry 1OC3 chain C) with the CP (yellow sticks) in positioned closer to each other which 
allows disulphide bridges to be formed between the CP and CR. A number of changes occur to the 
structural features of HsPrxV upon oxidation including the unfolding of the first two turns of the α2-
helix and the swinging away of the α6 helix allowing the CP and CR to be positioned near each other at a 
distance that allows disulphide bridges to be formed between these residues. The figure has been 
visualized using PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 1.24: Overlay of Populus tremula Prx5 and core Prx structure. The Prx5 structure was generated 
based on PDB entry 1TP9 (red) while the core Prx structure was generated based on PDB entry 2A4V 
(green).  The presence of a β-hairpin (β6 and β7) can be seen between α4 and β6 (core Prx structure 
numbering) in Prx5 but not in the core Prx structure. The length of helix α5 is shortened in the Prx5 
structure compared to that of the core Prx structure. The figure has been visualized using the PYMOL 
Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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Prx5 members form homodimers across an A-type interface. The active site is located 
very close to the dimer interface and each site contains parts of both monomers, in 
particular the β-hairpin β6β7, suggesting that homo-dimerisation may be essential for 
catalytic activity (Echalier, et al., 2005).  
 
The effect of oxidation on the oligomeric state of Prx5 peroxiredoxins has been 
examined by Evrard and co-workers and more recently by Noguera-Mazon and co-
workers (Evrard, et al., 2004; Noguera-Mazon, et al., 2006b). Evrard and co-workers 
reported that reduced and oxidised forms (sulphenic acid form) of human Prx5 eluted 
at the same volume in size exclusion analysis suggesting that the oligomeric state of 
Prx5 is not affected by oxidation. However the crystal structure of the oxidised protein 
showed structural changes including the unwinding of the N-terminus of the α2 helix. 
Noguera-Mazon and co-workers showed that the non-covalent homodimer of Populus 
tremula Prx is dissociated by glutathionylation of the CP. Results from NMR relaxtion 
analysis revealed that glutathionylation resulted in the complete unfolding of the α2 
helix, disrupting the interface and dissociating the homodimer into monomers 
(Noguera-Mazon, et al., 2006b).  
 
Glutathionylation followed by the rescue of the glutathionylated protein by 
glutaredoxin (Fig 1.25) has been proposed to represent the regeneration mechansim of 
the Prx5 subfamily. It is important to address the issue of the oligomeric state of 
XvPrx2 and to investigate the effect of oxidation and glutathionylation on the 
oligomeric state of XvPrx2. 
 
Based on the similarity of the decamer to dimer transition of the Prx1 subfamily and 
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Fig 1.25: Reaction mechanism for the Prx5 subfamily. The model proposes that glutathionylation 
induces the unwinding of the α2-helix resulting in the dissociation of the dimeric structure into 
monomers. The glutathionylated protein is then regenerated through its interaction with glutaradoxin. 
This figure was taken from Noguera-Mazon, et al., 2006b.  
 
 
 
 
 50 
the dimer to monomer transition of the Prx5 subfamily, we can assume that the 
monomeric form of Prx5 corresponds to the LU structure. At this present time, there 
are no reports of LU structures of the Prx5 subfamily with the 1-Cys reaction 
mechanism (Hall, et al., 2011) and we assume that this is partly due to the difficulty 
encountered in generating a stable monomeric form of the protein. pH is another factor 
which has been shown to affect the oligomeric state of Prx1 from decamer to dimer. 
Kristensen and colleagues showed that Prx1 decamers dissociated into dimers at a 
narrow range (pH 7 and 8) with the dimer observed at pH 8.53 and the decamer at pH 
5.4. There are no reports of the effect of pH on the oligomeric state of any other Prx 
subfamily. In an attempt to understand the factors that govern the interaction 
responsible for the oligomeric state of XvPrx2 we will investigate the effect of pH on 
the oligomeric state of XvPrx2.  
 
XvPrx2, the subject of this work, is a close homologue of Prx isolated from Populus 
tremula (PtPrxD). The structure of Populus tremula revealed an active site containing 
a histidine residue (H55), which is involved in hydrogen bonding network with Nη1-
Hη12 of Arg129 and with the carbonyl group of S153 (Echalier, et al., 2005). The H55 
is important as a hydrogen-bond acceptor positioning the conserved arginine in the 
active site of the Prx5 (Hall, et al., 2010). A comparison of the active sites of Prx5 and 
Prx6 revealed the presence of H39 (Prx6), which was closer to the Cp in Prx6 than the 
H55 is to the Cp in Prx5 (Choi, et al., 1998; Echalier, et al., 2005). 
 
H39 makes important interactions with Cp following the disruption of hydrogen bonds 
between the Cp and conserved arginine and upon the formation of the sulphenic acid 
group in Prx6 (Choi, et al., 1998). 
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H55 makes hydrogen-bonding interactions with the active site cysteine and arginine 
(see Fig 1.2B) and may play some role in the stability of deprotonated form of Prx5 
and contribute to the pKa of Prx5 proteins. In the later chapters of this work, we 
investigate the role of H55 in determining the pKa of the protein and the stability of the 
ionized state of the thiol group. 
1.6 Aims of the study 
XvPrx2 is a member of the Prx5 subfamily of peroxiredoxins found to be over-
expressed in Xerophyta viscosa under desiccation conditions suggesting it may play a 
role in the protection of proteins or cellular components against reactive oxygen and 
nitrogen species. Support for this was found in a previous study that revealed the 
presence of multiple homologues of XvPrx2 in X. viscosa, which were involved in ROS 
scavenging and thereby protecting nucleic acids from oxidative damage by ROS 
(Govender, 2006). No structure of XvPrx2 is available, although a structure of the 
closely related Prx from Populus tremula (PtPrxD) has been determined by X-ray 
crystallography. This structure and associated studies showed that PtPrxD forms non-
covalent homodimers across the A-type interface. Noguera-Mazon and co-workers 
showed that PtPrxD could form disulphide bonds with glutathione, and that this 
process led to unfolding of the Cp-loop and α2-helix and disruption of the homodimer. 
Noguera-Mazon and co-workers suggested furthermore that glutathionylation may play 
a physiological role in regeneration of peroxiredoxins of this subfamily and proposed a 
model for the reaction of the Prx5 subfamily (Fig 1.25) whereby Prx5 proteins undergo 
oxidation followed by glutathionylation and the glutathionylated species are rescued by 
glutaredoxin. 
 
The objectives of the study are as follows: 
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1. The structure of XvPrx2 will be determined using X-ray crystallography. This 
requires that milligram quantities of XvPrx2 be produced and purified to homogeneity. 
The fragment coding for peroxiredoxin will be amplified using Polymerase Chain 
Reaction and cloned into the pGEX-6P-2 expression plasmid for expression in E. coli. 
Purification will be achieved by glutathione affinity chromatography using the GST tag 
after which GST will be removed using 3C protease.  
 
2. The oligomeric state of XvPrx2 will be investigated using size exclusion 
chromatography (SEC), nuclear magnetic resonance spectroscopy (NMR) and mass 
spectrometry, to confirm that it forms a non-covalent homodimer like PtPrxD. 15N-
HSQC NMR spectra of both the monomeric and homodimer states will be assigned 
using triple resonance experiments on 13C- and 15N-enriched samples and used to 
determine the position of the dimerization interface.  
 
3. The effect of glutathionylation and oxidation on the structure will be investigated 
using SEC and NMR.  
 
4. The model proposed by Noguera-Mazon and co-workers for the regeneration of 
members of the Prx5 subfamily of peroxiredoxins will be tested by adding reduced 
glutathione to oxidised XvPrx2 or oxidized glutathione to reduced XvPrx2 and then 
attempting to reduce the resulting mixed disulphide either with DTT or glutaredoxin. 
 
The rest of the thesis is organized as follows:  
• Chapter 2 describes the materials and methods used in this work.  
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• Chapter 3 describes the generation of the pGEX-6P-2-XvPrx2 expression 
construct and the development of a protocol for large-scale production of 
XvPrx2 in bacteria and the purification of XvPrx2 to homogeneity.  
• Chapter 4 describes the preliminary characterization of XvPrx2 using 1D and 
15N-HSQC NMR spectra, the investigation of the effect of pH on the 
oligomeric state of XvPrx2 and the full and partial assignment of backbone and 
side chain resonances of the dimeric state respectively.  
• Chapter 5 investigates the contribution of His55 and Cys51 to the stability of 
the dimeric state of XvPrx2 as a function of pH and the effect of oxidation and 
glutathionylation of XvPrx2 on the oligomeric state of the protein.  
• Chapter 6 highlights our findings and outlines future lines of investigation. 
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Chapter 2: Materials and methods 
2.1 Bacterial strains used 
Escherichia coli (E. coli) BL21 (DE3) pLysS: F-omp T hsdSB (rB-mB-) gal dcm 
rne131 
 
MC1061 F– araD139 Δ(ara-leu)7696 galE15 galK16 Δ(lac)X74 rpsL (Strr) hsdR2 (rK–
mK+) mcrA mcrB1 
2.2 General stock solutions, buffers and media 
Ammonium Persulphate: 10 % stock solution was prepared in deionised water, 
stored at -20 °C. 
Ampicillin: 100 mg/ml stock solution was prepared in deionised H2O, sterilized by 
filtration using a 0.22 micron filter, stored at -20 °C.  
Bradford Dye Stock: 0.1 % Coomassie brilliant blue G 250, 8.5 % phosphoric acid 
and 4.75 % ethanol. The solution stored at 4 °C was diluted 5 times with deionized 
water prior to use and filtered using a 0.45 micron filter. 
Cell Lysis Buffer: 1 % Triton X-100, 50 µg/ml DNAse 1, 100 µg/ml lysozyme, 1 mM 
PMSF, 1 mM DTT, and 1 tablet of CompleteTM EDTA-free protease inhibitor cocktail 
in 50 ml of PBS. 
Coomassie Staining Solution: 0.025 % Coomassie Blue R-250, 40 % methanol and 
7 % acetic acid in 2000 ml deionised water. 
De-staining Solution: 10 % (v/v) acetic acid and 7 % (v/v) methanol. 
10X DNAse 1 Buffer: 0.5 M Tris-HCl pH 7.5, 0.1 M MnCl2, 0.5 mg/ml bovine serum 
albumin (BSA), sterilized by filtration, stored at -20 °C.  
DNAse free RNAse buffer: 0.1 M sodium acetate anhydrate, 0.1 mM EDTA, pH 4.8, 
stored at -20 °C. 
DTT: 1 M stock solution was prepared in 10 mM sodium acetate, pH 5.2, sterilized by 
filtration and stored at -20 °C. 
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ESI-MS buffer (non-denaturing): Ammonium acetate pH 5 to 8, filter sterilized 
using 0.22 micron filter, stored at room temperature. 
Ethidium Bromide: 10 mg/ml stock solution was prepared in water, and stored in the 
dark at 4 °C. 
GTE: 50 mM glucose, 50 mM Tris-HCl and 10 mM EDTA pH 8.0. 
Glutathionylation buffer: 100 mM GSSG stock solution prepared in 10 mM 
ammonium acetate pH 7, stored at 4 °C 
IPTG: A 1 M stock solution was prepared in deionised water, sterilized by filtration 
and stored at -20 °C. 
Luria agar: 10 g/l tryptone powder, 5 g/l yeast extract, 5 g/l NaCl and 14 g/l 
bacteriological agar. 
Luria broth: 10 g/l tryptone powder, 5 g/l yeast extract, and 5 g/l NaCl  
Lysis Solution:  200 mM NaOH containing 1 % SDS. 
Minimal media: 12.8 g/l Na2HPO4-7H2O, 3 g/l KH2PO4, 1 g/l NH4Cl and 0.5 g/l 
NaCl. The media was pH adjusted to 7.0 with NaOH and the solution was autoclaved. 
Immediately prior to use, the solution was supplemented with 2 ml of autoclaved 1 M 
MgSO4, 100 µl of autoclaved 1 M CaCl2 and 20 ml of filter-sterilized 20 % glucose. 
The solution was stored at room temperature. 
Neutralization solution: 3 M potassium acetate, pH 5.0. 
NMR buffer: 50 mM Sodium phosphate buffer pH 5.0, 6.0, 7.2, and 8.0 containing 20 
mM NaCl, 10 mM DTT and 1 mM NaN3. 
PBS: 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4-7H20 and 1.5 mM KH2PO4. The 
solution was pH adjusted to 7.4. 
PBS-T: PBS containing 1 % Triton X-100, stored at 4 °C. 
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Phenol: chloroform: isoamlyalcohol: 25 parts Tris-saturated 24 parts phenol and 1 
part chloroform. 
PMSF: A 10 mM stock solution was prepared in isopropanol, stored at -20 °C. 
3C protease cleavage buffer: 50 mM Tris pH 7.0 containing 150 mM NaCl, 1 mM 
DTT and 0.01 % Triton X-100. The solution was prepared fresh prior to use.  
Protein elution buffer: 10 mM reduced glutathione in 50 mM Tris pH 9.0 containing 
150 mM NaCl, 1 mM EDTA and 1 mM NaN3. 
2X SDS PAGE Sample buffer: 4 % SDS, 0.150 M Tris pH 6.8, 20 % glycerol and 
1 mg/ml Bromophenol Blue, stored at 4 °C. 
5X SDS Electrophoresis Buffer: 25 mM Tris, 25 mM glycine and 0.1 % SDS, 
pH 8.3.  
Separating buffer: 1.5 M Tris pH 8.8, stored at 4 °C. 
4X Stacking buffer: 0.5 M Tris pH 6.8, stored at 4 °C. 
10X TBE: 0.9 M Tris-HCl, 0.89 M boric acid and 25 mM EDTA, pH 8.3. The solution 
was diluted 10-fold with deionised water prior to use. 
TBS: 20 mM Tris-HCl and 150 mM NaCl, pH 7.4. 
TE: 10 mM Tris-HCl and 1 mM EDTA, pH 7.4. 
Tfb1 buffer: 30 mM potassium acetate, 50 mM MnCl2, 0.1 M KCl, 6.7 mM CaCl2 and 
15 % glycerol (v/v). 
Tbf2 buffer: 9 mM MOPS, 50 mM CaCl2, 10 mM KCl and 15 % glycerol (v/v). 
TYM broth: 20 g/l Tryptone powder, 5 g/l Yeast extract, 3.5 g/l NaCl and 2 g/l 
MgCl2. 
 
2.3 Primer design 
PCR primers were designed based on the sequence of XvPrx2, isolated from Xerophyta 
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viscosa (Baker) (accession number EU333003). The forward and reverse primers 
included BamHI and XhoI restriction sites respectively, allowing for the sub-cloning of 
the XvPrx2 insert from pGEM®-t Easy vector into the BamHI and XhoI restriction sites 
of the multiple cloning cassette of the pGEX-6P-2 vector. A TAG stop codon was 
included in the design of the reverse primer (Fig 3.1). 
2.4 PCR amplification 
Polymerase Chain Reaction (PCR) was used to amplify XvPrx2 using a template kindly 
provided by Dr Kershini Govender. The PCR reaction mix consisted of template DNA, 
1 X PCR reaction buffer, 200 µM dNTPs, 1.5 µM MgCl2, 2.5 U/50 µl Taq, and 0.4 µM 
of the forward and reverse primers respectively. PCR reactions were carried out by 
adding appropriate volumes of the reaction mix (Table 2.1) into PCR tubes followed 
by gentle flicking of tube content and brief centrifugation. PCR tubes were placed in a 
pre-heated (94 °C) thermal cycler (Gene Amp® 2700 PCR System, Applied 
Biosystems, USA) and the reaction performed using the following program: 94 ºC for 
2 minutes to denature the double stranded DNA, followed by 35 cycles each consisting 
of the following steps: 94 ºC for 30 seconds to denature the double stranded DNA, 55 
ºC for 40 seconds to anneal the double strands, 72 ºC for 45 seconds to extend the 
DNA and a final elongation step at 72 ºC for 10 minutes. The reaction products were 
analyzed on a 1 % agarose/ethidium bromide (EtBr) gel and purified using the 
QIAquick® PCR Purification kit (QIAGEN) according to the manufacturer’s 
instruction. 
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Reagents Final concentrations Volumes (µ l) 
Forward Primer 0.4 µM 8 
Reverse Primer 0.4 µM 8 
DNTPs 200 µM 8 
MgCl2 1.5 mM 6 
10 X PCR Buffer 10 X 20 
Template 20 ng 8 
Taq polymerase 2.5 u/50 µl 2 
H2O  140 
Total  200 
 
 
 
 
 
 
 
Table 2.1: Polymerase Chain Reaction (200 µl) Master Mix. All PCR reactions were carried 
out using final concentrations of reagents as shown in the Table.  
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2.5 Agarose gel electrophoresis of DNA 
DNA fragments were resolved using 1 % agarose gels. Gels were prepared by pouring 
appropriate amounts of agarose in 1 X TBE or TE, cooling to 55 - 60 ºC, adding EtBr 
to 0.5 µg/ml and allowing it to set in a gel tray. DNA samples were mixed with 
appropriate volumes of loading buffer prior to loading onto gels. Molecular weight 
markers loaded onto gels were used to estimate the size of DNA fragments. 
Electrophoresis was carried out in 1 X TBE at 10 V/cm until the dyes migrated an 
appropriate distance. DNA was visualized under UV light using a transilluminator 
operating at 254 nm. DNA to be recovered was visualized using a long wavelength 
(360 nm) to avoid damage to the DNA. 
2.6 Plasmids 
2.6.1 pGEM®-T Easy vector 
The pGEM®-t Easy vector system (Fig 2.1) (Promega) is suited for direct cloning of 
DNA fragments amplified using Taq polymerase, based on the fact that Taq 
polymerase adds an extra dATP nucleotide to the 3' end of amplicons (extendase 
activity), resulting in 3' A-overhangs at both ends of a double-stranded amplicon 
(Clark, 1988). The pGEM®-t Easy vector is supplied in a linearised form with a single 
3' T-overhang at both ends, allowing direct sticky-end cloning of PCR products. 
2.6.2 pGEX-6P-2 Expression vector system 
The pGEX gene fusion system (Amersham Pharmacia Biotech) gives high-level 
inducible expression of target proteins fused to the C-terminus of glutathione-S-
tranferase (GST) from Schistosoma japonicum and is used for expression, purification 
and detection of recombinant GST fusion protein. 
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Fig 2.1: Map of pGEM®-T Easy Vector System. T-overhangs and a number of restriction sites can be 
seen within its lacZ gene. 
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The pGEX-6P-2 expression vector (Fig 2.2) contains a tac promoter, which drives high 
levels of IPTG inducible expression of the recombinant fusion protein in E. coli. GST 
acts as an affinity tag that allows for affinity purification of recombinant fusion protein 
using glutathione sepharose (Sigma). The pGEX plasmid contains a recognition 
sequence for 3C protease from human rhinovirus, which allows for the removal of the 
GST domain following purification of recombinant fusion protein. 3C protease is also 
expressed as a GST-tagged fusion, allowing for removal of both 3C and cleaved GST 
in a second round of glutathione affinity purification. 
2.7 Cloning of PCR products into pGEM®-T Easy Vector 
PCR products were cloned into the pGEM®-T-Easy Vector System (Promega) (Fig 
2.1). Ligation reactions were set up as shown in Table 2.2 using various insert to vector 
ratios, calculated according to the formula shown in below Table 2.2. Ligation 
reactions were incubated at 4 ºC for 18 hours and products used to transform 
competent E. coli MC1061 cells which had been thawed on ice for 5 minutes. 
Transformation of the ligation products was carried out by adding 10 µl of the products 
to 100 µl of competent E. coli MC1061, followed by brief flicking of the tubes and 
incubation on ice for 25 minutes. Thereafter, the cells were heat-shocked at 42 oC for 
45 seconds followed by incubation on ice for 5 minutes following which 900 µl of pre-
warmed LB was added to the transformed cells and the cells incubated at 37 oC for 1 
hour. 50 µl of competent E. coli MC1061 cells, which had been transformed with the 
ligation products, was spread on LB agar plates containing 100 µg/ml ampicillin and 
incubated at 37 ºC for 18 hours. 
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Fig. 2.2: pGEX-6P-2 expression vector map. The map shows the Glutathione-S-transferase domain 
immediately upstream of the multiple cloning cassatte. The position of the PreScissionTM protease 
clevage site is shown between the GST domain and the multiple cloning site. 
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2.8 Screening colonies for the presence of insert using Colony PCR 
Colony PCR was carried out by suspending single colonies in 20 µl of distilled water. 
1 µl of each suspension was added to the PCR reaction to serve as template and the 
reaction carried out using the set up shown in Table (2.1), using M13 and gene specific 
primers respectively. Colonies positive for the presence of inserts were inoculated into 
LB medium containing 100 µg/ml ampicillin and incubated at 37 ºC for 18 hours. 
2.9 Isolation of Plasmid DNA  
Small scale plasmid DNA isolation was performed using the alkaline lysis method 
(Birnboim & Doly, 1979). 10 µl of a suspension of cells was inoculated into 15 ml LB 
broth containing 100 µg/ml ampicillin and incubated at 37 ºC for 18 hours. The 
overnight culture was harvested by centrifugation at 6000 x g for 10 minutes. The 
supernatant was discarded and the bacterial pellet re-suspended in 200 µl GTE. The 
mixture was incubated at room temperature for 5 minutes after which 400 µl of Lysis 
Solution was added. The mixture was gently mixed and incubated at room temperature 
for a further 5 minutes. 
 
The mixture was neutralized by the addition of 300 µl Neutralizing solution, mixed 
gently by inverting a few times and centrifuged at 10000 x g for 15 minutes. The pellet 
was discarded and the supernatant transferred into a fresh tube into which 0.7 volume 
of isopropanol was added. The mixture was incubated at -20 °C for 30 minutes to 
precipitate nucleic acids after which it was centrifuged at 10000 x g for 10 minutes. 
The resulting pellet was washed twice with 70 % ethanol, air-dried and then dissolved 
in 100 µl of 1 X TE. 100 µg/ml of RNAse was added to the plasmid and incubated in a 
water bath at 37 °C for 60 minutes. The nuclease-treated plasmid was extracted  
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Ligation Reaction Reagents Standard 
Reaction 
Positive 
Control 
Back ground 
Control 
2X Rapid Ligation Buffer, T4 DNA Ligase 5 µl 5 µl 5 µl 
pGEM®-t Easy vector (50ng/µl) 
 
1 µl 1 µl 1 µl 
PCR product 
 
X µl * - - 
Control Insert DNA 
 
- 1 µl - 
T4 DNA Ligase (3 Weiss units/µl) 
 
1 µl 1 µl 1 µl 
deionized water to a final volume of 
 
10 µl 10 µl 10 µl 
  3:1 and 1:3 PCR product: Vector molar ratio was used for ligation reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ng of Vector x Kb size of Insert 
 
Kb size of vector 
 
x insert: vector molar 
ratio 
= ng of insert 
Table 2.2: Experimental setup for cloning of PCR products into pGEM®-T Easy vector. 
The table shows generic setup of ligation reactions for pGEM®-T Easy vector-XvPrx2 inserts. 
3:1 and 1:3 PCR product: Vector molar ratios were used for optimal cloning. All ligation 
reactions were carried out at 4 oC for 18 hours. 
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with equal volumes of 25 parts phenol: 24 parts chloroform: 1 part isoamyl-alcohol. 
The tube was centrifuged at 10000 x g for 5 minutes and the upper aqueous phase 
containing the DNA recovered. 0.3 M sodium acetate was added and the mixture 
incubated at -20 °C for 30 minutes to precipitate the plasmid DNA. The precipitate was 
centrifuged at 10000 x g for 15 minutes, washed with 70 % ethanol, air-dried and re-
dissolved in 100 µl 1 X TE. 
2.10 Double digest of DNA constructs  
Double digest reactions were set up by transferring appropriate volumes of the reaction 
mix (Table 2.3) into 0.5 ml tubes followed by incubation of the mixture at 37 oC for 1 
hour. The digestion products were analyzed by electrophoresis on a 1 % 
agarose/ethidium bromide (EtBr) gel. Fragments corresponding to XvPrx2 inserts were 
purified from the gel using QIAquick® PCR Purification kit (QIAGEN), according to 
the manufacturer’s instruction. All double digest reactions were set up as shown in 
Table 2.3, using 10 units of enzyme for 1µg DNA concentrations. 
2.11 DNA Sequencing 
DNA sequencing of constructs was carried out at Inqaba Biotechnical 
Industries (Pty) Ltd. The experimentally determined sequences were compared with 
the expected sequences using the Blast2 sequence alignment tool 
(http://www.ncbi.nlm.nih.gov/BLAST/bl2seq/wblas2.cgi) (Tatusova & Madden, 
1999). Validation of base calling was performed by inspection of the raw sequencing 
trace, using the Finch TV software suite (http://www.geospiza.com/finchtv). 
Nucleotide sequences were translated to protein sequences using the ExPASy 
translation Tool (http://au.expasy.org/tools/dna.html). 
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Double Digest Reagents Reaction Volumes (µ l) 
BamHI 1 µl 
XhoI 1 µl 
DNA X µl = (1ug) 
Buffer R 1 µl 
H2O X µl H2O (to make up 
reaction volume to 10 µl) 
Total reaction volume 10 µl 
 
 
 
 
 
 
 
 
 
Table 2.3: Generic setup used for all double digest reactions. Double digest reactions carried out at 
various points differed with respect to volumes of reagents required for particular reactions. All 
digests were carried out at 4 oC for 18 hours. 
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2.12 Generation of pGEX-6P-2-XvPrx2 expression plasmid 
XvPrx2 was digested out of pGEM®-T-Easy-XvPrx2 using the flanking BamHI and 
XhoI sites and subcloned into pGEX-6P-2 using the procedure described in Section 
2.7. The resulting pGEX-6P-2-XvPrx2 construct was transformed into E. coli BL21 
(DE3) pLysS cells as described in Section 2.7. 
2.13 Expression screen of E. coli BL21 (DE3) pLysS cells transformed with 
expression construct for recombinant protein expression 
 
E. coli BL21 (DE3) pLysS cells transformed with pGEX-6P-2-XvPrx2 were plated out 
on LB plates containing 100 µg/ml ampicillin and incubated at 37 ºC for 18 hours. 
Single colonies were picked and sub-cultured in LB broth containing 100 µg/ml 
ampicillin and incubated with vigorous shaking at 37 ºC for 4 hours. 1 ml aliquots 
were transferred into two separate 15 ml tubes with 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG) added to one of the cultures (induced cells), whereas no 
IPTG was added to the other culture (un-induced cells). Both tubes were incubated for 
a further three hours at 37 ºC with vigorous shaking. 
 
Cells were harvested by centrifugation at 10000 x g for 6 minutes and the pellets re-
suspended in 100 µl of Sample Treatment Buffer. The suspension was incubated at 95 
ºC for 5 minutes, following which samples were analyzed by SDS-PAGE gel 
electrophoresis and the clone demonstrating the highest level of recombinant protein 
expression selected for large-scale expression. 
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2.14 Recombinant expression of double labelled 13C, 15N-GST-XvPrx2 fusion 
protein 
2.14.1 Expression 
Large-scale expression of GST-XvPrx2 was carried out either in LB or in minimal 
medium supplemented with 1g/ L 14NH4Cl and 2g/L 12C-glucose as the sources of 
nitrogen and carbon respectively. For 15N-enriched samples the 14NH4Cl was replaced 
with 15NH4Cl (Cambridge Isotope Laboratories, Andover MA, USA) and for 15N, 13C-
enriched samples 12C-glucose was additionally replaced with 13C-glucose (Cambridge 
Isotope Laboratories, Andover MA, USA). 
 
Large scale expression was achieved by inoculating 100 µl of culture from the highest 
expressing clone of E. coli BL21 (DE3) pLysS cells containing pGEX-6P-2-XvPrx2 
expression construct into 10 ml of LB or 100 ml of Minimal Media supplemented with 
1g/l NH4Cl and 2g/l glucose and 100 µg/ml ampicillin. Cells were incubated with 
vigorous shaking at 37 ºC for 18 hours following, which 990 ml of LB or 900 ml of 
Minimal Media containing 100 µg/ml of ampicillin was added to the primary culture 
and the cells incubated at 37 ºC until the OD600 was between 0.4 and 0.6. Expression of 
recombinant protein was induced by the addition of IPTG to a final concentration of 
1 mM and the cells incubated under gentle shaking at 25 ºC for 18 hours.  
2.14.2 Extraction  
Cells were harvested by centrifugation at 6000 x g at 4 ºC for 10 minutes and the pellets 
re-suspended in 15 ml Lysis Buffer. Cells were lysed using 3 cycles of freezing at -
80, followed by thawing at 37 ºC for 20 minutes respectively. 50 µg/ml DNase was 
added to the lysate and incubation carried out at 37 ºC for 45 minutes after which the 
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lysate was centrifuge at 10000 x g at 4 ºC for 30 minutes and clarified through a 
0.45 µm filter (OSMONICS). 
2.14.3 Affinity purification 
Affinity purification of the GST-XvPrx2 was carried out using a 20 x 1 cm Econo® 
Column packed with 10 ml glutathione-linked agarose (SIGMA® Aldrich), operated by 
gravity flow. The required amount of glutathione-linked agarose beads were suspended 
in deionised water and allowed to swell overnight at 4 °C after which the slurry was 
poured into a 20 x 1cm Econo® chromatography column (Amersham Pharmacia 
Biotech). The column was equilibrated with 5 column volumes (CVs) of equilibration 
buffer before use. 
 
Lysate from disrupted cells was loaded onto the pre-equilibrated glutathione-agarose 
column and the flow through collected. The column was then washed with 5 CV of 
Equilibration Buffer following which the fusion protein was eluted in 3 CVs of Elution 
buffer.  
2.14.4 3C Protease cleavage and recovery of XvPrx2 
Fractions containing eluted GST-XvPrx2 were pooled and placed in a dialysis 
bag (SnakeSkin, Thermo Scientific) with a molecular weight cut off of 3500 Daltons 
and dialyzed for 1 hour at 4 ºC in Cleavage Buffer. PreScission Protease 
 
3C protease was added to the protein solution and cleavage allowed to take place at 
4 ºC for 24 hours. Following cleavage, protein fractions were analyzed by SDS-PAGE 
electrophoresis for the presence of GST and XvPrx2 domains. The GST domain was 
removed by loading the cleaved protein solution back onto the glutathione agarose 
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column. The flow through, which contained XvPrx2, was subjected to further 
purification. 
2.14.5 Anion exchange chromatography 
Anion exchange chromatography was carried out using a 1.6 ml column containing 
20 HQ POROS media (Amersham Biosciences) on a BioCAD® SPRINTTM Perfusion 
Chromatography system (PerSeptive Biosystems) at a flow rate of 10 ml/minute. The 
instrument was operated using a pre-programmed sequence consisting of the following 
steps: 10 CV Equilibration Step (10 mM Tris-HCl pH 7 +10 mM NaCl), Injection of 
sample, 10 CV Wash Step (10 mM Tris-HCl pH 7.0 + 10 mM NaCl), 
15 CV gradient (10 mM Tris-HCl pH 7.0 + 0-0.5 M NaCl), 10 CV Clean 
Step (10 mM Tris-HCl pH 7.0 + 2M NaCl) and 10 CV Re-equilibration Step (10 mM 
Tris-HCl pH 7.0 + 10 mM NaCl). Eluted protein was monitored at 280 nm using an in-
line UV meter and NaCl concentration was monitored using an in-line conductivity 
meter. The presence of eluted protein was confirmed by subjecting the fractions to 
SDS-PAGE analysis. Fractions containing XvPrx2 were pooled and concentrated to 
900 µl using Amicon® Ultra centrifugal devices (Millipore) for size exclusion 
chromatography.  
2.14.6 Size exclusion chromatography  
Size exclusion chromatography was used as a final polishing step. Size exclusion 
chromatography was carried out using a 100 x 1.8 cm Econo® Column packed with 
150 ml HiPrepTM 16/100 Sephacryl S-100 High resolution gel (Amersham Pharmacia 
Biotech) on a BioCAD® SPRINTTM Perfusion Chromatography system (PerSeptive 
Biosystems). The column was equilibrated with 1.5 CV of phosphate buffer pH 7.2 
containing 20 mM NaCl, 1 mM NaN3 and 10 mM DTT, at a flow rate of 
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0.5 ml/minute. The protein sample was injected into a 1 ml injection loop using a 
Hamilton syringe and fractions collected using a Gilson® 203B fraction collector and 
eluted protein monitored using absorbance at 280 nm. Fractions were subjected to 
analysis by SDS-PAGE after which fractions containing XvPrx2 were concentrated to 
600 µl using an Amicon® Ultra Centrifugal Device (Millipore) with a molecular weight 
cut off (MWCO) of 3000 Daltons. 
2.15 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)  
Proteins samples were separated on SDS-PAGE gels according to Laemmli’s method 
(Laemmli, 1970), which utilizes a stacking gel to focus the proteins into a thin line 
before they enter the separating gel, which then separates them according to their 
molecular weight. 8 x 10 cm gels of 1.5 mm thickness were cast using Hoefer Mighty 
Small™ SE 245 Dual Gel casters (Hoefer), using 40 % premixed acrylamide: bis-
acrylamide 37.5:1 solution. 16 % separating gels were made up as follows: 3.2 ml de-
ionized H2O, 2.625 ml 1.5 M Tris pH 8.8, 4 ml 40 % premixed acrylamide: bis-
acrylamide 37.5:1, 105 µl 10 % SDS, 60 µl of 10 % ammonium persulphate (APS) and 
7.5 µl TEMED (N, N, N’, N’-tetramethylenediamine). 4 % stacking gels were prepared 
using 3.050 ml de-ionized H2O, 1.25 ml 0.5 M Tris pH 6.8, 0.75 ml 40 % premixed 
acrylamide: bis-acrylamide 37.5:1, 50 µl 10 % SDS, 25 µl of 10 % APS and 7.5 µl 
TEMED (Table 2.4).  
 
Samples were diluted with an equal amount of 1 x sample treatment buffer and boiled 
at 95 ºC for 5 minutes followed by centrifugation at 6000 x g for 30 seconds. Pre-
mixed protein molecular range marker was diluted 5 times before being subjected to 
the same treatment. Electrophoresis was carried out in 1 x SDS electrophoresis running 
buffer at an initial field strenght of 10 V/cm using a Mighty Small II Gel  
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Reagents 
 
16 % Separating gel 4 % Stacking gel 
Separating buffer 
 
2.625 ml - 
Stacking buffer 
 
- 1.25 ml 
Deionised water 3.2 ml 3.050 ml 
40  % Bis Acrylamide 37.5:1 
 
 
4.0 ml 0.75 ml 
10 % SDS 
 
105 μl 50 μl 
APS 0.05 % 
 
60 μl 25 μl 
TEMED 
 
7.5 μl 5.0 μl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.4: Composition of 16 % SDS PAGE gel 
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Electrophoresis System (Hoefer). The field strenght was adjusted to 15 V/cm when the 
 
Bromophenol blue dye reached the separating gel. Electrophoresis was stopped when 
the dye reached the bottom of the separating gel after which the gel was stained in 
Coomassie staining solution for 30 minutes and de-stained in de-staining solution for 
an appropriate length of time for visualization. 
2.16 Native Gel Electrophoresis 
Separating, stacking and polymerization solutions for native gel electrophoresis were 
prepared exactly as in the case of SDS-PAGE. SDS and reducing agents (DTT and β-
mercaptoethanol) were omitted from the sample and electrophoresis buffers. Protein 
samples were mixed with sample buffer prior to loading onto gels but were not 
subjected to heating. Electrophoresis was carried out at 2.5 V/cm and the gel tank was 
placed in an icebox to avoid over-heating. Electrophoresis was stopped when the dye 
reached the bottom of the separating gel after which the gel was stained in Coomassie 
staining solution for 30 minutes and de-stained for visualization. 
2.17 Determination of protein concentrations 
Protein concentrations were determined using two independent methods: the Bradford 
colorimetric assay method (Bradford, 1976) and absorption at 280nm. 
 
Bradford assay  
Bradford dye was diluted 5 fold immediately prior to use and filtered through a 
0.45 µM filter (OSMONICS) while incubating on ice. Serial dilutions of a 1mg/ml 
stock solution of bovine serum albumin (BSA) were prepared in NMR Buffer to give 
final concentrations ranging between 2 - 8 µg/ml, to serve as standards. Dilutions 1 in 
5000, 1 in 7500 and 1 in 10000 of the protein samples were made in NMR buffer and 
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briefly centrifuged. The Bradford dye was added to the standards and diluted protein 
samples were briefly centrifuged, transferred to cuvettes and incubated for 5 minutes at 
room temperature. 
 
The absorbance value was measured at 595 nm (A595), using a Labsystems Multiskan®- 
BIOCHROMATIC Spectrophotometer. The standard absorbance curve was 
constructed by plotting the absorbance of the BSA standards at 595 nm (A595) as a 
function of concentration in µg/ml, using Excel (Microsoft Corporation). An 
estimation of protein concentration was obtained by measuring absorbance values and 
extracting corresponding concentrations with the use of BSA standard curve. Final 
protein concentrations were calculated by multiplying the calculated values by sample 
dilution factors.   
 
Absorbance at 280 nm 
The protein sample was diluted four-fold in NMR buffer and the absorbance at 280 nm 
(A280) measured using a NanoDrop® ND-1000 Spectrophotometer (NanoDrop 
Technologies Inc.). The protein concentration C (in mM) was determined using the 
Beer Lamberts Law, A280 = εCL, where ε is the molar extinction coefficient (in units of 
mM-1 cm-1) and L=1cm is the path length. ε was estimated from the amino acid 
sequence of XvPrx2 using the Expert Protein Analysis System 
server (http://www.expasy.ch/cgi-bin/pi_tool) and found to be 13.980 mM-1 cm-1.  
2.18 Preliminary crystallization trials of XvPrx2 
A rigorous search for XvPrx2 crystallization conditions was pursued using protein 
concentrations in the range of 10-20 mg/ml. Crystallization trials were set up using the 
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hanging and sitting-drop vapour-diffusion methods at 277, 289 and 295K in 24 and 96 
well VDX plates (Hampton Research), by manual and semi automated methods 
(Mosquito 4B, Labtech). Typically, hanging drop vapour-diffusion methods required 2 
µl of protein samples, which was added onto siliconized cover slides (Hampton 
Research), followed by the addition of a pre-determined volume of precipitating 
solution depending on the intended final concentration of the protein. Cover slides 
were gently inverted over wells containing 700 µl of precipitating solutions (Reservoir 
solutions) and sealed with vacuum grease (Sigma). A total of about 1500 precipitating 
solutions, including commercial screens Crystal Screen 1 and 2, Crystal Screen Lite, 
PEG Ion Screen, Grid Screen NaCl, Grid Screen PEG 6000, JCSG Core I, II, III, IV, 
and other JCSG screens as well as home made precipitating buffers, were screened to 
identify conditions that allowed for growth of protein crystals. Conditions giving hits 
were optimized to improve the size of protein crystals by varying a number of factors 
including the pH of crystallization buffers, the ionic strength of protein buffer 
solutions, protein cncentration and temperatures under which the trials were set up. 
 
Attemps at data collection were pursued using the Rigaku RUH3R copper-rotating 
anode X-ray source operated at 40 KV, 22MA, located at University of the Western 
Cape, South Africa and the synchroton facility in Soleil, France. 
2.19 NMR spectroscopy 
Samples used to record NMR data were concentrated to 600 µl in 50 mM phosphate 
pH 7.2 or 8 and transferred to 5 ml NMR tubes (Wilmad). 10 % D2O was added to 
samples to serve as an internal reference to lock the spectrometer carrier frequency.  
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Complete triple resonance datasets were acquired using the 600 MHz Bruker 
Spectrometer (Bruker Billerica, MA) located at Institute of Genetics Molecular and 
Cellular Biology (IGBMC), Strasbourg, France and the Varian Unity Inova 600 MHz 
spectrometer in the Chemistry Department of Stellenbosch University, South Africa 
(Table 2.5). The Bruker instrument was equipped with a triple resonance cryoprobe 
whereas the Varian instrument was equipped with room temperature triple resonance 
probe. Triple resonance experiments were recorded with 128 increments in the carbon 
dimension, 64 increments in the nitrogen dimension and 4 transients per FID. Strip 
plots were generated in NMRViewJ (Johnson, 2004) and Cara (Rochus, 2004) using a 
peak list picked from the HNCO spectrum. Spectra were processed with the NMRPipe 
software package (Delaglio et al., 1995) and visualized using NMRViewJ (Johnson, 
2004) and Cara (Rochus, 2004).  
2.20 Sequential assignment of backbone resonances  
HNCA and HN(CO)CA experiments 
HNCA and HN(CO)CA spectra reviewed by (Bax & Ikura, 1991; Farmer, et al., 1992; 
Grzesiek & Bax, 1992; Kay, et al., 1990) constitute a pair of 3D NMR experiments 
commonly used for sequential backbone assignment of proteins. The magnetic transfer 
pathways of the HNCA and HN(CO)CA experiments are shown in Fig 2.3. The 
transfer of magnetization in HNCA starts with the large magnetization of the HN 
proton, following which the signal is transferred to the attached nitrogen nucleus and 
then either to the Cα nucleus of the same residue, referred to here as the “ith residue” or 
to the Cα nucleus of the preceding residue (i-1), through the CO group. The signal is 
then transferred back via the nitrogen to the HN proton for detection during t3. During 
the pseudo-evolution periods t1 and t2 the signal is amplitude modulated by the 
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precession frequencies of the Cα  and the nitrogen nuclei respectively where as during 
the real time interval t3 the signal is amplitude modulated by the HN nucleus. Fourier 
transformation with respect to t1, t2 and t3 results in a three dimensional spectrum in 
which the ω1 dimension corresponds to the 
13C chemical shifts, the ω2 dimension to the 
15N chemical shifts and the ω3 dimension to the HN chemical shifts. 
 
The HN(CO)CA spectrum, on the other hand, contains only one resonance 
corresponding to each (δHN, δN) frequency pair, corresponding to coordinates (δHN, 
δN, δCα(i -1)), since magnetic energy only flows from the H
N to the Cα(i -1) and not 
the Cα(i) (see Fig 2.3B). Since in the HNCA experiment magnetic energy flows from 
an HN to both Cα(i -1) and Cα(i) (see Fig 2.3A) and the signal is therefore modulated by 
the procession frequencies of both Cα nuclei, the resulting spectrum contains two 
resonances corresponding to each (δHN, δN) frequency pair, at coordinates (δHN, δN, 
δCα(i -1)) and (δH
N, δN, δCα(i)) respectively. 
HNCACB and HN(CO)CACB experiments 
The HNCACB and HN(CO)CACB (reviewed by (Grzesiek & Bax, 1992), constitute a 
pair of triple resonance experiments, which offer alternative information for 
establishing sequential backbone connectivity than that provided by the HN(CO)CA / 
HNCA pair. The flow of magnetic energy is shown in Fig 2.4. The resulting spectra are 
essentially the same as for the HN(CO)CA / HNCA pair except that resonances 
corresponding to the Cβ nuclei appear as (δH
N, δN, δCβ(i -1)) and (δH
N, δN, δCβ(i)) in 
the case of HNCACB and (δHN, δN, δCβ(i -1)) in the case HN(CO)CACB. In the 
HNCACB the Cβ resonances appear with opposite sign to the Cα resonances, which 
greately facilitates identification of serine and threonine resonances, for which δCB >  
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Fig 2.3: Coherence transfer pathway of HNCA and HN(CO)CA experiments for a pair of 
consecutive residues (i-1) and (i). In the HNCA experiment (A) magnetic energy is transferred from 
the Cα of both residues (i-1) and (i) to the N and H
N proton of residues (i-1) and (i). In the HN(CO)CA 
(B) magnetic energy is transferred from the Cα of residue (i-1) to the N and H
N proton of residue (i) 
through the CO group of residue (i-1). The resonance of the Cα of residue (i-1) is generally weaker in the 
HNCA compared to the Cα resonance of residue (i). Schematic strips corresponding to residue (i) are 
shown on the right hand side. 
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Fig 2.4: Coherence transfer pathways for HN(CO)CACB and HNCACB experiments for a pair of 
consecutive residues. In HN(CO)CACB depicted in (A), magnetization is transferred from the Cβ to the 
Cα of residue (i-1) to the N and HN proton of residue (i) through the CO group of residue (i-1), which is 
not observed in the spectra. In the HNCACB experiment shown in (B), magnetization is transferred from 
the Cβ and Cα of residues (i) and (i-1) to the N and HN proton of residues (i) and (i-1). In the HNCACB 
the Cβ resonances have opposite sign from the Cα resonances, indicated here by red for negative, black 
for positive. 
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δCA, compared to other residues. 
 
2.21. Sequential assignment of side chain resonances 
HCCH-TOCSY and HCCH-COSY spectra 
Side-chain carbon proton resonances were assigned using HCCH-TOCSY and HCCH-
COSY experiments. Here the transfer of magnetic energy between atoms occurs via J 
coupling. The magnetic energy is transferred between the side-chain hydrogen nuclei 
and their attached 13C nuclei following which there is an isotropic 13C mixing and a 
final transfer back to the side-chain hydrogen atoms for detection. The pathway for the 
transfer of magnetic energy in HCCH-TOCSY and HCCH-COSY experiments is 
shown in Fig 2.5. 
 
The strategy used for side chain assignment is summarized as follows: Read off the Cα 
and Cβ carbon shifts from the HN(CO)CACB and HNCACB. 
1 Display planes of the HCCH-TOCSY and HCCH-COSY spectra and insert the 
Cα and Cβ of interest into the z-dimension of the spectra. Look for peaks on the 
diagonal, which are found mostly in the expected regions based on the table 
shown in Fig 4.7B, which should have charateristic peaks displayed on the 
same line as the diagonal of peaks. Use the HCCH-TOCSY to check the spin 
system and confirm the topology using HCCH-COSY. 
2 Read off the proton shifts and note these. Change the dimensions of the panels 
such that the carbon dimension is now on the y-axis and one of the proton 
dimensions on the z-axis. Choose the range of the carbon shift to be ± 5ppm 
based on the expected shifts on Fig 4.7B and enter proton shift values obtained 
previously into the z-axis. The correct carbon shift should contain a number of  
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Fig 2.5: coherence transfer pathway in HCCH-TOCSY and HCCH-COSY experiments. 
(A) Shows the coherence transfer pathway in HCCH-TOCSY while  (B) shows the coherence 
transfer pathway in HCCH-COSY experiments respectively. The blue arrows show the 
direction of transfer of magnetic energy, which starts, from a side-chain proton (coloured red) 
to the directly attached carbon atom via the small 1J coupling (35-55 Hz) and then to the 
neighbouring carbon atoms and their attached protons. HCCH-TOCSY yields strips at each 
carbon frequency in the side chain in which all side-chain hydrogen resonances are visible. 
HCCH-COSY is a slightly less crowded version of HCCH-TOCSY but here only the hydrogen 
resonances of their own and neighbouring carbons are visible. 
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peaks based on the expected spin system and topology of the residue. The full list of 
NMR experiments performed appears in Table 2.5. 
2.22 Protein analysis by mass spectrometry 
Part of the MS data presented in this thesis was generated using the LTQ Orbitrap 
Velos instrument (Thermo Scientific) located at Stellenbosch University Health 
Faculty, Tygerberg Campus, Cape Town. The rest of the data and development of the 
method was carried out using the API Ultima Q-TOF spectrometer (Waters 
Corporation, Massachusetts, USA) at Stellenbosch University. Both instruments 
employed an electrospray ionisation source (ESI).  
 
Electrospray (ES) ionisation spectrometry was performed under both denaturing and 
non-denaturing conditions. For non-denaturing conditions, samples were injected in 40 
mM ammonium acetate. Denaturing conditions were achieved by the addition of 50 % 
HPLC-grade acetonitrile and 0.2 - 1% formic acid at a flow rate of between 5 and 100 
µl/min. Spectra scanning was done in ESI positive mode, capillary voltage 3 kV, cone 
voltage 4-60 V positive ion mode from m/z 100 to m/z 1990 or 1000 to 4000 m/z at a 
cone voltage of 35 V. Deconvolution of m/z traces was performed using MaxInt3 (API 
ultima) and ProMass Deconvolution software (Orbitrap). 
2.23 Analytical Size Exclusion Chromatography (SEC) 
Analytical SEC was carried out using a HiLoad 16/60 Superdex 75 prep grade column 
(GE Healthcare UK Limited) on an ÄKTATMFPLC system. 0.5 ml protein samples 
were applied to the system and analysis carried out at a flow rate of 0.5 ml/min. 1.5 ml 
fractions were collected and analyzed by SDS-PAGE and native PAGE 
electrophoresis. The column was calibrated by measuring the elution volumes of a  
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NMR Experiment Function of Experiment 
1D 1H homonuclear Evaluation of sample integrity and state of folding. 
15N-HSQC Evaluation of sample integrity and state of folding; 1H and 15N chemical shifts 
1H-15N NOE Characterization of folded state of backbone 
HNCO Carbonyl carbon chemical shifts 
HN(CA)CO Carbonyl carbon chemical shifts 
HN(CO)CACB Sequential assignment of backbone resonances; 13Cα and 13Cβ chemical 
shifts 
HNCACB Sequential assignment of backbone resonances; 13Cα and 13Cβ chemical 
shifts 
HNCA Sequential assignment of backbone; 13Cα chemical shifts 
HN(CO)CA Sequential assignment of backbone; 13Cα chemical shifts 
HC(C)H-TOCSY Side-chain 1H and 13C chemical shift assignments 
HC(C)H-COSY Side-chain 1H and 13C chemical shift assignments 
 
 
 
 
 
 
 
Table 2.5: List of some NMR experiments performed on XvPrx2 
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number of proteins of known molecular weight and plotting them as a function of 
log(MW) and fitting the graphs to a straight line of the form 
€ 
V = m × Log10 MW( ) + C  
where 
€ 
V  is the elution volume, from which values of constants 
€ 
m  and 
€ 
C  were 
extracted. The expression was inverted to give  which was used to 
determine the effective molecular weight of XvPrx2 corresponding to the elution 
volume V. 
2.24 Mutants 
Mutants were synthesized by Genscript (GenScript USA Inc. 860 Centennial Ave. 
Piscataway, NJ 08854 USA) by replacing histidine 55 with alanine (H55A) and 
cysteine 51 with serine (C51S) in pGEX-6P-2-XvPrx2 to create pGEX-6P-2-XvPrx2-
H55A and pGEX-6P-2-XvPrx2-C51S respectively. The expression and purification of 
the mutants was achieved using the protocol applied for the expression of the wild-type 
XvPrx2. 
2.25 Fitting of pH titrations 
Fitting of pH data was carried out using Profit (QuantumSoft, Bühlstr. 18, CH-8707 
Uetikon am See, Switzerland), using equation in Appendix II. Fitting of the wild type 
data was carried out by allowing the Ved, Vem and pKa to vary. 
2.26 Glutathionylation 
Gluathionylation was carried out by adding a 10-fold excess of oxidised glutathione 
(GSSG) to XvPrx2 in 40 mM ammonium acetate buffer, pH 7. The pH of the sample 
was adjusted back to 7 following the addition of GSSG using acetic acid. 
 
 
 
! 
MW =10
v"c( ) /m
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Chapter 3: Expression and purification of XvPrx2 
3.1 Introduction  
Structural and functional studies of protein molecules by X-ray crystallography and 
nuclear magnetic resonance spectroscopy (NMR) require the use of highly purified 
protein samples with a concentration in the range of 0.5 mM and above. Heterologous 
expression in bacteria is a cheap and rapid method for producing milligram quantities 
of proteins and additionally offers the capability of uniformly enriching with 13C and 
15N for triple resonance NMR studies. The pGEX-6P-2 expression system allows high-
level expression of heterologous proteins from a tac promoter, induced by IPTG. The 
protein is expressed as a GST fusion, allowing one-step purification using glutathione-
linked agarose beads. The GST can be conveniently removed using the 3C protease 
from rhinovirus, for which a recognition site is located in the linker region between 
GST and the multiple cloning cassette. 3C protease cleaves optimally at 4 °C, and can 
be expressed in-house fused to GST. Following cleavage the GST, uncleaved fusion 
protein and the 3C protease can be removed by a second round of glutathione affinity 
purification, leaving the target protein in the flow through. 
 
This chapter describes the generation of the pGEX-6P-XvPrx2 expression construct 
and the recombinant expression and purification of unlabelled and isotopically 
enriched XvPrx2 for structural studies. 
3.2 Generation of pGEX-6P-2-XvPrx2 expression construct 
3.2.1 PCR amplification of XvPrx2  
PCR amplification of XvPrx2 was carried out as described in Section 2.4, using primers 
designed based on the sequence of XvPrx2 (NCBI accession number EU333003), 
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isolated from Xerophyta viscosa (Baker). The primer sequences are shown in Fig 3.1. 
The forward and reverse primers included BamHI and XhoI restriction sites, 
respectively, allowing for sub-cloning of the amplicon into the BamHI and the XhoI 
sites of the pGEX-6P-2 vector. A stop codon (TAG) was included in the reverse primer 
(Fig 3.1). The result of PCR amplification of XvPrx2 is shown in Fig 3.2. Lane 2 shows 
an amplicon of approximately 516 bp, which corresponds to the expected size of 
XvPrx2. 
3.2.2 Cloning of PCR product into pGEM®-T Easy and pGEX-6P-2 vectors 
The XvPrx2 PCR amplification product was cloned into the pGEM®-t Easy vector (Fig 
2.1) as described in Section 2.7. Colony PCR was carried out to screen recombinant 
pGEM®-t Easy vector clones for the presence of the XvPrx2 insert (Fig 3.3), using gene 
specific and M13 primers. The sizes of the amplicons were consistent with the 
expected sizes of 516 bp for the gene specific primers (Lanes 3-7) and 872 bp for the 
M13 primers (Lanes 8-11). 
 
pGEM®-T Easy recombinant vector clones containing XvPrx2 inserts were transformed 
into MC1061 competent cells and spread on LB agar plates containing ampicillin (100 
µg/ml). Individual colonies were used to inoculate enriched media for small-scale 
DNA isolation as described in Section (2.9). Isolated plasmid DNA was digested with 
BamHI and XhoI restriction enzymes to release the XvPrx2 insert and separated on a 1 
% agarose gel. Fig 3.4, lane 2, shows two bands of approximately 500 bp and 3300 bp 
corresponding to XvPrx2 and parental pGEM®-t Easy vector respectively. The released 
insert was purified using a 1 % agarose/ethidium bromide (EtBr) gel using the 
QIAquick® PCR Purification kit (QIAGEN), according to the manufacturer’s 
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Fig 3.1: Primers used for PCR amplification of XvPrx2. BamHI (GGATCC) and XhoI (CTCGAG) 
restriction recognitions sites were included in the forward and reverse primers and have been highlighted 
in red and blue respectively. A stop codon (TAG) shown in bold was included in the reverse primer. 
 
 
 
 
 
 
 
-3’ 
ATGGCTCCGATCGCAGTCGGTGAAACGATCCCAGACGGAACGCTCGGATGGTTCGAC
GAGAAGGACGAGTTGAAGCAGATCTCGATCCACTCGCTCGCCGCCGGAAAGAAGATC
GTGCTCATCGGTGTCCCCGGCGCATTCACTCCTACTTGCAGTATGCAACACGTTCCA
AGTTTCATTGAGAAAGCAGAGGAGCTGAAAGCTAAGGGCGTTGATGAGTTCCTTGTT
ATTAGTGTTAATGATCCCTTCGTGATGAAGGCTTGGTCGAAAACATATCCTGAGAAC
AAGCATGTGAAGTTCCTAGCCGATGGATCGGGGAAGTACACCCAAGCTCTTGGCGTG
GAACTCGATCTGTCCGAGAAGGGGCTCGGGCTCCGTTCACGGAGGTTTGCTATCCTT
GTAGACGACTTGAAGGTTAAGGTTGCAAATGTCGAGGAGGGCGGAGCATTTACCATT
TCAGGTGCCGATGAGATCTTGAAGGCAGTCTAG 
5’- GATGCTGGATCCATGGCTCCGATCGCAGT -3’!
3’- CTAGAACTTCCGTCAGATCGAGCTCCAGAAG -5’ !
5’- 
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1  2 
396 bp 
501 bp 
1.2 kb 
XvPrx2 (516 bp) 
356 bp 
200 bp 
Fig 3.2: 1 % agarose gel electrophoresis of XvPrx2 PCR amplification product. Lane 1 
shows Mass Ruler DNA while lane 2 shows an amplicon of approximately 500 bp 
corresponding to XvPrx2 (516 bp). 
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Fig 3.3: 1% agarose gel electrophoresis of colony PCR screening of recombinant pGEM®-t Easy 
vector clones for the presence of XvPrx2 insert. Lane 1 shows Mass Ruler DNA LadderTM Mix, lanes 
3, 4, 5 and 6 show clones positive for XvPrx2 screened using M13 forward and reverse primers, while 
lanes 8, 9. 10 and 11 show clones positive for XvPrx2 inserts screened using gene specific primers. 
 
 
 
 
 
 
pGEM®-T Easy Vector-XvPrx2 
positive clones screened using 
M13 primers (lanes 3, 4, 5 and 6) 
and gene specific primers (lanes 
8, 9, 10 and 11) 
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396 bp 
501 bp 
1.2 kb 
201 bp 
356 bp 
XvPrx2 (506 bp) 
1 2 
pGEM®-T-Easy vector 
(3300 bp) 
Fig 3.4: 1 % agarose gel electrophoresis of double restriction digestion of recombinant 
pGEM®-T-Easy-XvPrx2 plasmid DNA. Lane 1 shows molecular weight marker while lane 2 
shows double restriction digestion products of pGEM®-T-Easy-XvPrx2 plasmid DNA. Lane 2 
shows two bands, a higher band at approximately 3300 bp, which corresponds to pGEM®-t-Easy 
vector, and a lower band approximately 506 bp, which corresponds to the released insert 
(XvPrx2).  
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instruction and ligated into the BamHI and XhoI sites of pGEX-6P-2 to create the 
pGEX-6P-2-XvPrx2 expression construct. 
 
Ligation products of XvPrx2 and pGEX-6P-2 were transformed into competent 
MC1061 cells (Section 2.7), plated out on LB plates containing 100 µg/ml ampicillin 
and incubated at 37 ºC for 18 hours. Colonies were screened for the presence of 
XvPrx2 inserts using colony PCR following which plasmid DNA was isolated from the 
positive clones. The plasmid DNA was subjected to double restriction digest using 
BamHI and XhoI restriction enzymes to positively confirm the presence of XvPrx2 
inserts. Fig 3.5, lane 2, shows two bands: a higher band at approximately 4900 bp, 
which corresponds to pGEX-6P-2, and a lower band approximately 502 bp in size, 
corresponding to the released insert (XvPrx2).  
3.2.3 DNA sequencing 
Five clones containing pGEX-6P-2-XvPrx2 plasmid DNA were subjected to 
sequencing by Inqaba Biotech. The clones in which the forward and reverse sequences 
matched exactly to the expected sequences (see Appendix 1) were used for 
heterologous expression of XvPrx2. 
3.3. Heterologous expression of XvPrx2 
XvPrx2 was expressed as a recombinant GST fusion protein using the pGEX-6P-2 
expression system. The expected amino acid sequence of XvPrx2 following the 
removal of GST is shown below. 
GPLGSMAPIAVGETIPDGTLGWFDEKDELKQISIHSLAAGKKIVLIGV
PGAFTPTCSMQHVPSFIEKAEELKAKGVDEFLVISVNDPFVMKAWSKT
YPENKHVKFLADGSGKYTQALGVELDLSEKGLGLRSRRFAILVDDLKV
KVANVEEGGAFTISGADEILKAV 
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Fig 3.5: 1% agarose gel electrophoresis of double restriction digestion of recombinant pGEX-
6P-2-XvPrx2 plasmid DNA.  Lane 1 shows Mass Ruler DNA LadderTM Mix while lane 2 shows 
pGEX-6P-2-XvPrx2 double digestion products. Lane 2 shows two bands, a higher band at 
approximately 4900 bp, which corresponds to pGEX-6P-2, and a lower band approximately 506 bp in 
size, corresponding to the released insert (XvPrx2).  
XvPrx2 (506 bp) 
(4bbpbp) 
300 bp 
500 bp 
1031 bp 
800 bp 
2000 bp 
1500 bp 
2500 bp 
pGEX-6P-2 ( 4900 bp) 
 
1 2 
5000 bp 
3000 bp 
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The first five residues (underlined above) represent an artifact of the expression 
system. The expected molecular weight of XvPrx2, as calculated using the ExPASy 
PROTPARAM server (http://ca.expasy.org/cgi-bin/protparam), is approximately 
17.9 kDa with an isoelectric point (pI) of 5.43 (Appendix 3). Since the molecular 
weight of GST is 26.7 kDa, the expected molecular weight of the GST-XvPrx2 fusion 
protein is approximately 45 kDa. 
 
E. coli BL21 (DE3) pLysS cells transformed with pGEX-6P-2-XvPrx2 were screened 
for expression of recombinant GST-XvPrx2 fusion protein using SDS-PAGE, as 
described in Section 2.13. Pairs of samples from induced and un-induced 1 ml cultures 
are shown in Fig 3.6. Strong expression of an approximately 45 kDa protein is visible 
in the induced lanes (2, 4, 6 and 8) but not in the un-induced lanes (3, 5, 7 and 9) 
indicating that successful expression of recombinant GST-XvPrx2 fusion protein had 
been induced.  
 
Large-scale expression of GST-XvPrx2 fusion protein was carried out as described in 
Section 2.14.1. Cell lysis, extraction and affinity purification of recombinant GST-
XvPrx2 fusion protein were carried out as described in Sections 2.14.2 and 2.14.3. A 
representative SDS-PAGE analysis of extraction and affinity purification of 
recombinant fusion protein is shown in Fig 3.7. The quantity of fusion protein eluted 
from the column, as well as the absence of significant amounts of degradation 
products, indicates that both the expression and purification were highly efficient. 
 
The fusion protein was subjected to 3C protease cleavage (Section 2.14.4) and cleaved 
protein samples were analyzed using SDS-PAGE as shown in Fig 3.8. Two bands are  
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25.0 kDa 
35. 0 kDa 
66.2 kDa 
45.0 kDa 
116.0 kDa 
14.4 kDa 
18.4 kDa 
1 2 3 4 5 6 7 8 9 
GST-XvPrx2 fusion  
protein (~ 45 kDa) 
Fig 3.6: Expression screen results of colonies transformed with pGEX-6P-2-XvPrx2. 
Lane 1 shows molecular range maker, lanes 2, 4, 6 and 8 show induced samples while lanes 
3, 5, 7 and 9 show un-induced samples. All induced samples demonstrate the presence of a 
strong band of approximately 45.0 kDa, corresponding to the expected combined size of 
GST-XvPrx2 fusion protein. 
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Fig 3.7: SDS-PAGE analysis of expression and affinity purification of GST-XvPrx2 fusion protein. 
Lane 1 shows molecular range maker, lane 2 shows total protein extract from induced cells, lane 3 
shows the flow through from glutathione affinity column, lane 4 shows the column wash and lane 5 
shows the eluted GST-fusion protein. 
 
 
 
 
 
 
 
 
 
 
Fig 3.8: 3C protease cleavage of GST-XvPrx2 fusion protein. Lane 1 shows molecular range marker, 
lane 2 shows un-cleaved GST-XvPrx2 fusion protein while lane 3 shows the fusion protein following 
cleavage. Two bands are observed in lane 3, a higher band at approximately 27 kDa which corresponds 
to GST, and a lower band approximately 18 kDa in size corresponding to XvPrx2.  
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visible, corresponding to GST (top) and XvPrx2 (bottom) respectively. No more than 
trace amounts of the original fusion protein (45 kDa) remain, indicating that cleavage 
of the GST-XvPrx2 fusion protein was completed within 24 hours. The intensities of 
the bands corresponding to GST and XvPrx2 are consistent with the relative sizes of 
both protein molecules indicating minimal loss of protein samples during cleavage of 
fusion protein. A second round of affinity purification was used to remove the 
separated GST domain. The chromatogram and associated SDS-PAGE in Fig 3.9 
show that most of the XvPrx2 was found in the flow through (peak A) and almost all 
the GST was retained on the column (peak B).  
 
An alternative method for removing trace amounts of GST following affinity 
purification of the cleaved fusion was developed involving the use of anion exchange 
chromatography (Section 2.14.5). Although the pIs of GST (5.7) and XvPrx2 (5.43) 
are close, pH scouting using a 20HQ column showed that good separation was 
achieved at pH 7 using 10 mM Tris, as shown in Fig 3.10. XvPrx2 was not retained by 
the column (with the exception of a small fraction in peak 6) whereas GST was 
retained by the column (peak 7 and 8), as confirmed by the associated SDS-PAGE in 
(B). The introduction of an additional purification step (anion exchange 
chromatography) following affinity purification therefore resulted in the removal of 
residual GST from XvPrx2 leading to significant purification of the XvPrx2 protein 
samples. 
 
Fractions containing XvPrx2 were pooled and concentrated to 900 µl using an 
Amicon® Ultra Centrifugal Device (Millipore) with a 5000 Dalton cut off. Size 
exclusion chromatography was carried out using a 100 x 1.8 cm Econo® Column 
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Fig 3.9:  Affinity purification chromatogram of cleaved GST-XvPrx2 purified over glutathione-
linked agarose column. The top left hand insert shows SDS-PAGE analysis of the cleaved GST-XvPrx2 
sample before and after glutathione-linked agarose column purification. Lane 1 shows molecular weight 
marker, lane 2 shows the cleaved sample (GST-XvPrx2) before affinity purification, lane 3 shows GST 
domain (peak B) and lane 4 shows XvPrx2 (peak A). Residual traces of the GST-XvPrx2 fusion protein 
(45 kDa) and GST domain can be seen in the flow through (peak A). The sample labelled A was 
subjected to further purification to remove traces of both the fusion protein and GST domain. 
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Fig 3.10: Removal of residual GST by anion exchange. (A) XvPrx2 sample containing small amounts 
of GST, corresponding to peak A in Fig 3.9, was applied to 20HQ anion exchange column in 10 mM 
Tris, pH 7. With the exception of a small amount in fraction 6, the majority of the XvPrx2 was found in 
the flow through whereas the GST was retained on the column. (B) SDS-PAGE analysis of fractions to 
confirm constituent proteins. 
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packed with 150 ml Sephacryl S100 gel operated using a BioCAD® SPRINTTM 
Perfusion chromatography system (PerSeptive Biosystems), as described in Section 
2.14.6. The SEC chromatogram (see Fig 3.11A) contains one major peak which SDS-
PAGE (Fig 3.11B) confirms corresponds to highly purified XvPrx2. Fractions 
containing XvPrx2 were pooled and concentrated to a final volume of 600 µl. SDS-
PAGE analysis of the concentrated XvPrx2 sample (Fig 3.12) shows no evidence of 
degradation products or contaminating protein suggesting that the sample was 
sufficiently pure and homogenous for crystallization trials or NMR analysis. 
3.4. Determination of protein concentration 
The concentration of XvPrx2 was calculated using the Bradford calometric assay and 
absorption at 280 nm as described in Section 2.17. Absorbance values for both the 
standard (BSA) and the XvPrx2 sample are presented in Table 3.1 and the 
corresponding straight-line plots are shown in Fig 3.13. Using the analysis described in 
Section 2.18; 
 
[XvPrx2(1/10000)] = 0.155/0.0433 = 3.580 µg/ml
  
 
Multiplying by the dilution factor yields the final concentration of XvPrx2: 
 
 
     [XvPrx2] = 35.80 mg/ml  
 
Since the molecular weight of XvPrx2 is 17.9 kDa, 1mM is equivalent to 17.9 mg/ml. 
Hence the final concentration is 35.80/17.9 = 2.0 mM. 
 
The protein concentration was independently determined using a NanoDrop® ND-
1000 Spectrophotometer (NanoDrop Technologies Inc.). The UV absorption spectrum 
of the sample at 5-fold dilution is shown in Fig 3.14; A280 ~ 7.4. (Note that the Nano- 
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Fig 3.11:  Size exclusion chromatogram of XvPrx2. (A) Shows the chromatogram of XvPrx2 sample 
while (B) shows SDS-PAGE analysis of the corresponding regions of the chromatogram. SEC was 
carried out to acahevie two purposes: (1) to polish XvPrx2 samples and (2) to exchange the protein 
buffer environment. The numberig of the SDS-PAGE lanes (B) corresponds to the numbering shown in 
the chromatogram (A). The SEC was carried out over a 100 x 1.8 cm Econo® column packed with 150 
ml HiPrepTM 16/100 Sephacryl S-100 High Resolution gel.  
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Fig 3.12: SDS-PAGE of concentrated XvPrx2 following size exclusion chromatography. Lane 1 
shows molecular range marker while lane 2 shows concentrated XvPrx2. The absence of additional 
bands corresponding to degradation products or contaminating proteins shows that the sample is highly 
homogenous. 
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Table 3.1: A280 readings for known concentrations of BSA and XvPrx2 at 1/5000 and 1/10000 
dilutions. Absorbance values were used to generate the standard curve shown in Fig 3.13 from which 
the unknown concentration of XvPrx2 was determined. 
 
 
 
 
 
 
 
 
 
Fig 3.13: Extraction of XvPrx2 concentration from BSA regression curve. The BSA regression 
curve was generated based on absorbance values (A595nm) obtained from known concentrations of BSA. 
Absorbance values obtained from XvPrx2 samples (diluted 1 in 5000 and 1 in 10000 times) were used to 
extract the concentration of the sample using dashed lines shown in Fig 3.13 or by substituting the 
absorbance values into the equation shown in Fig 3.13. The final concentration of XvPrx2 was obtained 
by multiplying the concentration of the diluted sample by the dilution factor and found to be 
approximately 2.0 mM. XvPrx2 concentration was sufficient to set up crystallization trials and the 
acquisition of NMR data, which typically require protein in the concentration range of 0.5 mM and 
above. 
 
 
BSA Concentration 
(ug/ml) 
Absorbance 
(595nm) 
2 0.072 
4 0.159 
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8 0.344 
10 0.440 
  
XvPrx2 Absorbance 
(595nm) 
1/5000 0.308 
1/10000 0.155 
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Fig 3.14: NanoDrop value of concentrated XvPrx2 (diluted 1 in 4). The value obtained using 
NanoDrop was 2. 067 mM, consistent with values obtained using Bradford assay. 
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Drop automatically adjusts the optical path length so that the absorbance falls within 
the linear range and then extrapolates up to a path length of 1 cm, so the high value of 
A280 is not of concern). The Beer lambert law states that 
 
     A280 = εCL, 
 
where ε is the extinction coefficient of the protein (in units of mM-1cm-1), C is the total 
concentration and L = 1 cm. Using A280 = 7.4, L = 1 cm and ε = 13.98 mM-1 cm-1, as 
determined by the ExPASy ProtParam server (http://ca.expasy.org/cgi-bin/protparam), 
C was calculated to be  approximately 2.1 mM.  
 
This value, which relies on prediction of the extinction coefficient from the amino acid 
sequence, is consistent with the value calculated using the Bradford assay, taking into 
consideration the uncertainties inherent in both methods. Since X-ray crystallization 
trials and NMR experiments both require concentrations of protein in the range of 
0.5 mM and above, we concluded that the XvPrx2 sample was of sufficient 
concentration and purity for structural studies using X-ray crystallography and NMR. 
3.5. Crystallization trials of XvPrx2 
A rigorous search for conditions suitable for crystallization was pursued using protein 
concentrations in the range of 10 - 20 mg/ml, using the hanging-drop and sitting-drop 
vapour-diffusion methods, as described in Section 2.18. Figs. 3.15-3.19 shows some 
crystals of XvPrx2 obtained using the crystallization conditions described in the 
legends on the associated figures.  
 
A number of attempts were made to record diffraction data using some of these  
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Fig 3.15: Showers of XvPrx2 micro crystals obtained in 0.1M MES pH 6.0, 25 % PEG 10000 using 
17mg/ml of protein. Crystals produced under this condition were not of sufficient size for data 
collection. 
 
 
 
 
 
 
 
 
 
 
Fig 3.16: XvPrx2 crystals obtained in in 0.1M MES pH 6.0, 25 % PEG 10000 using 11mg/ml of 
protein. Crystals produced under this condition did not produce sufficient reflections for structure 
solution using X-ray crystallography. 
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Fig 3.17: XvPrx2 crystals obtained in 0.2 M di-potassium Phosphate using 17mg/ml of protein. 
Crystals produced under this condition did not produce sufficient diffraction spots for structure solution. 
 
 
 
Fig 3.18: XvPrx2 crystals obtained in 0.1M Tris pH 6.5 containing 20 % PEG 20000 using 17 mg/ml 
of protein. Crystals produced under this condition did not produce sufficient diffraction spots for structure 
solution. 
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crystals on the in-house X-ray source located University of the Western Cape, South 
Africa and the synchrotron facility in Soleil, France. However, in all the cases the data 
showed insufficient numbers of reflections for structure calculation. 
 
Summary 
In this chapter we reported the successful amplification of XvPrx2 using PCR, 
generation of the pGEX-6P-2-XvPrx2 expression construct, expression of unlabelled, 
15N-labelled and 15N, 13C-enriched XvPrx2 samples in E. coli and their purification to 
homogeneity. The data relating to bacterial expression of XvPrx2 presented in this 
work is representative of both labelled and unlabelled protein samples. The 
concentration of the resulting sample was of the order of 2 mM. More than two 
thousand crystallization conditions were screened using manual and semi-automated 
means and, while several crystals were obtained, none of them produced sufficient 
refections for structure determination. In the next chapter we describe the biophysical 
characterization of XvPrx2 using a variety of methods as well as the backbone and side 
chain assignment of XvPrx2 using heteronuclear nuclear magnetic resonance 
spectroscopy. 
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Chapter 4: Biophysical characterisation of XvPrx2 using nuclear 
magnetic resonance spectroscopy, electrospray ionisation mass 
spectrometry and analytical size exclusion chromatography 
 
Peroxiredoxins (Prxs) have been classified into six distinct groups, namely Prx1, Prx6, 
Prx5, TPx, BCP and AhpE, based on structural alignment of conserved residues found 
within the vicinity of the active site as well as other residues found within a distance of 
10Å to key conserved residues (Section 1.5). XvPrx2 belongs to the Prx5 subfamily, 
showing closest homology to PrxD from Populus tremula (PtPrxD). PtPrxD and 
Saccharomyces cerevisiae alkylhydroperoxide reductase (Ahp1) both occur as non-
covalent homodimers, with the homodimeric interface perpendicularly aligned to the 
central β-sheet (A-type dimer, see Section 1.4.1, Fig 1.8) (Echalier, et al., 2005; 
Trivelli, et al., 2003a). The residues involved in the interaction of the interface appear 
to be conserved in all Prx5 subfamily members suggesting that all proteins of this 
subfamily homodimerize using the same interface (Echalier, et al., 2005). A functional 
role for the interface has been suggested on the basis of the fact that residues from each 
monomer are involved in forming the substrate binding pocket (Hall, et al., 2011). 
 
A number of factors including pH have been suggested to play a role in determining 
the oligomeric state of Prxs. A role for pH on the oligomeric state of Prxs has been 
reported in only one instance involving calpromotin, a Prx1 subfamily member protein 
derived from human red blood cells. Calmoprotin was observed to form large 
aggregates of about 300 kDa at pH 5.4 and a dimer of about 50 kDa at pH 8.53 
(Kristensen, et al., 1999). However, the effect of pH on the oligomeric state of Prx5 
subfamily members has not been reported.  
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A number of tools including NMR, ESI-MS and analytical SEC have been used to 
investigate the oligomeric state of Prxs (Echalier, et al., 2005; Evrard, et al., 2004; 
Noguera-Mazon, et al., 2006b; Trivelli, et al., 2003a). NMR supplies direct structural 
data on biomolecules, as well as their state of folding, the presence of intra-and 
intermolecular bonding, the size of proteins as a function of their rate of tumbling and 
the signature of proteins associated with different oligomeric states. The presence of a 
number of isoforms of a protein, which may be associated with different oligomeric 
states, can be distinguished and their signatures assigned using NMR. Modern mass 
spectrometers serve as excellent tools to investigate the oligomeric state of proteins 
and have been used to determine the molecular weight of proteins or protein complexes 
with accuracies of less than 1Da, (Loo, 1997). MS data used to observe non-covalently 
linked protein complexes needs to be recorded under non-denaturing conditions. 
Analytical SEC allows the apparent molecular weight of proteins to be estimated based 
on the elution volumes of protein standards with known molecular weight. SEC is not 
dependent on the choice of buffer and is therefore ideal for investigating the molecular 
weight of complexes or the apparent molecular weight of molecules in exchange 
between different oligomeric states. 
 
This chapter presents an investigation of the oligomeric state of XvPrx2 using NMR, 
ESI-MS and analytical SEC. Furthermore, it examines the effect of pH on the 
oligomeric state of XvPrx2 and concludes by presenting the full assignment of 
backbone resonances of XvPrx2 in the homodimeric state.  
4.1 Characterization of the folding properties of XvPrx2 using NMR 
1D proton spectrum  
The 1D proton spectrum of a protein contains sufficient information for assessing the 
 110 
state of folding of the protein (Rehm, et al., 2002). Whereas the spectrum of an 
unfolded protein is essentially the sum of the random coil spectra of each amino acid 
within the protein, the spectra of folded proteins are shifted away from random coil 
values due to the structural diversity and the presence of different microenvironments 
within the interior of the structure. The most significant differences are the result of 
shielding from ring currents arising from aromatic side chains (Rehm, et al., 2002). 
The degree of protein folding can thus be predicted on the basis of the chemical shift 
dispersion of proton signals compared to random coil values: in folded proteins 
backbone amide proton (HN) chemical resonances are found between 6.5 and 10.5 
ppm, Hα resonances between 3.2 and 5.5 ppm and methyl groups between 0.5 and -1.0 
ppm (Cavanagh, 1996). In contrast, in unfolded proteins proton chemical shifts are 
more narrowly distributed, with backbone HN resonances clustered around 8.3 ppm, 
methyl groups between 0.8 and 1.1 ppm (Wüthrich, 1986) and Hα  protons in the region 
4.1- 4.4 ppm (Cavanagh, 1996). 
 
The 1D proton spectrum of XvPrx2 (Fig 4.1) shows ample dispersion away from 
random coil values. A number of HN resonances are shifted significantly up-field into 
the range 8.5-10.5 ppm, including one observed at approximately 11.1 ppm. A number 
of methyl group resonances have been downshifted into the range < 0.8 ppm, including 
one at approximately -0.52 ppm. The identity of this resonance is reported in Section 
4.4 and the implication of its shift for the oligomeric state of XvPrx2 is examined in 
Section 5.2. 
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Fig 4.1: 1D 1H spectrum of XvPrx2 at pH 7.0, 25 °C recorded at 600 MHz. The spectrum shows 
a good dispersion of proton resonances suggestive of a folded protein. Of particular interest are the 
resonances at -0.52 ppm and > 10 ppm.  
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15N HSQC spectrum 
15N-HSQC spectra are excellent tools for assessing the state of folding and integrity of 
proteins, providing data with improved resolution and higher information content 
compared to 1D NMR experiments (Rehm, et al., 2002). The majority of resonances in 
a 15N-HSQC spectrum correspond to backbone amide groups, with the horizontal 
coordinate corresponding to the HN chemical shift and the vertical coordinate to 
chemical shift of the attached nitrogen. However other groups containing directly 
bonded to the nitrogen atoms also appear in the spectrum, including the ε-amino group 
of each arginine residue, the side chain indole group of tryptophan residues (although 
there are none in XvPrx2) and the backbone NH2 groups of arginine and asparagine 
residues. The latter appear as two peaks with the same nitrogen chemical shift and two 
different proton shifts; a number of them have been indicated using a horizontal lines 
in Fig 4.2. The Hη1 and Hη2 NH2 groups of arginine residues may sometimes be 
observed but typically are not due to broadening resulting from rapid exchange with 
the solvent. Prolines lack NH groups and are thus not observed in 15N-HSQC spectra. 
The degree of structure or disorderliness within proteins is indicated by the dispersion 
(spread) of resonances analogous to that observed in 1D NMR spectrum. Spectra of 
unfolded proteins show a characteristic clumping of resonances around HN chemical 
shifts of approximately 8.3 ppm while the spectra of folded proteins show large 
dispersions of peaks in the range 6 -12 ppm and 105 - 135 ppm in the HN and N 
dimensions respectively (Rehm, et al., 2002).  
 
The 15N-HSQC spectrum of XvPrx2 at pH 7 is shown in Fig 4.2. It shows a number 
resonances shifted significantly upfield in the 1H dimension including those at (δ15N, 
δ1H) = (132.5, 9.64), (131, 10.25), (129, 11.03), (126.9, 9.72), (120.1, 9.55), (120.5,  
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Fig 4.2: 15N-HSQC spectrum of XvPrx2 at pH 7, 25 °C, recorded at 600 MHz. The resonances are 
well dispersed in both the 1H and the 15N dimensions, which is indicative of a well folded, compact 
protein. Most of the resonances correspond to the backbone NH groups, although a number of side chain 
NH2 groups can be seen joined by the horizontal lines in the top right-hand corner. The observed number 
of resonances (167) is consistent with the expected number (169).  
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10.4). The high degree of dispersion indicates that the protein is properly folded. The 
expressed protein is expected to contain 3 asparagine and 2 glutamine residues, each of 
which has a side chain NH2 group, and 8 prolines which do not have backbone amide 
groups. Since the native protein is 162 residues long, with the inclusion of the 5 non-
native residues at the N-terminus we expect a total of 167-8+2*5 = 169 resonances, 
which is consistent with the observed number of 167. On the whole, the spectrum 
appears to be a good representation of the protein with a reasonable degree of spread of 
its resonances suggesting a compact fold under these conditions. 
4.2 Investigation of pH effect on the conformation XvPrx2 using NMR 
Changes in environmental factors of a protein such as pH and temperature can affect 
the shape and conformation of a protein, which may affect the number, dispersion and 
location of resonances in the 15N-HSQC spectrum. The pH of a protein environment 
can affect its ability to make covalent or non-covalent interactions, which are often 
responsible for holding a protein in a particular configuration. NMR studies have 
revealed pH dependent effects on a number of proteins, including the SH3 domain of 
Drosophila drk, Dynein light chain protein, a part of the cytoplasmic motor assembly 
and human thioredoxin (Andersen, et al., 1997; Mohan, et al., 2006; Zhang & Forman-
Kay, 1995). 
 
1D spectra of XvPrx2 at pH 5 and 7 are shown in Fig 4.3. At pH 7 a highly shifted peak 
can be observed at -0.52 ppm, which is not present at pH 5. 
 
Significant differences are also apparent in 15N-HSQC spectra recorded at pH 5, 6, 7 
and 8, which are shown in Fig 4.4. Two different conformations dominate at pH 5 and 
pH 8 respectively, and at pH 6 the spectrum contains approximately equal populations  
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Fig 4.3: 1D proton spectra of XvPrx2 at pH 5 and 7, recorded at 600 MHz at 25 °C. The 
degree of dispersion is consistent with folding at both pH values. However a significantly down-
field shifted resonance is visible at pH 7 (indicated with arrow) which is not present at pH 5.  
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of each conformation. This is most clearly seen in the boxed regions in which a 
doubling of peaks occurs at pH 6. The effect is presented in more detail in Fig 4.5 
where the same regions of pH 5 (blue), pH 6 (red) and pH 7 (black) are overlaid. The 
fact that both conformations are observed in the spectrum implies that the rate of 
interconversions between them is slow on the time scale of NMR. 
 
The protein was found to be substantially less stable at pH 5 than at higher pH, starting 
to precipitate during the concentration step and precipitating significantly after 12 - 24 
hours. The protein was also significantly less stable at 25 °C than at 4 °C. The poor 
stability at pH 5 significantly affected the quality of the data that could be obtained 
under these conditions and resulted in our inability to assign backbone and side chain 
resonances at pH 5. 
 
15N NMR dynamics experiments are excellent tools for investigating the effective mass 
of a protein and hence its oligomeric state. T1 and T2 values, which describes the time 
it takes for a nuclea spin to return to its equlibrium value, were measured at pH 8 
(without needing to assign the protein) and analysed by Dr Andrew Atkinson, Kings 
College London, giving a value of 27 kDa for the effective molecular weight. Since 
this value is intermediate between monomer and homodimer it raised the possibility 
that the pH-dependent effect corresponded to a monomer-dimer transformation. 
However, which spectrum corresponded to the monomer and which to the dimer, was 
not yet clear. We were unable to measure the apparent molecular weight at pH 5 due to 
the instability of the protein at this pH. Non-denaturing mass spectrometry was used to 
investigate this question further, as described in Section 4.5. 
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Fig 4.4: 15N-HSQC spectra of XvPrx2 at pH 5(A), 6(B), 7(C) and 8(D) at 25 °C, recorded at 600 
MHz. Significant differences are apparent in the 15N-HSQC spectrum recorded at pH 5, 6, 7 and 8. It is 
clear that two different conformations dominate at pH 5 and pH 8 respectively, and that the pH 6 data 
contains approximately equal populations of each conformation while the pH 7 data is very similar to 
the pH 8 data. This is most clearly seen in the boxed regions in which the doubling of peaks has 
occurred. This is shown in more detail in Fig 4.5 in which the same regions of pH 5 (blue), pH 6 (red) 
and pH 7 (black) are overlaid. The pH 7 and pH 8 spectra are almost identical. 
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Fig 4.5: Overlay of 15N-HSQC spectra of XvPrx2 at pH 5, 6 and 7, recorded at 600 MHz 
at 25 °C. (A) shows the overlay of full spectra of XvPrx2 at pH 5 (blue), pH 6 (red) and pH 7 
(black) while (B) shows an expanded view of regions marked “1” and “2” in (A). The overlay 
shows that the two different conformations present at pH 5 and 7 are both present in 
approximately equal amounts at pH 6.  
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4.3 Sequential assignment of XvPrx2 backbone resonances at pH 7.2 
As a first step towards determination of the structure of XvPrx2 at pH 8, as well as for 
interpretation of the pH dependent chemical shift changes discussed in the previous 
section, 13C, 15N-labelled samples were generated and used to record triple resonance 
spectra required for assignment of backbone chemical shifts.  
 
A number of triple resonance experiments can be interpreted as separating the 2-
dimensional 15N-HSQC spectrum into a third frequency dimension, corresponding in 
this case to the 13C dimension. The simplest example is the HNCO spectrum, in which 
the 3rd dimension corresponds to the frequency of the carbonyl carbon attached to each 
backbone NH group. Since the projection of the HNCO spectrum along the carbon 
dimension yields a spectrum identical to the 15N-HSQC (with the exception of the non-
backbone resonances), but with less overlap due to separation in the carbon dimension, 
resonances in the 15N-HSQC spectra are usually picked using the HNCO spectrum. 
The resulting peak list contains coordinates δ1H, δ15N, δ13C, of which only the δ1H and 
δ15N are used for generating strip plots.  
 
Two-dimensional H-C and N-C strip plots were set up using the NMRView software 
package. H-C strip plots were generated from HN(CO)CA and HNCA by extracting 
strips of width 2δ in the 1H dimension (where δ is a small fraction of the spectral width 
in the 1H dimension) centered on each HN resonance and extending across the full 13C 
spectral width. N-C strip plots were generated similarly.  
 
As has been described in Section 2.21, the HN(CO)CA generates only one peak 
corresponding to the preceding α-carbon Cα(i-1), whereas the HNCA generates two 
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peaks corresponding to the α-carbon of residue i (Cα(i)) in addition to Cα(i-1). 
Comparison of HNCA and HN(CO)CA side-by-side using a strip plot allows the 
connectivities of the amides to be established; a double strip plot generated by 
interlinking strips from HN(CO)CA (gold) and HNCA (blue) is shown in Fig 4.6. The 
aim is to order the pairs of strips so that the Cα(i) of one pair (in the blue strip) has the 
same chemical shift as the Cα(i-1) (in the gold strip) of the next pair to the right. A 
similar strip plot for HNCACB and HN(CO)CACB is shown in Fig 4.7 while the table 
used to cross reference resonance shifts for identification is shown in Fig 4.8.  
 
Initial attempts the assign the 15N-HSQC at pH 6 were abandoned after the doubling 
seen in Fig 4.4(B) was identified. Initial promising triple resonance spectra recorded at 
Stellenbosch at pH 8 were followed up by more careful optimization under the 
guidance of Dr Andrew Atkinson at the Institute of Genetics Molecular and Cellular 
Biology (IGBMC) in Strasbourg, France. Thermofluor-based high-throughput stability 
optimization experiments revealed that our protein remained stable at low 
concentrations of salt (20 mM) in the complete absence of EDTA and at temperatures 
as high as 40 °C, allowing us to change sample conditions and the temperature used for 
data acquisition. A temperature of 38 °C resulted in increased molecular tumbling and 
thereby reduced the width of the spectral lines, improving the resolution of triple 
resonance experiments significantly. Using these conditions a full backbone 
assignment was achieved at pH 7.2. The assigned 15N-HSQC spectrum of XvPrx2 
recorded at pH 7.2 is shown in Fig 4.9. 
 
In total we were able to assign backbone resonances of 152 of the 162 residues of 
XvPrx2 (ignoring the five artifactual residues (GPLGS) found at the N-terminus of the  
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Fig 4.6: Double strip plots showing backbone sequential connectivities of some XvPrx2 residues. 
The golden strips are taken from a HN(CO)CA spectrum while the blue strips are from the 
corresponding HNCA spectrum. The golden strips shows one peak corresponding to the Cα of the 
preceding residue i-1 while the blue strips show 2 peaks corresponding to the Cα of residue i and i-1 of 
which the peak of residue i is more intense. Peaks within the blue strip, which do not have 
corresponding equivalents in the golden strip, correspond to the Cα peak of residue i while peaks, which 
have equivalents in the golden strips correspond to the Cα of residue i-1. The red arrow shows 
connectivity of peaks during the assignment process. The red dashed line indicates magnetization 
transfer from the Cα of residue i-1 to the H-N groups of residue i, while the black non-dashed lines 
indicate the transfer of magnetic energy from the Cα resonance of the residue i to adjacent HN groups of 
residue i, thus permitting residue-specific sequential connectivity. The strips have been arranged such 
that adjacent strips contain corresponding carbon shifts. 
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Fig 4.7: Double strip plots showing backbone sequential connectivities of some XvPrx2 residues. 
Gold strips are taken from HN(CO)CACB spectrum while blue strips are from the corresponding 
HNCACB spectrum. Black arrows indicate transfer of magnetic energy from Cα or Cβ resonance to 
adjacent H-N groups of residue i, while green arrows indicate the transfer of magnetic energy from the Cα 
or Cβ resonance to adjacent HN groups of residue i-1 thus permitting the establishment of sequential 
residue connectivity. The strips have been arranged such that adjacent strips contain corresponding 
carbon shifts. 
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Fig 4.8: Chemical shifts for all 20 naturally-occurring amino acid residues. Average Cα and Cβ 
chemical shifts are shown in (A) with the aliphatic side-chain amide 1H chemical shifts in (B). Adapted 
from Cavanagh, 1996.  
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Fig 4.9: 15N-HSQC spectrum of XvPrx2 recorded at pH 7.2, 38 °C and 600 MHz. Each assigned 
peak is labelled with a numbering system in which the residues are counted from the initiation 
methionine. The initiation methionine is the 6th residue of the protein when the N-terminal sequence 
(GPLGS), which are artifacts of the cloning system, is considered (Section 3.3). The numbering system 
used in this Fig. differs by six when compared to those shown in Appendix IV. Labels beginning with # 
symbol (blue) are unassigned. 
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protein). The residues we were unable to assign were Met1, Ser52, Met53, Gln54, 
His55, Val56, Glu119 and Lys120, either because their corresponding resonances were 
not observable, most probably due to local chemical exchange, or due to poor 
connectivity to other residues. The HN, N, Cα and Cβ chemical shifts of all the assigned 
atoms were extracted from the spectra using NMRView and are tabulated in Appendix 
IV.  
 
Only after assignment had been completed was it confirmed that XvPrx2 is 
homodimeric at pH 7.2, giving it an effective molecular weight of 38 kDa. This places 
the protein near the upper limit of feasibility for backbone assignment using standard 
(non-TROSY) and non-deuterated triple techniques. Despite attempts at both pH 7.2 
and 8 we were unable to assign enough side chain resonances for determination of the 
structure of the wild type protein. However we were able to assign the resonance at δH 
= -0.52 ppm that is present at pH 8 but not at pH 5. The procedure for doing that is 
reported in the remainder of this section and the structural implication of the presence 
or absence of the resonance at -0.52 ppm is discussed in chapter 5. 
 
A 2D homonuclear TOCSY spectrum is a 2-dimensional spectrum in which cross-
peaks between positions on the diagonal correspond to transfer of magnetic energy 
through covalent bonds between the protons corresponding to diagonal positions. The 
horizontal and vertical axes both correspond to proton chemical shifts. Energy transfer 
occurs among all protons in an amino acid, but cannot cross the peptide bond from one 
amino acid to another, making the experiments ideal for identifying protons belonging 
to a particular amino acid  (colloquially referred to as a “spin system”). 
 
 126 
The 3D HC(C)H-TOCSY is a 3-dimensional version of the homonuclear TOCSY in 
which the over-crowded and overlapping cross-peaks have been separated into the 3rd 
dimension according to the chemical shifts of carbon attached to one of the diagonal 
protons. Since the un-bracketed “C” in “HC(C)H” refers to the vertical proton 
dimension, the nomenclature makes it clear that the cross peaks will be labelled (and 
hence positioned in the 3rd dimension) according to the chemical shift of the carbon 
directly bonded to the proton on the vertical axis (proton 2 in Fig 4.10A). 
Consequently, a 2D-plane corresponding to a particular carbon chemical shift will 
contain only the cross-peaks (appearing in the form of a horizontal line) in which the 
proton directly attached to the carbon in question lies on the diagonal (see Fig 
4.10(C)). Identical patterns are expected at carbon chemical shifts corresponding to 
each of the protons in the amino acid, allowing the chemical shifts of each carbon and 
each proton to be systematically determined. 
 
The HC(C)H-COSY is essentially the same as the HC(C)H-TOCSY, with the 
exception that magnetic energy is only transferred between protons joined by up to 3 
covalent bonds. In the case of amino acids this means either H-C-C-H or H-C-H. As 
well as being less crowded and of increased sensitivity, the HC(C)H-COSY is useful in 
establishing covalent topology that is not clear from the HC(C)H-TOCSY. 
 
The procedure for assigning side chains of protons is illustrated here for the case of 
Ile41. Fig 4.11 shows sections of 2-D planes from the HC(C)H-COSY spectrum 
corresponding to the Cα, Cβ, Cγ1, Cγ2 and Cδ1 carbons of Ile41. A diagram of the 
topology of isoleucine is shown in Fig 4.11 (B). Since this is a COSY spectrum, the Cα 
plane contains only the Hα and Hβ, with Hα on the diagonal. The Cβ plane however,  
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Fig 4.10: Proton cross peaks in a 2-proton, 2D-TOCSY and HC(C)H-TOCSY spin system. (A) 
Shows cross peaks between proton 1 and 2 in a 2-proton system. (B) 2D-TOCSY of a typical 4 - proton 
amino acid residue is shown in (B) while (C) shows a plane of HC(C)H-TOCSY spectrum single 
resonance, do not appear because the Cδ1 is not directly coupled to the Cβ. The Cγ2 plane contains only Hβ 
and the Hγ2 methyl resonance on the diagonal, again as expcted, since the Cγ2 is connected only to the Cβ 
.corresponding to the chemical shift of the carbon directly attached to proton 2. 
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contains Hα, the Hγ2 methyl and the Hγ11 and Hγ12 methylenes, as well as Hβ on the 
diagonal. This is because Cγ2, Cγ1 and Cα are all directly connected to Cβ. However the 
Hδ1 methyl protons, which (as with all methyl groups in protein NMR) appear as a 
single resonance, do not appear because the Cδ1 is not directly coupled to the Cβ. The 
Cγ2 plane contains only Hβ and the Hγ2 methyl resonance on the diagonal, again as 
expcted, since the Cγ2 is connected only to the Cβ . 
 
The Cγ1 plane contains two rows of identical cross-peaks, one in which Hγ11 is on the 
diagonal and one in which Hγ12 is on the diagonal. Both sets contain Hβ and Hδ1 as well 
as a cross peak between the two Hγ1 protons. The Cδ1 plane contains Hγ21 and Hγ22 with 
Hδ1 on the diagonal. 
 
The same information is contained in the HC(C)H-TOCSY spectrum in Fig 4.12, 
although the spectral quality is poorer. However the conclusion to be drawn from Figs. 
4.11 and 4.12 is that the carbon chemical shifts of the planes (shown at the right) 
unambiguously identify the amino acid giving rise to the resonances as Ile 41. The 
structural significance of this result will be discussed in Chapter 5.  
4.5. Investigation of pH-dependent oligomerisation of XvPrx2 using ESI-MS 
NMR analysis revealed a significant pH-dependent effect consistent with large 
conformational changes or changes of oligomeric state. It had been previously reported 
that a number of factors, including pH, play a role in the change of the oligomeric state 
of the Prx1 subfamily proteins from dimer to decamer or vice versa (Kristensen, et al., 
1999). However, there are no reports of pH dependent effects on the oligomeric state  
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Fig 4.11: Selected planes of the HC(C)H-COSY spectrum of XvPrx2 at pH 7.2. (A) Planes 
correspond to the chemical shifts of carbon atoms of Ile 41. The same proton resonances occur in each 
plane, filtered by the three-bond rule appropriate to COSY spectra, as explained in the text. (B) 
Topology of isoleucine.  
1H 
C!2 
C" 
C# 
C!1 
C$1  
C 
N 
HN 
H" 
H# 
HN 
H!11 
H!12 
H!21 
H!21 
H!21 
H$11  
H$11  
H$11  
O 
O 
B 
A 
!C! 
!C" 
!C#1 
H! H" 
H! H
" H$12 H$11 H$21 
!C%1 
!C#2 
H%1 
H" H$21 
H$12 H$11 
H%1 H" H$12 H$11 
H" H$12 H$11 H%1 
0.52 ppm 
1H 
1H 
- 
 130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.12: Selected planes of the HC(C)H-TOCSY spectrum of XvPrx2.  
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of Prx5 subfamily proteins although they have been reported to form non-covalent 
homodimers at pH 7.0 (Echalier, et al., 2005). Non-denaturing mass spectrometry has 
been used to explore pH dependent changes in a number of proteins and a link to their 
oligomeric states (Hanefeld, et al., 2001; Kashiwagi, et al., 2000).  
 
Commercial mass spectrometers utilize a range of different technologies for detection, 
including Time-Of-Flight (TOF), Quadru9pole and Orbitrap, as well as for the 
ionisation of the sample, of which the most common are the Matrix Assisted Laser 
Desorption Ionisation (MALDI) and Electrospray Ionisation (ESI). Whereas MALDI 
tends to produce only singly and doubly ionized species, ESI produces a spectrum of 
different ionisations, each of which contains the same information. The resulting 
spectrum of resonances can either be analysed directly (the “raw” data) or can be 
integrated to give a spectrum containing a single resonance corresponding to the mass 
of the protein. 
 
Mass spectrometry (MS) conventionally determines only the mass to charge ratio of an 
ionised species, requiring the charged state (and therefore the mass) to be inferred from 
additional factors. However the resolution of modern mass spectrometers allows for 
detection of the complete isotope spectrum of each ionisation, from which the mass of 
each ionisation can be unambigously determined. 
 
MS is most commonly carried out under denaturing conditions, typically achieved by 
addition of 0.2 % formic acid. While denaturing conditions tend to increase the number 
of charges acquired by the protein in ESI, the unfolded state of the protein means that 
non-covalent interactions cannot be observed. In recent years MS has been used to 
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study proteins in non-denaturing conditions by the use of volatile solvents such as 
ammonium acetate, and soft ionisation conditions such as low cone voltages (Hanefeld, 
et al., 2001; Kashiwagi, et al., 2000).  
 
Fig 4.13 shows the “raw” mass spectrum of XvPrx2 at pH 7 under non-denaturing 
conditions. The resonances marked “8+”, “7+”, and “6+” have been identified by the 
instrument as containing 8, 7 and 6 positive charges respectively, based on their 
isotopic spectra. The m/z values of 2238.5793, 2557.8013 and 2983.9717 therefore 
correspond to independent estimations of the mass of the protein. The overall mass of 
the protein is obtained by multiplying the m/z value by the number of charged ions 
followed by the subtraction of the mass of the charged ions as shown in the formular 
below: 
 
  
€ 
m z =
M + xH[ ]x+
x  
 
where 
€ 
m z  represents the mass to charged ratio, 
€ 
M  the overall mass of the protein and 
x the number of charged ions or states. 
 
Using the argument above the m/z values of 2238.5793, 2557.8013 and 2983.9717 
corresponding to the 8th, 7th and 6th states respectively, corresponding to protein 
masses of 17900.6 (2238.5793 x 8 - 8), 17897.6 (2557.8013 x 7 - 7) and 17897.8 
(2983.9717 x 6 - 6) Da respectively, which are all consistent with the expected value of 
17899 Da. 
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Using the same reasoning the resonance at m/z = 2754 should correspond to 
17899/2754 ≈ 6.5 positive charges. However, since half-integral charges are not 
physically possible, this resonance can only correspond to 13 charges on the 
homodimeric state, giving an m/z value of (2 × 17899)/13 = 2754. This resonance was 
independently identified as carrying 13 charges based on its isotopic spectrum, in 
agreement with the above argument. Similarly the resonance at m/z = 3256 corresponds 
to the 11th ionisation of the homodimer. The resonances marked 8+, 7+ and 6+ will also 
contain contributions from the 16th, 14th and 12th ionisations of the homodimer 
respectively, but it is difficult to separate the contributions; however the 13th and 11th 
ionisations can only arise from the homodimer, and therefore constitute independent 
evidence that the protein is at least partly homodimeric at pH 7. When the “raw” data 
was deconvoluted using the MaxInt1 and MaxInt3 algorithms the expected two mass 
species were identified, corresponding to the monomeric (17899 Da) and homodimeric 
(35797 Da) forms of the protein respectively (Fig 4.13B).  
 
Similar mass spectra acquired at pH 5, 6 and 8 are shown in Figs. 4.14 - 4.16 (the 
corresonding deconvoluted spectrum is shown only for pH 5). At pH 8 the relative 
heights of the peaks indicative of the homodimer (m/z = 2754 and 3256) appear similar 
to those at pH 7. However, the same peaks (the 13th and 11th ionisations of the 
homodimer appear to have decreased in height at pH 6 and have disappeared 
completely at pH 5, which suggests that the protein is entirely monomeric at pH 5.  
 
Our ESI-MS data suggests that the fraction of XvPrx2 molecules involved in 
homodimerization increases as the pH increases from 5 to 8, from zero at pH 5 to 
around 1/3 at pH 8. Since it is likely that at least some of the homodimers have  
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Fig 4.13: ESI-MS spectrum of XvPrx2 acquired at pH 7 under non-denaturing reducing conditions. 
(A) The “raw” data exhibits a spectrum of different ionisations which are indicated by the numbers above. 
Single circles represent a sum of the 9th, 8th, 7th and 6th ionisations of the monomer and the 18th, 16th, 14th 
and 12th ionisations of the homodimer, respectively. Peaks denoted with double circles can only correspond 
to the 11th and 13th ionisations of the homodimer, as half integral charges (6.5 and 5.5 respectively) are not 
physical. These resonances confirm that the homodimeric state is present at pH 7. The deconvoluted 
spectrum is shown in (B), confirming the conclusion drawn from the raw data that a significant fraction of 
the protein is homodimeric at pH 7.  
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Fig 4.14: ESI-MS spectrum of XvPrx2 acquired at pH 5 under non-denaturing reducing conditions. 
(A) shows the “raw” ESI-MS spectrum of XvPrx2 at pH 5 acquired under non-denaturing conditions; 
displaying a number of peaks (circled and denoted with arrows) respresenting the respective charged ion 
states of the protein and collectively corresponding to the monomeric configuration of XvPrx2. Arrows 
pointing in from below the spectrum (Fig 4.14A), which have not been circled, show the positions that 
would have been occupied by peaks corresponding to the homodimeric configuration of the protein. The 
deconvoluted form of the same data shown in Fig 4.14A is shown in (B), showing one peak (17897.5 Da) 
corresponding to the monomeric form of the protein. The fact that the peaks representative of the 
homodimeric form of the protein are completely absent in Fig 4.14A coupled with the presence of only 
the monomer peak (17897.5 Da) in Fig 4.14B indicates that XvPrx2 is completely monomeric at pH 5. 
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Fig 4.15: ESI-MS spectrum of XvPrx2 acquired at pH 6 under non-denaturing reducing 
conditions. The spectrum show peaks (circled and denoted with arrows) indicating the number of 
charged ionic states. Single circles represent peaks that correspond to the monomeric configuration (9th, 
8th, 6th) while double circles represent homodimeric peaks. The 13th and 11th ionizatons infact 
correspond to (17899/2754.4609 ≈ 6.5+ and 17899/3255.2625 ≈ 5.5+ ionisations). However since half 
integral charges are not physical, the 13th and 11th resonances can only correspond to charges on the 
homodimeric state, giving an m/z value of (2 × 17899)/13 = 2754, (2 × 17899)/11 = 3255. The 
ionisations marked 6.5+ or 13+, and 5.5+ or 11+ are independent evidence that the homodimeric states 
are present at pH 6 although the resonances marked 9+, 8+, 7+ and 6+ could also contain contributions 
from the 18th, 16th, 14th, and 12th ionisations of the homodimer, but it is difficult to separate the 
contributions of the homodimer to the monomer for such ionisation states.  
 
 
 
 
 
 
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
 
m/z 
9+ 
6+ 
8+ 
6.5+ or 13 
7+ 5.5+ or 11 
pH 6 
 137 
 
 
 
 
Fig 4.16: ESI-MS spectrum of XvPrx2 acquired at pH 8 under non-denaturing reducing 
conditions. The mass spectrum show peaks (circled and denoted with arrows) indicating the number of 
charged ionic states. Single circles indicate peaks that correspond to the monomeric form of the protein 
while double circles indicate peaks which have been determined to correspond to the 15th, 13th, and 11th 
ionizatons (2398.5103, 2754.4609, 3255.2625 Da). The 15th, 13th, and 11th resonances can only 
correspond to (17899/2398.5103 ≈ 7.5+, 17899/2754.4609 ≈ 6.5+, and 17899/3255.2625 ≈ 5.5+. 
However, since half integral charges are not physically possible, the 15th, 13th and 11th resonances can 
only correspond to charges on the homodimeric state, giving an m/z value of (2 × 17899)/15 = 2398, (2 
× 17899)/13 = 2754, (2 × 17899)/11 = 3255. The presence of dimer peaks as well as monomer peaks 
suggests that XvPrx2 appears as monomers and dimers at pH 8. We notice a gradual increase in the 
population and intensity of dimeric peaks as the protein buffer pH increase (pH 6 to 8) suggesting that 
the protein is more dimeric at pH 8 compared to pH 6. 
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dissociated during ionisation, despite the soft ionisation conditions, the fraction 
involved in homodimerisation at pH 8 is likely to be an underestimate. Dimers are also 
known to ionise less effectively than monomers (Loo, 1997), which would lead to 
further underestimation of the homodimerisation fraction. On the basis of the above 
evidence, we conclude that the NMR spectra recorded at pH 5 and pH 8 (Fig 4.4) 
correspond to the monomeric and homodimeric forms of XvPrx2 respectively. On the 
basis of the NMR data we conclude furthermore that by pH 8 XvPrx2 is entirely 
homodimeric, rather than the 30% suggested by MS (Fig 4.13B), which is therefore 
deemed to be an underestimate. 
 
Since all of the above ESI-MS and NMR spectra were recorded in the presence of 10 
mM DTT, we conclude that the homodimers from the high pH conformation are non-
covalent, rather than being the result of intermolecular disulphide bonds. 
 
To confirm this conclusion, 1% formic acid was added to denature the protein, as 
shown in Fig 4.17 (B). The homodimeric peak completely disappeared, indicating that 
it was entirely dependent on the folded state of the protein, i.e it corresponded to non-
covalent homodimers. The effect of omitting DTT from the original spectrum is shown 
in Fig 4.17 (C). The fraction of homodimers appears to be slightly larger than when 
DTT is present (A), indicating that in non-reducing conditions most of the protein is in 
the form of non-convalent homodimers, but a smaller fraction are in the form of 
covalent dimers. This conclusion is supported by the fact that when the non-reduced 
protein is denatured (Fig 4.17D) a small fraction of homodimers remain, which 
therefore correspond to covalent homodimers.  
 
 139 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.17: Deconvoluted ESI-MS spectrum of XvPrx2 acquired at pH 7 under non-denaturing 
and denaturing conditions. (A) Under non-denaturing, reducing conditions a significant fraction of 
the protein is in the form of homodimers, which must be non-covalent due to the present of 10 mM 
DTT. (B) Confirm this, when the sample used in (A) is denatured the homodimeric fraction 
disappears, confirming that the homodimers in (A) are indeed non-covalent. (C) When DTT was 
omitted from the sample used in (A) the fraction of homodimers increases, presumably corresponding 
to non-covalent plus covalent homodimers (inter-molecular disulphide bridges). (D) Confirming this, 
when the sample used in (C) is denatured a small fraction of homodimers remain, which must 
covalent due to the denaturing conditions. 
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The effect of DTT on the formation of covalent homodimers was further investigated 
using denaturing SDS-PAGE. Lane 2 of Fig 4.18 shows that when DTT is omitted a 
significant fraction of XvPrx2 migrates as covalent dimers (upper band at 
approximately 36 kDa), whereas when DTT is included the upper band disappears 
completely (lane 3). We conclude that 10 mM DTT is sufficient to suppress all inter-
molecular disuphide bonds and therefore that the homodimers detected both by ESI-MS 
and NMR in the presence of 10 mM DTT are entirely due to non-covalent interactions.  
 
Since all of the above ESI-MS and NMR spectra were recorded in the presence of 10 
mM DTT, we conclude that the homodimers from the high pH conformation are non-
covalent, rather than being the result of intermolecular disulphide bonds. 
4.6 Investigation of the effect of pH on the oligomeric state of XvPrx2 using SEC 
NMR and non-denaturing ESI-MS provided evidence that XvPrx2 is monomeric at pH 
5, forms a non-covalant homodimer at pH 8 and exits in a mixture of monomer and 
dimer at pH values in between. The mechanism by which pH changes affected the 
dimerisation state was, however, still unclear. To address this, XvPrx2 was subjected to 
analytical size exclusion chromatography (SEC) at a range of different pH values. 
 
SEC provides a convenient method for estimating apparent molecular weight of 
proteins. The column used was a HiLoad 16/60 Superdex 75 prep grade, which means 
that protein of molecular weight > ~70 kDa will have access only to the volume 
excluded by the beads, whereas those with molecular weight < ~70 kDa will have 
access to spaces within the beads, with the result that they will take longer to transit the 
column. An approximately linear relationship has been found to hold between the 
volume at which proteins elute and the logarithm of the molecular weight of the 
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Fig 4.18: SDS-PAGE gel of XvPrx2 under non-reducing and reducing conditions. XvPrx2 at 
pH 7 is shown in non-reducing conditions (lane 2) and reducing conditions (10 mM DTT) (lane 3). 
The top band in lane 2 corresponds to covalent homodimers (inter-molecular disulphide bridges). 
The complete absence of the top band in lane 3 shows that 10 mM DTT is sufficient to suppress all 
inter-molecular disulphide bridges. 
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protein. This relationship can be calibrated using standard proteins of known molecular 
weight, after which the relationship can be used to infer the molecular weight of 
proteins of unknown molecular weight based on the volume at which they elute. The 
method is ideal for investigating the apparent molecular weight of proteins involved in 
oligomerization. In addition, the fact that the pH of the buffer plays no role in the 
chromatographic separation makes it ideal for the current investigation of pH-
dependent oligomerization.  
 
SEC was carried out at range of pH values from 5 to 8, yielding the elution volumes 
shown in Table 4.1. An overlay of the chromatograms (Fig 4.19) reveals a decrease in 
elution volume, or equivalently an increase in effective molecular weight, with 
increasing pH.  
Superposition of the chromatograms with those of a number of standards of known 
molecular weight (see Table 4.2 for details of elution volumes) shows that the apparent 
molecular weights are greater than 13.7 kDa (RNAse A) but less than 44 kDa 
(Ovalbumin) (Fig 4.20). A more quantitative analysis of the effective molecular 
weights is provided in Table 4.3, based on the calibration of the SEC column using the 
standard proteins, shown in Fig 4.21, as described in Section 2.24. The molecular 
weights are entirely consistent with the conclusion derived from NMR and ESI-MS that 
XvPrx2 exists as a monomer at pH 5 and a non-covalent homodimer at pH 8.  
 
The presence of 10 mM DTT in both sample and SEC buffer further guarantees that 
that homodimer is non-covalent. When the DTT was omitted it had no effect at pH 7, as 
shown in Fig 4.22, which is consistent with our previous conclusion that at pH 7 the 
protein is almost completely dimeric, whether covalent or non-covalent cannot be  
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Fig 4.19: Overlay of SEC of XvPrx2 under different pH conditions. The elution times of 
XvPrx2 at pH 8, 7, 6 and 5 are given in Table 4.1. The overlay reveals that the effective volume 
of the protein increases with increasing pH. The effective size of the protein as a function of pH 
is shown in (Table 4.3) based on the elution volumes of protein standards of known molecular 
(Fig 4.20).  
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Fig 4.20: Overlay of XvPrx2 SEC under different pH conditions with protein standards. 
XvPrx2 elutes at volumes between 44 kDa (ovalbumin) and 13.7 kDa (RNase), indicating that it 
is a mixture of monomer and homodimer. The effective size of the protein at different pH values 
is shown in Table 4.3, based on the standard curve shown in Fig 4.21. 
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pH  Elution Volume (ml) 
5.0 79.14 
5.5 78.26 
6.0 73.62 
6.5 69.40 
7.0 68.10 
8.0 67.35 
 
 
Table 4.1: Elution volume of XvPrx2 at different pHs. XvPrx2 samples were separated 
under the same condition and buffer environment (50 mM ammonium acetate containing of 
10 mM DTT), with a variation of pH (5 - 8). The elution volumn at each pH was used to 
estimate the effective molecular weight (Table 4.3) based on a calibration curve (Fig 4.21) 
generated using values presented in Table 4.2.  
 
 
 
Protein standards Elution Volume 
(ml) 
Molecular weight 
(kDa) 
Conalbumin 62.09 75 
Bovine Serum Albumin 61.42 67 
Ovalbumin 65.97 44 
Carbonic Anhydrase 74.73 29 
RNAse 91.75 13.7 
 
 
Table 4.2: Elution volume of protein standards separated through a HiLoad 16/60 
Superdex 75 Prep grade column. All standards were separated under the same condition 
and buffer environment (50 mM ammonium acetate pH 8 in the presence of 10 mM DTT). 
The elution volume was obtained by noting the values from the point of injection to the 
centre of the peak.  
 
 
pH Elution Volume 
(ml) 
Molecular 
weight (kDa) 
5.0 79.14 24.1 
5.5 78.26 25.1 
6.0 73.62 30.9 
6.5 69.40 37.4 
7.0 68.10 39.6 
8.0 67.35 41.0 
 
Table 4.3: Effective molecular weight of XvPrx2 at different pH values, based on the 
standard curve shown in Fig 4.21.  
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Fig 4.21: SEC standard curve. The SEC standard curve was generated based on the data shown in 
Table 4.2. 
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Fig 4.22: Overlay of SEC of XvPrx2 at pH 7 and pH 5 in the presence and absence of DTT. pH and 
reducing conditions are as indicated. Omission of DTT had a large effect at pH5, with almost half of the 
sample eluting at the volume expected for homodimers, which must therefore correspond to inter-
molecular disulphide bonds. However omission of DTT had little effect at pH 7, where the protein forms 
non-covalent homodimers under reducing conditions and presumably a mixture of covalent and non-
covalent dimers under reducing conditions. 
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determined by this method. At pH 5, on the other hand, where the protein is known to 
be completely monomeric, when DTT is omitted a significant fraction of the protein 
becomes disulphide bonded, producing a second peak at the position expected for the 
homodimeric state, as shown in Fig 4.22. The fact that the protein elutes at volumes 
between those expected for the dimer or the monomer can be explained by a model in 
which the protein flips repeatedly between monomer and dimer during its passage down 
the column. If we assume that a fraction α are monomeric at any one time (0 ≤ α ≤ 1) 
then, as shown in Appendix II, the protein will elute at 
€ 
Ve =Ved +α Vem −Ved( ) , where 
€ 
Ved is the elution volume at which pure dimer elutes and 
€ 
Vem  the volume at which pure 
monomer elutes. 
 
If we assume further that the transition between the monomer and dimer corresponds to 
the ionisation or protonation of a single group in the interface, with dimerisation only 
being possible when the group is ionized then, as is also shown in Appendix II, the 
Henderson-Hasselbalch equation gives the following expression for the elution volume 
in terms of the pH and the pKa of the ionisable group:  
 
    
€ 
Ve =Ved + Ve
m −Ved
1+10pH− pKa  
 
Fitting this expression to a graph of 
€ 
Ve  as a function of pH (Fig 4.23) allows extraction 
of values for the pKa, as well as for 
€ 
Ved and 
€ 
Vem . The fit is in excellent agreement with 
the data and yields a value for the pKa of 6.0 ± 0.1. This value suggests that at pH 5.0 
the protein is only 90% monomeric 
€ 
α =
1
1+105−6 = 0.9
 
 
 ,
 
 
  whereas at pH 8.0 it is 99% 
homodimeric. If the values of 
€ 
Vem  = 81.1 and 
€ 
Ved = 66. 9 ml are used to calculate the  
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Fig 4.23: Ve (elution volume) plotted as a function of pH. The filled squares correspond to the values 
given in Table 4.1 and the dotted line to the theoretical expression given in the text. The fit allowed for 
the extraction of pKa, Ved and Vem. XvPrx2 has a pKa of 6, which is consistent with the pKa extracted from 
a number of Prxs (ranging from 5.4 to 6.0) (Nelson, et al., 2008; Ogusucu, et al., 2007). 
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effective molecular weights of the monomer and dimer using the standard curve shown 
in Fig 4.21, the corresponding values are 22.1 kDa for the monomer and 41.8 kDa for 
the dimer. These are in satisfactory agreement with the expected values of 18 kDa and 
36 kDa respectively. 
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Chapter 5: Investigation of the role of Cys51 and His55 in the 
monomer to dimer pH-dependent shift and the effect of oxidation and 
glutathionylation on the stability of the non-covalent homodimer 
 
In the previous chapter it was shown that XvPrx2 forms a non-covalent homodimer 
above pH 6, and monomeric below. The fact that Prx5 subfamily (“D-type”) 
peroxiredoxins form non-covalent homodimers has been previously reported for 
PfAOP from Plasmodium falciparum (Sarma, et al., 2005) and PtPrxD from Populus 
tremula (Echalier, et al., 2005), which is highly homologous to XvPrx2 (see Fig 5.1 for 
an alignment). That study was carried out at pH 7 and no attempt was made to 
investigate the effect of pH on the stability of the homodimer. However attachment of 
a glutathione group to the catalytic cysteine of PtPrxD was shown to lead to 
dissolution of the non-covalent homodimer, an effect that Noguera-Mazon and co-
workers suggested may play a role in the catalytic mechanism of the enzyme 
(Noguera-Mazon, et al., 2006b). 
 
The PtPrxD homodimer forms across an A-type (“perpendicular”) interface, with helix 
α2 well structured and packing against the central β-sheet. Since the N-terminal end of 
the helix forms part of the dimersation interface it has been suggested that unfolding of 
the α2-helix would not be compatible with formation of the homodimer (Noguera-
Mazon, et al., 2006b). The helix is stabilized by a network of hydrogen bonds donated 
by Arg129 and accepted by the thiolate group of Cys51 and the side chain nitrogen of 
His55 (see Fig 1.2B). Both Cys51 and His55 are located near the N-terminal end of 
helix α2, facing in towards Arg129, which lies between the central β-sheet and the α2-
helix. His55 is replaced in some other members of the Prx5 family by glutamine and 
glutamic acid, both of which are able to accept hydrogen bonds. In PfAOP from 
Plasmodium falciparum this position is occupied by a methionine which is able to  
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Fig 5.1: Sequence alignment of P. tremula Prx (PtPrxD, PDB entry 1TP9) and X. viscosa Prx 
(XvPrx2). The alignment was generated using MUSCLE (Edgar, 2004) and shows a high conservation 
of residues between PtPrxD and XvPrx2. Cys51 (catalytic cysteine), His55 and Arg129, which are 
involved in hydrogen bonding interaction (Fig 5.2) have all been boxed (black) and highlighted (red).  
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accept hydrogen bonds, although it rarely does so (Gregoret, L. M., Rader, S. D., 
Fletterick, R. J. & Cohen, F. E. (1991). In the monomeric form, in contrast, helix α2 
was found to be unstructured, presumably swinging out, away from the core of the 
protein. Abolition of the dimer by glutathionylation was accompanied by unfolding of 
the α2-helix, supporting the assertion that the dimer can only form when the α2-helix is 
structured.  
 
Cys51 and His55 are also present in XvPrx2, as can be seen from the alignment in Fig 
5.1. Since they are both ionisable they were the obvious places to begin looking for the 
cause of the pH-dependent effects reported in the previous chapter. The pKa of the 
imidazole group of histidine is very close to the value of 6.0 extracted from SEC data 
in Fig 4.23, and although the pKa of the side chain thiol group of cysteine in solution is 
approximately 8.3 (Klomsiri, et al., 2010), in folded Prxs it has been reported to be 
lowered to around 6 in a number of cases (Nelson, et al., 2008; Ogusucu, et al., 2007). 
 
In order to define the structural context for our investigation of the pH-dependent 
dimerisation of XvPrx2, we began by generating a model of the molecular structure 
using the close homologue from P. tremula. The 3D Jury server was used to generate a 
multiple alignment from which the sequence from P.tremula was selected for 
homology modeling using MODELLER (Sali and Blundell 1993). A cartoon 
representation of the model is shown in Fig 5.2A while an overlay of the model with 
the PtPrxD structure is shown in Fig 5.2B.  
 
Consistent with the PtPrxD structure, the model of XvPrx2 predicts that Arg129 is at 
the centre of a network of hydrogen bonds. As shown in Fig 5.3B the side-chain Nη1  
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Fig 5.2: Cartoon representation of XvPrx2. (A) Structural model of XvPrx2 built using the 
close homologue PrxD from Populus tremula (PDB entry 1TP9). (B) The overlay of XvPrx2 
(green) and PtPrxD (pink) reveals the high structural similarity (RSMD 0.266). Molecular 
fitting was performed using the DaliLite server (Holm & Park, 2000). (C) Cartoon 
representation of the XvPrx2 homodimer, modeled on the structure of PfAOP from Plasmodium 
falciparum. The figure has been visualized using the PYMOL Molecular Graphics System 
(2003) Delano Scientific, San Carlos, CA, USA. 
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Fig 5.3: Hydrogen bonding interactions stabilising the α2-helix in XvPrx2. Expanded view of the 
active site of XvPrx2 showing the hydrogen bonding network between R129, C51 and H55 which 
stabilize the α2-helix and, by extension, the homodimeric state. The model was generated based on the 
structure of PrxD from P. tremula (PDB entry 1TP9) and the figure was visualized using the PYMOL 
Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
 
 
 
 
 
 
 
SG
 
O 
C
5
1
 
N 
O OG1 
T48 
P44 
CD
 
R129
 
G45 
N
H
2
 
N
H
1
 
H55 
N
D
1
 
B 
 156 
and Nη2 are predicted to donate hydrogen bonds to the side chain Nδ1 of His55 and the 
thiolate of Cys51 respectively. 
 
Since His55 Nδ1 can only accept hydrogen bonds when it is ionized, which is the case 
when pH values are above its pKa, our data suggests that the Arg129 - His55 hydrogen 
bond plays a dominant role in stabilising the α2-helix at pH > 6. To test this model we 
mutated His55 to alanine and repeated the SEC analysis. The results are shown in Fig 
5.4 and the elution volumes are tabulated as a function of pH in Table 5.1. As 
compared to the wild-type (solid curve, Fig 5.4), the elevated elution volumes in the 
pH region 6 - 9 show that the H55A mutant remains a monomer at higher pH values 
than the wild type. This confirms our model that the hydrogen bond between between 
Arg129 and His55 plays the major role in stabilising the α2-helix and allowing the 
homodimer to form. 
 
A surprising feature of Fig 5.4 is that at sufficiently high pH the H55A mutant again 
forms dimers. Since the major increase in dimerisation occurs between pH 8 and 9, in 
the vicinity of the cysteine thiol group, suspicion fell on Cys51, which our structural 
model predicts accepts a hydrogen bond from Arg129 Nη2. Since the thiol group can 
only accept a hydrogen bond at pH values above its pKa, this mechanism is likely to 
lead to stabilization of the homodimer above pH 8.3, which is consistent with what is 
observed. 
 
However the H55A data in Fig 5.4 suggests that a greater fraction of homodimer is 
present in the pH range 6 - 8 than would be expected for a single ionisation with the 
pKa of 8.3. The data lacks the sigmoidal shape seen in the wild-type data (solid line)  
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Fig 5.4: The effect of mutations H55A (open diamonds) and C51S (filled squares) on the 
pH-dependent transition from monomer to homodimer. The solid line represents the wild-
type behaviour, which is shown for purposes of comparison. The H55A mutation is monomeric 
at higher pH values than the wild type, suggesting that the hydrogen bond between R129 and 
H55 plays an important role in stabilising the homodimeric state. Surprisingly the homodimeric 
state is still present at high pH values. Replacing C51 with a serine stabilizes the homodimer at 
lower H values than the wild type, an effect which is difficult to explain. 
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pH (H55A) Elution Volume 
(ml) 
5.0 79.30 
6.0 77.33 
7.0 76.30 
8.0 74.64 
9.0 70.00 
10.0 68.68 
 
 
Table 5.1: SEC elution volumes for XvPrx2-H55A at various pH values. All other 
parameters were the same as for to the wild type protein.  
 
 
 
pH (C51S) Elution Volume 
(ml) 
5.00 79.14 
5.25 74.90 
5.50 70.15 
6.00 68.55 
7.00 67.80 
8.00 67.69 
 
 
Table 5.2: SEC elution volumes for XvPrx2-C51S at various pH values. All other 
parameters were the same as for to the wild type protein. 
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which may indicate a more complex mechanism than that assumed in Appendix II. 
However our NMR data (see later, Section 5.1, Fig 5.5) suggests that at pH 7 the H55A 
mutant is still almost entirely monomeric, and therefore we suspect that the SEC data 
over-estimates the amount of homodimer present. 
 
To test our model that Cys51 plays a role in the stabilizing the homodimer at high pH 
we replaced it with serine. Although similar in size and chemical characteristics to 
cysteine, serine has a higher solution pKa of 9.15. We therefore expected the 
replacement of cysteine by serine to have no effect on the stability of the homodimer at 
low pH. To our surprise it had the opposite effect, reducing the apparent pKa from 6.0 
to 5.3 (Fig 5.4, solid black squares). 
 
The SEC results reported above are consistent with results generated using NMR. The 
1D proton spectrum of H55A at pH 7 is shown in Fig 5.5A: the absence of the 
signature peaks at -0.5 ppm and 11.1 ppm shows that H55A is almost completely 
monomeric (compare with Fig 4.3(A)). However both peaks are present in the 1D 
spectrum of C51S (Fig 5.5(B)), confirming that it is homodimeric at pH 7. 
 
Chemical shifts of -0.5 ppm represent large deviations from random coil values, and 
typically result from packing of the corresponding nucleus against an aromatic ring. 
The magnetic shielding produced by rings is known as “ring current effects” and is 
largest along the axis of the ring (the line through the centre of the ring and 
perpendicular to the plane of the ring). Analysis of the modelled structure shows that 
Ile 41 lies in the space between the central β-sheet and helix α2, where it packs directly 
against the sidechain ring of Phe 59, as shown in Fig 5.6. Phe 59 lies on helix α2, one  
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Fig 5.5: 1D proton spectra of XvPrx2-H55A and XvPrx2-C51S recorded at pH 7.0, 25 °C and 600 
MHz. Red arrows indicate resonances which are expected in the homodimeric form, but not in the 
monomeric form. The spectra show that XvPrx2-H55A is almost completely monomeric at pH 7 (A) 
whereas XvPrx2-C51S is predominantly homodimeric (B), consistent with the SEC data shown in Fig 
5.4.  
 
H55A pH 7 A 
C51S pH 7 B 
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Fig 5.6: Ile41 packs directly against the ring of Phe 59, which explains the downfield shift of the 
Hγ11  proton of Ile41 to -0.52 ppm when the α2-helix is structured. The model was generated based on 
structure of Populus tremula Prx (PDB entry 1TP9) and the figure has been visualized using the 
PYMOL Molecular Graphics System (2003) Delano Scientific, San Carlos, CA, USA. 
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turn away from His55, and therefore is only expected to influence Ile 41 Hγ12 when 
helix α2 is structured. The 1D NMR spectrum therefore provides strong evidence that 
helix α2 is structured when the protein is homodimeric, but unstructured when 
monomeric. 
 
Additional evidence that H55A is monomeric at higher pH values than the wt is 
provided by 15N-HSQC spectra. The overlay of H55A and wt in Fig 5.7 (A) at pH 7 
confirms that H55A has contributions from the monomeric spectrum not seen in the wt 
at this pH. As expected the H55A spectrum at pH 7 overlays very well with the wt 
spectrum at pH 5 (Fig 5.7B), which has been shown to be almost entirely monomeric. 
 
Fig 5.8 shows a comparison of 15N-HSQC spectra of H55A at pH 7, 8 and 9. As the pH 
increases peaks associated with the monomer are increasingly replaced by peaks 
associated with the homodimer, as shown most clearly in the boxed resonances, which 
correspond to the backbone amide of Leu40. At pH 8 there are almost equal amounts 
of monomer and homodimer from which we can conclude that the pKa of the H55A is 
in the vicinity of pH 8, which is in general agreement with the results shown in Fig 5.4. 
Expanded views of the boxed regions in Fig 5.8 are presented in Fig 5.9A and the 
volumes extracted from the peaks used to determine the monomeric fraction, which is 
plotted in Fig 5.9B. The solid curve corresponds to fitting on the expression shown in 
Appendix II. The monomer-homodimer transition is approximately at pH 8. Fig 5.9B is 
consistent with Fig 5.5A in suggesting that at pH 7 there is very little of the dimer 
present and that Fig 5.4 over-estimates the amount of homodimer present for H55A. 
 
Our data shows that by replacing H55 by an alanine we have raised the maximium pH  
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Fig 5.7: Overlay of 15N-HSQC spectra of XvPrx2 and XvPrx2-H55A recorded at pH 7, 25 
°C and 600 MHz. The spectrum of XvPrx2-H55A pH 7 (red) is manifestly different to that of 
the wild type at pH7 (black) (A), which is homodimeric, but much more similar to that of the 
wild-type at pH5 whci is monomeric.  
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Fig 5.8: 15N-HSQC spectra of XvPrx2-H55A recorded at pH 7, 8 and 9, at 25 °C and 600 
MHz. The boxed region shows two resonances associated with either the monomeric (top 
resonance) or dimeric (bottom resonance) configurations. Vertical cross sections (circled) 
through these resonances are shown at right. Increasing the pH from 7 to 9 results in an 
increase in the height of the bottom resonance and a corresponding decrease in the height of the 
top resonance, indicating a change from monomer to homodimer.  
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Fig 5.9: Expanded view of XvPrx2-H55A mutant Leu40 resonance at pH 7, 8 and 9. (A) 
Increasing the pH from 7 to 9 results in an increase in the height of the bottom resonance and a 
corresponding decrease in the height of the top resonance, indicating a change from monomer 
to homodimer. (B) The monomeric fraction of the protein was calculated using the volumes of 
the peaks shown in (A) and the solid line represents a fit of the expression in Appendix II, 
giving an effective pKa of 7.9. The data shows that XvPrx2-H55A is almost entirely monomeric 
at pH 7 (97 %) while a mixture of monomers and dimers is observed at pH 8 (40 % 
monomeric) and pH 9 (20 % monomeric).  
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at which XvPrx2 is monomeric from 5 to 7. Since wild type XvPrx2 was found to be 
too unstable at pH 5 for NMR structural analysis, this opens the possibility that H55A 
will be sufficiently stable at pH 6 or 7 for structure determination. Preliminary data 
suggests that it is more stable at these pHs than the wild type at pH 5. 
5.2 Oxidation of XvPrx2  
Peroxiredoxins protect proteins and other cellular components from oxidative damage 
induced by reactive oxygen (ROS) and nitrogen species. Their activity results in the 
reduction of hydroxyl radicals or peroxide substrates to water, alcohol and other break 
down products. The detailed overview of the catalytic cycle of Prxs has been presented 
in Section 1.2 (Fig 1.1). Briefly, it involves a nucleophillic attack of hydroxyl radicals 
or peroxides or other substrates using the catalytic cysteine residue (CP) resulting in the 
oxidation of the sulfhydryl side chain (-SPH) group to sulphenic (-SPOH) acid groups, 
which may be oxidised further to sulphinic (-SPO2H) and sulphonic (-SPO3H) states. 
The sulphinic and sulphonic acid forms have been reported to be resistant to reduction 
and therefore inactive, although reports by Biteau and co-workers suggest that SPO2H 
can be reduced by the thiol-containing protein sulphiredoxin (Biteau, et al., 2003).  
 
Some reports have suggested a link between the state of oxidation of the catalytic 
cysteine and the oligomeric state of Prxs. For example, Wood and co-workers showed 
that the Prx1 subfamily occurs as a decamer in reduced and overly-oxidised states but 
as a disulphide-bonded dimer in the oxidised state. The decamer associated with the 
overly-oxidised form is poorly recycled by electron donors like thioredoxins while the 
disulphide-bonded dimeric form displays low peroxidase activity (Wood, et al., 2002). 
The effect of oxidation of the catalytic cysteine on two members of the Prx5 subfamily, 
the human Prx5 and Saccharomyces cerevisiae alkylhydroperoxide reductase (Ahp1), 
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has been reported. Both proteins contain two cysteine residues that form intra- and or 
intermolecular disulphide bond during their catalytic cycle and occur as dimers under 
reducing and oxidised (human Prx5) or overly oxidised (Ahp1) states (Evrard, et al., 
2004; Lian, et al., 2012; Trivelli, et al., 2003a). Some changes to the structures of the 
oxidised forms consistent with the unfolding of the N-terminus of the α2-helix have 
been reported although the overall oligomeric state of both proteins remained 
unchanged following oxidation. 
 
There are no reports of the effect of oxidation on the oligomeric state of 1-Cys Prx5 
subfamily proteins. This section will focus on the effect of oxidation on the oligomeric 
state of XvPrx2.  
5.2.1 The effect of oxidation on the oligomeric state of XvPrx2 
In order to investigate the effect of H2O2 on XvPrx2 we incubated it with various 
concentrations of H2O2, followed by denaturing mass spectrometry. The “raw” MS 
spectrum of the oxidised sample shown in Fig 5.10A shows that the protein has 
acquired an additional 32 Da, consistent with the sulphinic acid form of the protein 
(XvPrx2-SO2H). For example, the 8th ionisation has m/z = 2242.3333, which 
corresponds to m = 2242.3333 x 8 - 8 = 17930.66 while the 9th ionisation has m/z = 
1993.2963 corresponding to m = 1993.2963 x 9 - 9 = 17930.66. This can be compared 
with the spectrum recorded in the absence of H2O2 (Fig 5.10B) in which m/z = 2238.18 
and 1989.69 for the 8th and 9th ionization states, corresponding to m = 17897 and 
17898 respectively. As expected the deconvoluted spectrum for the H2O2-exposed 
sample (Fig 5.10C) displays a major peak at 17930.6 Da, corresponding to the 
sulphinic acid form, and a smaller peak at 17898.6 Da corresponding to the non- 
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Fig 5.10: Mass spectra of oxidised and non-oxidised XvPrx2 pH 8. (A) Shows the annotated “raw” 
mass spectrum of oxidised XvPrx2 pH 8 while (B) shows a similar spectrum obtained from the sample 
prior to incubation with H2O2. The deconvoluted spectrum of the sample exposed to H2O2 is shown in 
(C). A shift in peak sizes by approximately 32 Da can be seen in the spectrum shown in (A) when 
compared to that shown in (B). The deconvoluted spectrum (C) shows 2 peaks, the one at 17930 
corresponding to the sulphinic acid (XvPrx2-S2OH) form of the protein (17898 + 32 = 17930), and the 
non-oxidised form of the protein at 17898. The sulphinic acid form of the protein (XvPrx2-SOH) is not 
observed. 
+7 
+8 
+9 
Mass = (8 x 2242.20 - 8 = 17929.6 Da) 
Mass = (7 x 2562.38 - 7 = 17929.6 Da) 
A pH 8 Plus H2O2 
m/z 
7+ 
8+ 
9+ 
Mass = (8 x 2238.18 - 8  = 179897.44 Da) 
Mass = (7 x 2557.92 - 7 = 17898.44 Da) 
B pH 8 No H2O2 
m/z 
Deconvoluted pH 8 plus H2O2 
 XvPrx2-SO
2
H 
XvPrx2-SH   
C 
Mass 
 XvPrx2-SO
2
H + Na+ 
 169 
oxidised form. The peak at 17952.5 Da corresponds to the sulphinic form complexed 
with a single Na+ ion rather than the sulphonic acid form.  
 
Despite several attempts we were unable to observe the sulphenic acid (singly 
oxidised) form of the protein. Figs. 5.11B and C show two scenerios observed 
following oxidation consisting of non-oxidised and doubly oxidised forms of the 
protein. The fact that non-oxidised and doubly oxidised forms of the protein were 
simultaneously observed suggests that the concentrations of H2O2 used were optimal 
for observing singly oxidised forms of the protein rather than being excessive. We 
conclude that the singly oxidised form of the protein is highly unstable with a high 
propensity to be further oxidised to the next oxidation state, as has been reported for a 
number of other 1-Cys peroxiredoxins. 
 
The effect of oxidation was further investigated using NMR. 1D NMR spectra before 
and after addition of a 2-fold excess of H2O2 are shown in Fig 5.12. The most notably 
feature is the almost complete disappearance of the resonances at -0.5 ppm and 11.1 
ppm. It was shown in Section 4.3 that the resonance at -0.5 ppm corresponds to Ile 41 
packing against Phe 59, which is diagnostic of helix α2 packing against the central β-
sheet. The peak at 11.1 ppm is similarly diagnostic of fully folded state of the reduced 
protein at pH 8. The absence of these peaks therefore implies that oxidation leads to 
unfolding of the α2-helix.  
 
However an overlay of 15N-HSQC spectrum of the oxidised sample with that of the 
non-oxidised sample at pH 8 (Fig 5.13), which has been shown to be homodimeric, and 
the non-oxidised sample at pH 5 (Fig 5.14) which is monomeric, suggests that the  
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Fig 5.11: Deconvoluted MS spectra of non-oxidised and doubly-oxidised forms of XvPrx2. (A) 
shows spectrum of non-oxidised XvPrx2 while (B) and (C) show spectra of oxidised XvPrx2 at 1:0.4 and 
1:1.5 XvPrx2 to H2O2 concentrations respectively. The spectrum shown in (B) is mostly non-oxidised 
while that shown in (C) is mostly doubly oxidised (-SO2H). We could not observe the singly oxidised 
form of XvPrx2 (-SOH) at all concentrations of H2O2 used.  
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Fig 5.12: 1D 1H spectrum of XvPrx2 oxidised and non-oxidised at pH 8, 25 °C recorded at 600 
MHz. (A) Shows the 1D proton spectrum of XvPrx2 pH 8 non oxidised (no H2O2) while (B) shows the 
oxidised version of the same spectrum (+ H2O2). Both spectra are strikingly similar. Of particular 
interest is the absence of the resonances at -0.5 ppm and 11.1 ppm in the oxidised spectrum but not the 
non-oxidised spectrum. These peaks have been shown to be signatures of the dimeric form of the 
protein. The fact that these peaks are either reduced or changed in position in the oxidised but not the 
non-oxidised spectrum suggests that oxidation induces the partial or full unfolding of the α2-helix. 
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Fig 5.13: Overlay of 15N-HSQC spectra of XvPrx2 at pH 8 oxidised (red) and non-
oxidised (black) at 25 °C, recorded at 600 MHz. (A) shows a full view of the overlay while 
(B) shows expanded view of regions “1” and “2” of the full view. The oxidised sample appears 
to have a small trace of the monomeric configuration appearing (small separate peaks). Overall 
both spectra overlay near perfectly suggesting that the oxidised sample is dimeric just like the 
non-oxidised sample.  
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Fig 5.14: Overlay of 15N-HSQC spectra of oxidised XvPrx2 at pH 8 (red) and the 
monomeric pH 5 configuration (blue) at 25 °C, recorded at 600 MHz. (A) shows a full 
view of the overlay while (B) shows expanded view of regions “1” and “2” of the full view. 
The oxidised sample appears to have a small trace of the monomeric configuration appearing 
(small separate red peaks). A clear difference is seen in the resonance positions of the 
monomeric sample suggesting that the oxidised sample is not monomeric.  
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sample remains predominantly dimeric following oxidation. In a number of cases, such 
as the resonances in boxes marked “1” and “2”, the oxidized spectrum appears similar 
to the homodimeric spectrum (pH 8), with a small contribution from the monomeric 
spectrum (pH 5). But on the whole the spectrum does not look similar to either the 
homodimeric or the monomeric spectrum. The above data leads us to the hypothesis  
that oxidation unfolds the α2-helix, and that this destabilizes the protein, causing a 
small fraction of molecules to dissociate into monomers. However the majoriy of the 
molecules remain homodimeric. 
 
Analytical SEC provides additional support for this hypothesis. At pH 7 both oxidised 
(+ 2 fold H2O2) and un-oxidised (+ 10 mM DTT) XvPrx2 elute at the same volume (Fig 
5.15), which corresponds to the dimeric form, rather than at the position of the pH 5 
sample, which corresponds to the monomeric form.  
 
Hence we conclude that oxidation does not disrupt the homodimer at pH 7 although it 
does destabilize it to an extent, cause a small fraction of the molecules to unfold. We 
also suspect that the α2-helix becomes unfolded. We are unable to account for the 
widespread changes brought about by oxidation, changes that do not correspond either 
to the monomeric or the homodimeric spectrum. A possible explanation is that it is due 
to conformational changes to the tertiary structure of each monomer, probably brought 
about by unfolding of the α2-helix. 
5.3 Glutathionylation 
Glutathionylation is a covalent modification of cysteine thiol groups involving the 
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Fig 5.15: Overlay of XvPrx2 SEC at pH 7 + DTT (non-oxidised, black), pH 7 + H2O2 
(oxidised, green) and pH 5 + DTT (non-oxidised, red). The oxidised and non-oxidised pH 7 
samples elute at the same volume demonstrating that oxidation does not affect the oligomeric 
state of XvPrx2 at pH 7. The non-oxidised pH 7 sample had previously been shown to be a non-
covalent homodimer (Fig 4.20, Table 4.3) implying that the oxidised sample is also non-
covalent homodimeric. Although some monomeric peaks are visible in the 15N-HSQC spectrum 
of the oxidised pH 7 sample (Fig 5.13 and 5.14) suggesting a change in local conformation of 
the protein, the overlay of the oxidised pH 7 and the non-oxidised pH 5 (monomeric) samples 
show that the oxidation does not induce the dissociation of the non-covalent homodimer into 
monomers. Our SEC data provides evidence that oxidation does not affect the oligomeric state 
of XvPrx2. 
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formation of a disulphide bond with the thiol group of the tri-peptide glutathione. 
Glutathione is comprised of amino acids glutamic acid, cysteine and glycine, 
incorporating a non-standard peptide bond between the side chain carbonyl of glutamic 
acid and the backbone amino group of cysteine. When the thiol group is reduced the 
molecule is denoted “GSH”; under oxidizing conditions the thiol can form inter-
molecular disulphide bonds, in which case the molecule is denoted “GSSG”. 
 
Proteins are reported to be glutathionylated under conditions of stress (Chock et al., 
2010). Glutathionylation is reported to protect thiols from becoming irreversibly 
oxidised and a number of enzymes have been identified which de-glutathionylate thiols 
once stress levels have reduced (Chock et al., 2010). 
5.3.1 The effect of glutathionylation on the oligomeric state of XvPrx2 
Noguera-Mazon and co-workers (Noguera-Mazon, et al., 2006b) reported that PrxD 
from Populus tremula, which is a close homologue of XvPrx2, became glutathionylated 
when incubated with 10 to 20-fold excess oxidised glutathione (GSSG), and that 
glutathionylation completely disrupted the non-covalent homodimer. The resulting 
monomers adopted a similar tertiary structure to that in the homodimer, although the 
α2-helix incorporating the peroxidatic cysteine was shown to be unstructured.  
 
Glutathionylation could be partially reduced by the addition of DTT, resulting in the 
reversal of the monomers back into dimers. However Noguera-Mazon and co-workers 
could not completely regenerate the homodimer, leading them to conclude that 
glutathionylation plays other roles apart from forming intermolecular disulphide 
bridges. 
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The regeneration mechanism for the Prx5 subfamily proposed by Noguera-Mazon and 
co-workers (Fig 1.25) suggests that the mixed disulphide (PtPrxD-GS) is reduced by 
an electron donor, glutaredoxin, regenerating PtPrxD back to its reduced (-SH) state. A 
similar mechanism for the reduction of 1-Cys Prx from Prx6 subfamily had previously 
been reported (Manevich, et al., 2004), although GSH alone was not able regenerate 
the protein but required the presence of πGST. The suggestion is that GSH is not able 
to gain access to the CP, but that a heterodimer between πGST and 1-CysPrx succeeds 
in opening up access to CP, resulting in the glutathionylation of the oxidised CP. The 
dissociation of the heterodimeric complex through a spontaneous reduction by GSH 
results in a glutathionylated protein with fully restored activity. 
 
We therefore set out to determine whether XvPrx2 could be directly glutathionylated 
by oxidised glutathione (GSSG). Glutathionylation was investigated by incubating 
XvPrx2 with 10-fold excess GSSG (in the absence of DTT), following which ESI-MS 
was recorded, as shown in Fig 5.16B. When compared to the un-glutathionylated 
spectrum (Fig 5.16A), the raw glutathionylated spectrum contains many new species 
corresponding to 1, 3, 5 and 7 glutathione adducts. Species which become 
glutathionylated will increase in size by approximately 306 Da. For example, the 8th 
ionisation of XvPrx2 has shifted from m/z = 2238 to 2276, 2353 and 2430, 
corresponding to m = 18200, 18816 and 19432 Da respectively, which corresponds in 
turn to 17897 + 303, 17897 + 3 x 306.33 and 17897 + 5 x 307 Da respectively, as seen 
in the deconvoluted spectrum in Fig 5.17A. The resonance at m/z  = 2754, which was  
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Fig 5.16: Non-denaturing electrospray mass spectrometry of annotated “raw” spectrum of 
glutathionylated and non-glutathionylated XvPrx2 at pH 7. (A) Shows the mass spectrum of XvPrx2 
at pH 7 in the absence of GSSG while (B) shows the same mass spectrum in the presence of 10 fold 
excess GSSG. An increase in peaks size by 307 Da or a multiple thereof can be seen in the 8th and 9th 
ionisation states of the glutathionylated spectrum but not in the non-glutathionylated spectrum. For 
example the 8th ionisation state of the non-glutathionylated sample has m/z = 2238.17 (17897.36 Da) 
while same state for the glutathionylated sample has m/z = 2276.44, 2352.95, 2429.61 and 2506.51  
corresponding to 18203, 18815.6, 19428.8 and 20044.08 Da, which corresponds to XvPrx2 + 1GS, 
+1GS and GSSG + 1GS and 2GSSG and + 1GS and 3GSSG molecules respectively. A similar 
observation is made for the 9th ionisation state where the protein is attached to +1GS, +1GS and GSSG 
and + 1GS + 2GSSG molecules respectively. The peak at 2754 in the non-glutathionylated sample 
(previously shown to be evidence of the non-covalent homodimer) should have a value of 
approximately 2801 Da following glutathionylation. The absence of this peak in the glutathionylated 
spectrum suggests that the non-covalent homodimer has been abolished following glutathionylation. 
The 7th and 6th ionisation states present in the non-glutathionylated sample are absent in the 
glutathionylated sample suggesting that they represent the homodimeric state. Our data confirms that 
gluathionylation leads to the dissociation of the non-covalent homodimer of XvPrx2 to monomers 
similar to results obtained by Noguera-Mazon and co-workers for Prx from P. tremula (PtPrxD) 
(Noguera-Mazon, et al., 2006b). 
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previously shown to arise entirely from the homodimeric form, should have a value of  
approximately 2801 Da following glutathionylation. The absence of this peak indicates 
that glutathionylation disrupts the homodimer. 
 
GSSG has been previously reported to associate non-covalently with proteins, 
suggesting that the +3GS and +5GS aducts seen in Fig 5.17(A) may correspond to non-
covalent association or 1 or 2 GSSG molecules with glutathionylated XvPrx2. To test 
this hypothesis, the sample was subjected to denaturing mass spectrometry. As 
expected, only the +1GS resonance remained (Fig 5.17B).  
 
1D proton spectra of XvPrx2 at pH 7 in the presence and absence of GSSG are shown 
in Fig 5.18. With the exception of the sharp resonances in the vicinity of 8 ppm, which 
correspond to free glutathione, the GSSG sample is strikingly similar to the monomeric 
spectrum previously seen in the wild type at pH 5 (Fig 4.3A) and in the H55A mutant 
at pH 7 (Fig 5.5A). In particular the resonances at -0.5 ppm and at 11.1 ppm, which 
have been shown to be signatures of the dimeric form, are no longer observable in the 
presence of GSSG, suggesting that glutathionylated XvPrx2 is monomeric. 
 
A 15N-labelled sample of XvPrx2 was glutathionylated as above and used to record 
15N-HSQC spectra at pH 7. The overlaid spectra in Fig 5.19A reveal clear differences 
between the glutathionylated and non-glutathionylated samples at pH 7, whereas the 
glutathionylated spectrum is almost undistinguishable from the spectrum of XvPrx2-
H55A at pH7 (Fig 5.19B) and similar to the spectrum of XvPrx2 at pH5, both of which 
have previously been shown to be monomeric. 
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Fig 5.17: Deconvoluted ESI-MS spectra of glutathionylated XvPrx2 at pH 7. (A) The MS 
spectrum of glutathionylated XvPrx2 recorded under non-denaturing conditions displaying peaks 
corresponding to 1, 3 and 5 GS molecules attached to XvPrx2 respectively. The spectrum in (B) 
was acquired in denaturing conditions; the disappearance of the +3GS and +5GS species shows 
that they correspond to non-covalent interactions.  
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Fig 5.18: 1D 1H spectrum of XvPrx2 at pH 7, 25 ° C recorded at 600 MHz. (A) Shows the 1D proton 
spectrum of XvPrx2 pH 7 in the absence of GSSG while (B) shows the same spectrum in the presence 
10-fold excess GSSG. Both spectra are strikingly similar with the exception of sharp resonances found 
in the 8 ppm region, which correspond to GSH resonances. Of particular interest is the absence of the 
resonances at -0.5 ppm and 11.1 ppm, in the spectrum containing GSSG but not in the spectrum without 
GSSG. These resonances (-0.5 ppm and 11.1 ppm indicated with an arrow) have both previously been 
shown to be signatures of the dimeric form of the protein. The fact that the GSSG spectrum lacks the 
dimeric peak confirms that the non-covalent homodimeric configuration undergoes dissociation to 
monomers following glutathionylation.  
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Fig 5.19: 15N-HSQC spectra showing that glutathionylated XvPrx2 is monomeric at pH 7. 
Glutathionylated XvPrx2 at pH 7, shown in red in all panels, is overlaid with (A) un-glutathionylated 
XvPrxs at pH 7, shown in black, (B) XvPrx2-H55A at pH7, shown in black and (C) XvPrx2 pH5, shown 
in blue. Glutathionylated XvPrx2 at pH7 is more similar to XvPrx2-H55A at pH7 (panel B) and to 
XvPrx2 at pH5 (panel C), both of which have been shown to be monomeric, than to homodimeric 
XvPrx2 at pH 7. A large number of poorly-resolved resonances near the centre of the spectrum are 
evidence that the glutathionylated protein is partially unfolded. Both the glutathionylated and the pH 5 
samples of XvPrx2 used in this experiment precipitated overnight at 25 °C, whereas XvPrx2-H55A was 
stable at pH 7 for more than 6 weeks at 25 °C, suggesting that the H55A mutant may be a useful proxy 
for either of the other conditions. 
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this is clear evidence that glutathionylated XvPrx2 is monomeric at pH 7. Fig 5.19C 
similarly shows that the 15N-HSQC of glutathionylated wild type XvPrx2 is essentially 
identical to the H55A mutant, which was previously shown to be monomeric at pH 7. 
Note that the spectrum of H55A appears to be sharper and contain fewer poorly 
dispersed peaks than the spectrum of either the glutathionylated or wild type pH 5. 
This is consistent with our observation that while the H55A protein remained stable for 
more than six weeks at 25 °C, both the pH 5 and the glutathionylated samples 
precipitated within 24 hours at 25 °C. This suggests that the H55A sample may be 
more suitable for the structural investigation of the monomeric form than either the 
glutathionylated or the wild type pH 5 samples.  
 
A consequence of the model shown in Fig 1.25 is that glutathionylation can occur by 
two different mechanisms: (I) by reacting oxidised glutathione (GSSG) with reduced 
peroxiredoxin (-SH), and (II) by reacting reduced glutathione (GSH) with oxidised 
peroxiredoxin (-SOH). 
 
Pathway I has already been demonstrated above. To confirm that XvPrx2 could be 
glutathionylated according to pathway (II), a sample of XvPrx2 was first oxidised by 
addition of H2O2 and then incubated with reduced glutathione (GSH). MS was then 
performed, as shown in Fig 5.20. The sample used was 15N-enriched, giving a 
molecular weight of 18102 (Fig 5.20A) corresponding to 99 % enrichment (204 of the 
206 nitrogen atoms being 15N isotopes. Addition of an equal molar quantity of H2O2 
led to partial oxidation of the protein to sulphinic acid form (-SOOH), corresponding to 
the addition of 32 Da as seen in Fig 5.20B, and additon of twice the molar quantity 
resulted in complete oxidation of the protein to the sulphinic state (data not shown).  
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Fig 5.20: Deconvoluted MS spectra of non-oxidised and oxidised 15N-labelled XvPrx2. Spectrum of 
non-oxidised 15N-labelled sample (+ DTT) (A) and partially oxidised (B) 15N-labelled XvPrx2. The 
spectrum in (B) contains peaks at 18102 and 18133 corresponding to the non-oxidised and oxidised 
forms respectively. The difference of the sizes of the non-oxidised and oxidised peaks is approximately 
32 Da suggesting that the oxidised form is sulphinic (-SO2H). The sulphenic (-SOH) acid form was not 
observed. 
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Again no evidence of the singly oxidised form was observed, as has been noted 
previously. Addition of 10-fold excess (GSH) to the oxidised sample led to complete 
glutathionylation of the protein, corresponding to the addition of 306 Da (Fig 5.21B). 
However addition of GSH without prior oxidation of the protein (Fig 5.21C) did not 
result in glutathionylation, suggesting that the protein needs to be oxidised for 
glutathionylation with GSH to occur. 
 
A possible alternative explanation might be that glutathionylation by GSH is due to 
prior oxidation of GSH to GSSG by the excess H2O2 present in the sample, followed 
by glutathionylation by GSSG. The raw spectrum shown in Fig 5.21(A) discounts this 
possibility: although a peak corresponding to GSH is observed at 306 Da, no peak 
corresponding to GSSG is observed at around 612 Da. We conclude that 
glutathionylation of the oxidised XvPrx2 is due to GSH alone. 
 
When 10 mM DTT was added to the glutathionylated (15N-labelled) XvPrx2 shown in 
Fig 5.21B the mass reduced to 18104, showing that it had been completely de-
glutathionylated (Fig 5.22). The 15N-HSQC spectrum of de-glutathionylated XvPrx2 is 
virtually identical to that of glutathionylated XvPrx2 (Fig 5.23), showing that the 
addition of DTT resulted in complete regeneration of the protein from glutathionylated 
monomer to non-covalent homodimer. Similar experiments performed on PrxD  from 
P. tremula suggested that DTT could only partially restore the dimeric configuration as 
some evidence of monomeric peaks were observed following addition of large 
quantities of DTT (Noguera-Mazon, et al., 2006b). The reason for the discrepancy is 
not clear at this stage. 
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Fig 5.21: ESI-MS spectrum of glutathionylated 15N-labelled XvPrx2 pH 7. (A) Raw spectrum 
showing the 9th and 8th ionisation states (2046 and 2032 Da) of glutathionylated 15N-labelled XvPrx2, 
following addition of 10 mM DTT to oxidised XvPrx2. Reduced glutathione (308 Da) is also visible. 
The absence of a peak at 616 Da corresponding to GSSG shows that glutathionylation of XvPrx2 due to 
GSH and not due to prior oxidation of GSH by H2O2. (B) Deconvoluted spectrum of glutathionylated 
XvPrx2 at 18407. (C) In the absence of H2O2 GSH was unable to glutathionylate XvPrx2, resulting in a 
peak at 18103 Da, corresponding to the mass of reduced 15N-labelled XvPrx2. 
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Fig 5.22: Addition of DTT effectively regenerates un-glutathionylated XvPrx2. Deconvoluted MS 
spectrum of 15N-labelled XvPrx2 at pH 7 in the presence of 10 mM DTT. The peak at  m = 18104 
corresponds to the size of fully reduced XvPrx2, showing that DTT breaks the mixed disulphide between 
XvPrx2 and GS. 
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5.23: Addition of DTT effectively regenerates un-glutathionylated XvPrx2. Following addition of 10 
mM DTT the 15N-HSQC spectra of glutathionylated XvPrx2 (red) overlays perfectly with the spectrum of 
un-glutathionylated, reduced XvPrx2 (black), showing that the tertiary configuration, as well as the 
homodimeric state, have been completely regenerated. Both spectra were recorded at pH 7.  
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Hence we can conclude that, as proposed by Noguera-Mazon and co-workers 
(Noguera-Mazon, et al., 2006b), oxidised XvPrx2 can be efficiently regenerated by 
addition of GSH and DTT. Provided a physiological replacement for DTT could be 
found, this mechanism would potentially provide a mechanism for regeneration of 
XvPrx2 in vivo. Importantly, since the oxidised sample used for glutathionylation was 
predominantly in the sulphinic acid (-SOOH) form, this mechanism should would 
work for over-oxidised as well as single-oxidised XvPrx2, without the need for 
sulphiredoxins. 
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Chapter 6: Conclusions and future work 
6.1 Conclusions 
 
XvPrx2 is a member of the Prx5 subfamily of peroxiredoxins isolated from the 
resurrection plant Xerophyta viscosa. These plants are desiccation tolerant and can 
survive dehydration to 5% relative water content and yet reach full physiological 
activity within 3 days following rehydration (Sherwin & Farrant, 1998). XvPrx2 was 
originally identified as one of the genes upregulated during periods of desiccation 
(Mowla, et al., 2002) and subsequent work confirmed a role for XvPrx2 in protecting 
nucleic acids and other cellular proteins from oxidative damage by reactive oxygen 
species (Govender, 2006). 
 
A structure of XvPrx2 is yet to be elucidated although the structure of the closely 
related PrxD from Populus tremula has been reported. The structure of PtPrxD and 
associated studies revealed that it forms non-covalent homodimers across an A-type 
interface. Noguera-Mazon and co-workers showed that PtPrxD could form disulphide 
bonds with glutathione (glutathionylation), and that this process resulted in the 
unfolding of the Cp-loop and α2-helix and disruption of the homodimer. Noguera-
Mazon and co-workers suggested furthermore that glutathionylation might play a 
physiological role in the regeneration of all members of the Prx5 subfamily. 
 
The objectives we set out to achieve at the time of inception of this study included 
determination of the structure of XvPrx2 using X-ray crystallography, investigation of 
the presence of a non-covalent homodimer, investigation of the effect of oxidation on 
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the oligomeric state of the protein and the validation of the proposed regeneration cycle 
for the Prx5 subfamily. 
 
pH-dependent homodimerisation of XvPrx2 
 
Despite repeated attempts with high quality samples of XvPrx2 we were unable to get 
sufficiently well diffracting crystals for determination of the structure using X-ray 
diffraction. It is possible that the mixture of monomeric and dimeric isoforms 
identified in this work are responsible for the unwillingness of the protein to 
crystallise, something that possibly warrants further investigation. Our data suggests 
that future crystallization trials should be carried out at pH values either above 8 or 
below 5, where the protein is predominantly homodimeric or monomeric respectively. 
Mutant forms such as the H55A mutant reported in this thesis may prove more 
amenable to crystallization due to different oligomerization properties. 
 
Attempts to determine the structure using nuclear magnetic resonance spectroscopy 
were also unsuccessful, due to poor sensitivity of the triple resonance data and broad 
line widths. With hindsight we conclude that this is due to the fact that wild type 
XvPrx2 is either partially or completely homodimeric at pH ≥ 6; at ~ 36 kDa the dimer 
is beyond the capability of NMR without the use of a cryoprobe, which was not 
available, or partial deutration, which was not attempted. However we were able to 
almost completely assign the 15N-HSQC spectrum of wild type XvPrx2, and the 
spectrum proved to be a useful tool for investigating the oligomeric state of the protein 
and the effects of oxidation and glutathionylation. The assigned backbone chemical 
shifts will be useful for future endeavours aimed at completing the structure of the 
dimeric form of the protein using TROSY-based methods or deuterated samples. 
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Although assignment of the side chain resonances was not achieved due to the poor 
sensitivity of HC(C)H-TOCSY spectra, we were able to assign the highly downfield-
shifted resonance at -0.5 ppm, which served as a useful marker for the homodimeric 
state (see below). 
 
NMR studies suggested from an early stage that at pH 6 XvPrx2 is a mixture of two 
different isoforms, which were slow exchange on the NMR timescale. At pH ≤ 5.5 one 
of the two predominated almost completely and at pH ≥ 7 the other predominated 
almost completely. Subsequent studies using non-denaturing mass spectrometry and 
analytical size exclusion chromatography showed that the high pH isoform 
corresponded to the homodimer and the low pH isoform to the monomer. Attempts to 
assign the 15N-HSQC of the monomer at pH 5.0 were frustrated by the poor stability of 
the protein at this pH, which precipitated out of solution within a few hours at 25 °C as 
a result of which complete chemical shift perturbation analysis of the monomer/dimer 
switch was not possible.  
 
Analysis of size exclusion data (Fig 4.23) suggested that it was consistent with 
ionisation of a single group with a pKa in the vicinity of 6. Analysis of a homology 
model of XvPrx2 based on the structure of PrxD from Populus tremula revealed the 
presence of His55 close to the peroxidatic cysteine (CP). His55 is conserved in all 
members of the Prx5 subfamily and the same position is typically occupied by 
glutamic acid or glutamine in other Prx subfamilies. His55 had previously been 
identified as participating in the network of hydrogen bonds around Arg129 which is 
responsible for stabilising the α2-helix and pulling it in towards the 5-stranded β-sheet 
at the core of the protein. Since the side-chain Nδ1 of His55 is only able to accept a 
 193 
hydrogen bond when it is deprotonated (i.e. below its pKa, which is in the region of 
6.5) our data implies that breaking of this hydrogen bond is responsible for the loss of 
structure in the α2-helix at low pH and the resulting breaking of the homodimer. 
 
In order to test the model we generated a mutant form of the protein by replacing 
His55 by alanine. As expected the H55A mutant remained monomeric at higher pH 
values than the wild type, as determined by size exclusion chromatography and NMR 
(Figs. 5.4 and 5.5A). To our surprise, however, the homodimer was reformed at pH 
values above 8. Since the only residue in the vicinity with the pKa in this region is 
Cys51, the peroxidatic cysteine, we speculated that the proposed hydrogen bond 
accepted by the thiolate group of Cys51 from Arg129 may be responsible for re-
formation of the α2-helix at pH ≥ 8 when the thiol group of Cys51 is ionised. However 
when we replaced Cys51 by serine the dimeric form of the mutant was found to be 
stable at even lower pH values than the wild type. With hindsight it would possibly 
have been preferable to have generated the double mutant H55A-C51S or H55A-C51A 
in order to judge the effects of both H55 and C51 on the stability of the dimeric form 
of XvPrx2. 
 
Oxidation of XvPrx2 and its effect on the oligomeric state of the protein 
We investigated oxidation of XvPrx2 by H2O2 and its effect on the oligomeric state of 
the protein. The protein readily became oxidised into the sulphinic (XvPrx2-SO2H) 
acid form but we were unable to observe the singly oxidised form of the protein at 
various concentrations of H2O2 despite the co-existence of the non-oxidised and doubly 
oxidised forms of the protein (Figs. 5.11B and C). 1D NMR showed that the peaks at -
0.5 ppm and 11.1 ppm, which had previously been identified as markers for the 
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homodimeric state, were absent from the oxidised sample, suggesting that it may be 
monomeric. However although the 15N-HSQC spectrum of the oxidised sample was 
very different from that of the un-oxidised sample, it was qualitatively more similar to 
the spectrum seen at pH 8 than to that seen at pH 5, suggesting that the protein was still 
homodimeric. In SEC both oxidised and non-oxidised samples eluted at the same 
volume, consistent with the dimeric configuration.  
 
We conclude from the above that oxidation does not affect the homodimeric state of 
XvPrx2 at pH 7. However the widespread changes seen in the 15N-HSQC do suggest 
significant structural re-arrangement. The NMR resonance at -0.5 ppm is diagnostic of 
the α2-helix packing against to the central β-sheet of the protein; its absence suggests 
that the α2-helix becomes unfolded when the protein is oxidised. However, unlike in 
the case of glutathionylation, oxidation does not appear to induce the dissociation of 
the non-covalent homodimer.  
 
Previous reports on the effect of oxidation on two Prx5 subfamily members, human 
Prx5 and alkylhydroperoxide reductase from Saccharomyces cerevisiae, both of which 
are 2-Cys peroxiredoxins and form either intermolecular or intramolecular disulphide 
bonds during their reaction cycle, showed that oxidation did not affect the oligomeric 
state of these proteins. Our work provides the first report of a similar effect involving a 
1-Cys member of the Prx5 subfamily.  
 
Attempts to reduce the oxidised protein directly using DTT were only partially 
successful; small amounts of DTT partially reversed H2O2-induced changes to the 15N-
HSQC spectrum, but even larger amounts of DTT were unable to completely 
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regenerate the spectrum. It is possible that this is due to the fact that large amounts of 
H2O2 were used to oxidize the protein, which are likely to have over-oxidised it to the 
sulphinic acid form. However, in combination with reduced glutathione, DTT was able 
to completely regenerate even over-oxidised protein, completely restoring the 15N-
HSQC of the un-oxidised protein (see below). 
 
Glutathionylation of XvPrx2 and its effect on the oligomeric state of the protein 
We investigated the direct glutathionylation of XvPrx2 through two independent routes. 
The first involved the incubation of reduced XvPrx2 with oxidised glutathione (GSSG) 
and the second involved the incubation of oxidised XvPrx2 with reduced glutathione 
(GSH).  
 
Denaturing MS following incubation of XvPrx2 with GSSG showed an increase in the 
size of the protein by 306 Da, indicative of covalent attachment of a single GS 
molecule; i.e glutathionylation. Interestingly, non-denaturing MS revealed additional 
species with +3GS and +5GS, corresponding to non-covalent attachment of one and 
two GSSG molecules respectively. 1D NMR showed the complete disappearance of 
the resonances at -0.5 ppm and 11.1 ppm (Fig 5.18B), which had previously been 
identified as markers of the dimeric state, indicating that the glutathionylated XvPrx2 is 
monomeric. In support of this conclusion, at pH 7 the 15N-HSQC spectrum of 
glutathionylated XvPrx2 overlaid almost perfectly with the H55A mutant at pH 7 and 
reasonably well the non-glutathionylated spectrum at pH 5, both of which have been 
shown to be monomeric. 
 
As predicted by Noguera-Mazon and co-workers, incubation of oxidised XvPrx2 with 
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GSH yielded the same result as incubation of reduced XvPrx2 with GSSG: 
glutathionylation of the peroxidatic cysteine. What was surprising was that GSH was 
able to glutathionylate over-oxidised XvPrx2, which was the only oxidized state that 
we were able to observe using mass spectrometry. 
 
Incubation of glutathionylated XvPrx2 with DTT completely regenerated the protein, 
yielding a 15N-HSQC spectrum undistinguishable from the original. The implication is 
that even over-oxidised XvPrx2 may be regenerated by the combined action of reduced 
glutathione (GSH) and DTT. This is in contrast to other Prxs such as members of the 
Prx6 subfamily which require πGST to facilitate the access of GSH to the catalytic 
cysteine, or other Prxs reported to require sulferodoxins for the regeneration of over-
oxidised CPs.  
 
Since DTT is not present under physiological condition, another agent must be 
responsible for reduction of the disulphide bond between glutathione and XvPrx2. 
Glutaredoxin has been proposed as a likely candidate. Further investigations will be 
required to test this hypothesis. 
 
Likely biological significance of this work 
The biological significance of the pH-dependent change in the oligomeric state of 
XvPrx2 remains unclear at this time. However, given that previous work revealed the 
presence of multiple homologues of XvPrx2 in X. viscosa (Govender, 2006) which may 
be localized to different cellular compartments with varying pH requirements, it is 
possible that the protein may need to adopt different structures as a function of pH to 
access and remain functional within such compartments.  
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6.2 Future outlook 
Investigation of the role of homodimerisation in the activity of XvPrx2 
 
The Prx5 subfamily of peroxiredoxins are considered obligate homodimers that have 
only been reported to exist as monomers following the attachment of a glutathione 
molecule to the catalytic cysteine (Noguera-Mazon, et al., 2006b). The importance of 
homodimerization for the activity of the protein has not been investigated up to now, 
presumably because monomeric forms of the protein with intact catalytic cysteine have 
not been available. Our own attempts to investigate the interface by chemical shift 
perturbation analysis were frustrated by the fact that the monomeric form at pH 5 was 
too unstable for assignment of the 15N-HSQC to be completed. The H55A mutant 
reported in this thesis, which is monomeric and apparently stable at pH 7, may provide 
a useful opportunities for structural and functional studies, as discussed below. 
 
Determination of the monomeric structure of XvPrx2 
A recent review of peroxiredoxins has highlighted the fact that no monomeric structure 
of a 1-Cys member of the Prx5 is currently available, and the importance of such a 
structure for understanding the role of oligomerisation in the activity of the enzyme 
(Hall, et al., 2011). The H55A mutant reported here should be ideal for structure 
determination by NMR as the 15N-HSQC exhibits narrower bandwidths than the wild 
type and is stable for many weeks at 25 °C. Crystallization should also be attempted. 
 
The first milestone would be backbone assignment of the H55A at both pH 6, at which 
it is monomeric and at pH 9, at which it is dimeric, from which the dimerisation 
interface could be mapped using chemical shift perturbation. 
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Investigation of the complete reaction cycle of XvPrx2 
In this thesis we have shown that XvPrx2 can reduce H2O2, becoming oxidized itself in 
the process, following which a combination of GSH and DTT is able to regenerate the 
enzyme. It should therefore be possible to set up a continuous reaction in which a large 
amount of H2O2 is reduced by a small amount of XvPrx2. Kinetic studies could be 
carried out to determine kinetic parameters such as the VMAX and KM, monitoring the 
decrease in the amount of H2O2 using a colourimetric assay.  
 
Since DTT is not a physiologically-relevant electron donor, attempts should be made to 
determine the physiological electron donor. Glutaredoxin, as proposed by Noguera-
Mazon and co-workers (Noguera-Mazon, et al., 2006b) is a promising candidate which 
reduces protein-glutathione disulphides by itself becoming oxidized, which involves 
the formation of an inter-molecular disulphide bond. Oxidised glutaredoxin is 
regenerated by GSH (reduced glutathione), yielding GSSG (oxidised glutathione). 
Finally, GSSG is reduced to GSH by glutathione reductase in conjunction with the 
oxidation of NADPH to NADP+. Hence enzymatic assays to reduce H2O2 could be 
carried out in the presence of glutaredoxin, GSH, glutathione reductase and NADPH, 
monitoring the decrease in the absorbance of NADPH at 340 nm (Rouhier, et al., 
2002).  
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APPENDICES 
 
APPENDIX I: Alignment of Peroxiredoxin from Xerophyta viscosa (Insilco) and 
sequenced Xerophyta viscosa sequence 
Identities = 513/513 (100%), Gaps = 0/513 (0%) 
Strand = Plus/Minus 
Query 1    GATGCTGGATCCATGGCTCCGATCGCAGTCGGTGAAACGATCCCAGACGGAACGCTCGGA 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 609  GATGCTGGATCCATGGCTCCGATCGCAGTCGGTGAAACGATCCCAGACGGAACGCTCGGA 550 
  
Query 61   TGGTTCGACGAGAAGGACGAGTTGAAGCAGATCTCGATCCACTCGCTCGCCGCCGGAAAG 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 549  TGGTTCGACGAGAAGGACGAGTTGAAGCAGATCTCGATCCACTCGCTCGCCGCCGGAAAG 490 
 
Query 121  AAGATCGTGCTCATCGGTGTCCCCGGCGCATTCACTCCTACTTGCAGTATGCAACACGTT 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 489  AAGATCGTGCTCATCGGTGTCCCCGGCGCATTCACTCCTACTTGCAGTATGCAACACGTT 430 
 
Query 181  CCAAGTTTCATTGAGAAAGCAGAGGAGCTGAAAGCTAAGGGCGTTGATGAGTTCCTTGTT 240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 429  CCAAGTTTCATTGAGAAAGCAGAGGAGCTGAAAGCTAAGGGCGTTGATGAGTTCCTTGTT 370 
 
Query 241  ATTAGTGTTAATGATCCCTTCGTGATGAAGGCTTGGTCGAAAACATATCCTGAGAACAAG 300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 369  ATTAGTGTTAATGATCCCTTCGTGATGAAGGCTTGGTCGAAAACATATCCTGAGAACAAG 310 
 
Query 301  CATGTGAAGTTCCTAGCCGATGGATCGGGGAAGTACACCCAAGCTCTTGGCGTGGAACTC 360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 309  CATGTGAAGTTCCTAGCCGATGGATCGGGGAAGTACACCCAAGCTCTTGGCGTGGAACTC 250 
 
Query 361  GATCTGTCCGAGAAGGGGCTCGGGCTCCGTTCACGGAGGTTTGCTATCCTTGTAGACGAC 420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 249  GATCTGTCCGAGAAGGGGCTCGGGCTCCGTTCACGGAGGTTTGCTATCCTTGTAGACGAC 190 
 
Query 421  TTGAAGGTTAAGGTTGCAAATGTCGAGGAGGGCGGAGCATTTACCATTTCAGGTGCCGAT 480 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 189  TTGAAGGTTAAGGTTGCAAATGTCGAGGAGGGCGGAGCATTTACCATTTCAGGTGCCGAT 130 
 
Query 481  GAGATCTTGAAGGCAGTCTAGCTCGAGGTCTTC 513 
           ||||||||||||||||||||||||||||||||| 
Sbjct 129  GAGATCTTGAAGGCAGTCTAGCTCGAGGTCTTC 97 
 
 
Identities = 513/513 (100%), Gaps = 0/513 (0%) 
Strand=Plus/Plus 
Query 1    GATGCTGGATCCATGGCTCCGATCGCAGTCGGTGAAACGATCCCAGACGGAACGCTCGGA 60 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 119  GATGCTGGATCCATGGCTCCGATCGCAGTCGGTGAAACGATCCCAGACGGAACGCTCGGA 178 
 
Query 61   TGGTTCGACGAGAAGGACGAGTTGAAGCAGATCTCGATCCACTCGCTCGCCGCCGGAAAG 120 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 179  TGGTTCGACGAGAAGGACGAGTTGAAGCAGATCTCGATCCACTCGCTCGCCGCCGGAAAG 238 
 
Query 121  AAGATCGTGCTCATCGGTGTCCCCGGCGCATTCACTCCTACTTGCAGTATGCAACACGTT 180 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 239  AAGATCGTGCTCATCGGTGTCCCCGGCGCATTCACTCCTACTTGCAGTATGCAACACGTT 298 
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Query 181  CCAAGTTTCATTGAGAAAGCAGAGGAGCTGAAAGCTAAGGGCGTTGATGAGTTCCTTGTT  240 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 299  CCAAGTTTCATTGAGAAAGCAGAGGAGCTGAAAGCTAAGGGCGTTGATGAGTTCCTTGTT  358 
 
Query 241  ATTAGTGTTAATGATCCCTTCGTGATGAAGGCTTGGTCGAAAACATATCCTGAGAACAAG  300 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 359  ATTAGTGTTAATGATCCCTTCGTGATGAAGGCTTGGTCGAAAACATATCCTGAGAACAAG  418 
 
Query 301  CATGTGAAGTTCCTAGCCGATGGATCGGGGAAGTACACCCAAGCTCTTGGCGTGGAACTC  360 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 419  CATGTGAAGTTCCTAGCCGATGGATCGGGGAAGTACACCCAAGCTCTTGGCGTGGAACTC  478 
 
Query  361 GATCTGTCCGAGAAGGGGCTCGGGCTCCGTTCACGGAGGTTTGCTATCCTTGTAGACGAC  420 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  479 GATCTGTCCGAGAAGGGGCTCGGGCTCCGTTCACGGAGGTTTGCTATCCTTGTAGACGAC  538 
 
Query  421 TTGAAGGTTAAGGTTGCAAATGTCGAGGAGGGCGGAGCATTTACCATTTCAGGTGCCGAT  480 
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  539 TTGAAGGTTAAGGTTGCAAATGTCGAGGAGGGCGGAGCATTTACCATTTCAGGTGCCGAT  598 
 
Query  481 GAGATCTTGAAGGCAGTCTAGCTCGAGGTCTTC  513 
           ||||||||||||||||||||||||||||||||| 
Sbjct  599 GAGATCTTGAAGGCAGTCTAGCTCGAGGTCTTC  631 
 
 
Restriction sites are highlighted in red, GGATCC- BamHI and CTCGAG- XhoI. 
“Query” denotes the expected sequence, and “Sbjct” denotes the experimental 
sequence determined by sequencing. A comparison of the expected sequence against 
the Plus and Minus strands of the experimental sequence showed that the experimental 
sequence matched a 100 percent to the expected sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 210 
APPENDIX II: Analysis of effect of pH on size exclusion volume 
 
1. We assume that a purely monomeric sample of the protein elutes at volume 
€ 
Vem , 
and a purely homodimeric sample elutes at 
€ 
Ved . A mixture of monomeric and 
homodimeric molecules will elute at an intermediate volume 
€ 
Ve . 
2. We assume that an individual protein molecule interchanges rapidly between the 
monomeric and homodimeric forms, spending a fraction 
€ 
α  of its time in the 
monomeric state and 
€ 
1−α  in the homodimeric state 
€ 
0 ≤α ≤1, then 
€ 
Ve  should be 
given by the expression: 
        
€ 
Ve =αVem + 1−α( )Ved   
3. The above expression can be re-written as 
           
€ 
Ve =Ved +α Vem −Ved( )  
€ 
0 ≤α ≤1   
which states that the fractional shift in the peak is given by the monomeric fraction 
€ 
α . 
4. We assume that there is a single ionisable group in the interface and that the dimer 
can only form when the group is ionized. This is equivalent to saying that 
€ 
α , the 
monomeric fraction, also corresponds to the fraction of molecules that are 
protonated. 
5.  If we represent the protonated state as HA and the ionized state as 
€ 
A− , then 
     
€ 
HA↔H + + A−  
from which the Henderson Hasselbach equations follows: 
        
€ 
pH = pKa + log10
A−[ ]
HA[ ]
     
Re-arranging gives: 
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€ 
A−[ ]
HA[ ]
=10pH− pka    
6. Since  corresponds to the protonated fraction, 
        
€ 
α =
HA[ ]
HA[ ] + A−[ ]
=
1
1+ A−[ ] HA[ ]
=
1
1+10pH− pKa   
and we finally have that: 
    
€ 
Ve =Ved + Ve
m −Ved
1+10pH− pKa      . 
7. This expresses the elution volume 
€ 
Ve  as a function of 
€ 
pH , with unknown 
parameters 
€ 
Ved , 
€ 
Vem  and 
€ 
pKa . Fitting the expression to an experimentally-
determined graph of 
€ 
Ve  as a function of 
€ 
pH  will allow the values of 
€ 
Ved , 
€ 
Vem  and 
€ 
pKa  to be extracted. 
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APPENDIX III: Prediction of protein parameters  
Parameters for XvPrx2  
Protparam user-provided sequence: 
        10         20         30         40         50         60  
GPLGSMAPIA VGETIPDGTL GWFDEKDELK QISIHSLAAG KKIVLIGVPG AFTPTCSMQH  
 
        70         80         90        100        110        120  
VPSFIEKAEE LKAKGVDEFL VISVNDPFVM KAWSKTYPEN KHVKFLADGS GKYTQALGVE  
 
       130        140        150        160  
LDLSEKGLGL RSRRFAILVD DLKVKVANVE EGGAFTISGA DEILKAV  
 
 
Number of amino acids: 167 
 
Molecular weight: 17898.6 
 
Theoretical pI: 5.43 
 
Amino acid composition:  
 
Ala(A)15 9.0% Arg(R)3 1.8% Asn(N)3 1.8% Asp(D)10 6.0% 
Cys(C)1 0.6% Gln(Q)3 1.8% Glu(E)13 7.8% Gly(G)17  10.2% 
His(H)3 1.8% Ile(I)11 6.6% Leu(L)16 9.6% Lys(K)16 9.6% 
Met(M)3 1.8% Phe(F)8 4.8% Pro(P)8 4.8% Ser(S)11 6.6% 
Thr(T)7 4.2% Trp(W)2 1.2% Tyr(Y)2 1.2% Val(V)15  9.0% 
Pyl(O)0 0.0% Sec(U)0 0.0% (B)0 0.0% (Z)0 0.0% (X)0  0.0% 
 
 
Total number of negatively charged residues (Asp + Glu): 23 
Total number of positively charged residues (Arg + Lys): 19 
 
Atomic composition: 
 
Carbon  C        811 
Hydrogen H       1294 
Nitrogen N        206 
Oxygen O        240 
Sulfur S            4 
 
Formula: C811H1294N206O240S4 
Total number of atoms: 2555 
 
Extinction coefficients: 
 
Extinction coefficients are in units of  M-1 cm-1, at 280 nm measured in water. 
 
Ext. coefficient 13980 
Abs 0.1% (=1 g/l) 0.781, assuming all pairs of Cys residues form cystines 
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Ext. coefficient 13980 
Abs 0.1% (=1 g/l) 0.781, assuming all Cys residues are reduced 
 
Estimated half-life: 
 
The N-terminal of the sequence considered is G (Gly). 
 
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
                            >20 hours (yeast, in vivo). 
                            >10 hours (Escherichia coli, in vivo). 
 
 
Instability index: 
 
The instability index (II) is computed to be 29.24 
This classifies the protein as stable. 
 
Aliphatic index: 98.08 
 
Grand average of hydropathicity (GRAVY): 0.037 
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APPENDIX IV: XvPrx2 Chemical shifts  
Residue number Residue name Atom name Chemical shift 
1 M CA 55.90 
1 M CB 33.46 
2 A N 126.62 
2 A HN 31.95 
2 A CA 50.96 
2 A CB 19.39 
3 P CA 63.45 
3 P CB 32.74 
4 I N 121.04 
4 I HN 7.51 
4 I CA 61.13 
4 I CB 38.99 
5 A N 127.80 
5 A HN 47.82 
5 A CA 50.51 
5 A CB 22.50 
6 V N 118.92 
6 V HN 8.13 
6 V CA 65.32 
6 V CB 32.06 
7 G N 111.14 
7 G HN 9.21 
7 G CA 45.22 
8 E N 120.90 
8 E HN 7.92 
8 E CA 56.45 
8 E CB 30.99 
9 T N 119.02 
9 T HN 8.76 
9 T CA 62.23 
9 T CB 70.21 
10 I N 124.77 
10 I HN 8.94 
10 I CA 59.23 
10 I CB 38.62 
11 P CA 63.00 
11 P CB 31.85 
12 D N 122.19 
12 D HN 8.65 
12 D CA 52.78 
12 D CB 41.15 
13 G N 109.72 
13 G HN 8.55 
13 G CA 45.91 
14 T N 115.08 
14 T HN 8.37 
14 T CA 60.11 
14 T CB 70.74 
15 L N 128.89 
15 L HN 9.24 
15 L CA 54.216 
15 L CB 46.093 
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Residue number Residue name Atom name Chemical shift 
16 G N 107.95 
16 G HN 8.84 
16 G CA 45.67 
17 W N 126.63 
17 W HN 9.13 
17 W CA 58.11 
17 W CB 32.77 
18 F N 128.16 
18 F HN 8.42 
18 F CA 58.68 
18 F CB 40.83 
19 D N 124.93 
19 D HN 8.20 
19 D CA 52.35 
19 D CB 42.69 
20 E N 117.49 
20 E HN 9.18 
20 E CA 59.37 
20 E CB 28.78 
21 K N 122.05 
21 K HN 8.34 
21 K CA 55.83 
21 K CB 32.01 
22 D N 118.19 
22 D HN 8.48 
22 D CA 56.51 
22 D CB 40.05 
23 E N 120.06 
23 E HN 8.49 
23 E CA 55.89 
23 E CB 31.49 
24 L N 126.87 
24 L HN 8.49 
24 L CA 55.71 
24 L CB 40.75 
25 K N 130.76 
25 K HN 9.31 
25 K CA 53.94 
25 K CB 35.26 
26 Q N 120.72 
26 Q HN 8.40 
26 Q CA 54.59 
26 Q CB 29.14 
27 I N 124.95 
27 I HN 9.36 
27 I CA 59.17 
27 I CB 41.40 
28 S N 121.09 
28 S HN 8.49 
28 S CA 55.98 
28 S CB 64.08 
29 I N 129.54 
29 I HN 8.59 
29 I CA 63.28 
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Residue number Residue name Atom name Chemical shift 
29 I CB 37.32 
30 H N 120.85 
30 H HN 9.15 
30 H CA 60.45 
30 H CB 31.40 
31 S N 115.30 
31 S HN 7.91 
31 S CA 61.88 
31 S CB 63.22 
32 L N 121.82 
32 L HN 7.50 
32 L CA 56.87 
32 L CB 43.91 
33 A N 118.21 
33 A HN 8.24 
33 A CA 53.25 
33 A CB 21.47 
34 A N 124.37 
34 A HN 7.95 
34 A CA 55.08 
34 A CB 18.17 
35 G N 112.22 
35 G HN 9.54 
35 G CA 46.51 
36 K N 118.68 
36 K HN 7.75 
36 K CA 55.19 
36 K CB 38.09 
37 K N 124.52 
37 K HN 9.46 
37 K CA 56.12 
37 K CB 33.73 
38 I N 118.57 
38 I HN 9.32 
38 I CA 58.38 
38 I CB 42.80 
39 V N 121.58 
39 V HN 8.24 
39 V CA 60.09 
39 V CB 35.10 
40 L N 128.14 
40 L HN 9.39 
40 L CA 53.83 
40 L CB 44.64 
41 I N 129.45 
41 I HN 9.47 
41 I CA 60.79 
41 I CB 39.47 
42 G N 119.30 
42 G HN 8.04 
42 G CA 44.74 
43 V N 114.34 
43 V HN 8.02 
43 V CA 56.962 
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Residue number Residue name Atom name Chemical shift 
43 V CB 33.46 
44 P CA 64.57 
44 P CB 33.27 
45 G N 108.25 
45 G HN 8.88 
45 G CA 48.88 
46 A N 129.32 
46 A HN 7.92 
46 A CA 52.16 
46 A CB 19.92 
47 F N 129.47 
47 F CA 63.22 
47 F CB 36.04 
48 T N 113.73 
48 T HN 7.49 
48 T CA 62.23 
48 T CB 66.98 
49 P CA 65.10 
49 P CB 32.79 
50 T N 111.27 
50 T HN 8.30 
50 T CA 61.15 
50 T CB 64.79 
51 C N 116.91 
51 C HN 8.91 
51 C CA 56.86 
51 C CB 33.99 
57 P CA 66.84 
57 P CB 31.58 
58 S N 112.96 
58 S HN 7.25 
58 S CA 62.39 
58 S CB 63.60 
59 F N 118.27 
59 F HN 7.39 
59 F CA 63.16 
59 F CB 40.70 
60 I N 119.83 
60 I HN 7.80 
60 I CA 66.26 
60 I CB 38.08 
61 E N 118.27 
61 E HN 8.51 
61 E CA 59.46 
61 E CB 30.21 
62 K N 115.12 
62 K HN 7.06 
62 K CA 55.05 
62 K CB 32.97 
63 A N 125.30 
63 A HN 7.51 
63 A CA 56.89 
63 A CB 18.40 
64 E N 116.46 
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64 E HN 8.68 
64 E CA 60.61 
64 E CB 29.17 
65 E N 122.96 
65 E HN 8.13 
65 E CA 60.04 
66 L N 120.15 
66 L HN 8.42 
66 L CA 59.09 
66 L CB 43.03 
67 K N 123.78 
67 K HN 9.29 
67 K CA 45.89 
68 A N 123.63 
68 A HN 8.02 
68 A CA 54.88 
68 A CB 18.30 
69 K N 117.37 
69 K HN 7.47 
69 K CA 56.20 
69 K CB 33.19 
70 G N 106.85 
70 G HN 7.90 
70 G CA 45.92 
71 V N 121.63 
71 V HN 7.97 
71 V CA 47.59 
72 D N 125.30 
72 D HN 8.99 
72 D CA 57.52 
72 D CB 45.66 
73 E N 112.86 
73 E HN 6.77 
73 E CA 54.40 
73 E CB 33.86 
74 F N 122.43 
74 F HN 9.51 
74 F CA 56.29 
74 F CB 41.99 
75 L N 123.81 
75 L HN 8.81 
75 L CA 53.10 
76 V N 127.50 
76 V HN 9.00 
76 V CA 61.50 
76 V CB 32.23 
77 I N 128.33 
77 I HN 9.29 
77 I CA 60.59 
77 I CB 41.34 
78 S N 115.82 
78 S HN 7.41 
78 S CA 56.24 
78 S CB 66.03 
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79 V N 132.70 
79 V HN 9.73 
79 V CA 61.31 
79 V CB 29.30 
80 N N 122.32 
80 N HN 8.26 
80 N CA 53.99 
81 D N 115.01 
81 D HN 8.12 
82 P CA 65.78 
82 P CB 32.72 
83 F N 121.03 
83 F HN 8.97 
83 F CA 62.23 
83 F CB 37.15 
84 V N 124.90 
84 V HN 8.68 
84 V CA 67.12 
84 V CB 32.76 
85 M N 117.39 
85 M HN 8.24 
85 M CA 57.88 
85 M CB 31.70 
86 K N 121.95 
86 K HN 8.51 
86 K CA 59.75 
86 K CB 32.08 
87 A N 123.74 
87 A HN 7.71 
87 A CA 55.79 
87 A CB 17.61 
88 W N 120.84 
88 W HN 8.94 
88 W CA 57.94 
88 W CB 28.72 
89 S N 118.72 
89 S HN 8.61 
89 S CA 61.79 
89 S CB 62.86 
90 K N 121.00 
90 K HN 7.23 
90 K CA 57.85 
90 K CB 32.41 
91 T N 110.49 
91 T HN 7.82 
91 T CA 63.19 
91 T CB 69.44 
92 Y N 120.02 
92 Y HN 7.05 
93 P CA 65.20 
93 P CB 32.30 
94 E N 118.22 
94 E HN 9.38 
94 E CA 57.22 
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94 E CB 29.30 
95 N N 119.73 
95 N HN 7.96 
95 N CA 54.77 
95 N CB 40.07 
96 K CA 58.38 
96 K CB 32.24 
97 H N 121.39 
97 H HN 8.22 
97 H CA 58.24 
97 H CB 35.34 
98 V N 122.19 
98 V HN 9.05 
98 V CA 63.81 
98 V CB 31.88 
99 K N 129.37 
99 K HN 8.77 
99 K CA 56.35 
99 K CB 36.65 
100 F N 122.91 
100 F HN 9.25 
100 F CA 58.28 
100 F CB 40.09 
101 L N 127.10 
101 L HN 9.85 
101 L CA 55.00 
101 L CB 45.07 
102 A N 123.13 
102 A HN 9.15 
102 A CA 52.86 
102 A CB 22.84 
103 D N 127.66 
103 D HN 9.06 
103 D CA 52.83 
103 D CB 43.29 
104 G N 109.27 
104 G HN 8.63 
104 G CA 49.29 
105 S CA 57.99 
105 S CB 64.54 
106 G N 112.50 
106 G HN 8.69 
106 G CA 46.82 
107 K N 120.22 
107 K HN 7.68 
107 K CA 59.90 
107 K CB 33.60 
108 Y N 129.61 
108 Y HN 11.15 
108 Y CA 63.02 
108 Y CB 38.65 
109 T N 120.42 
109 T HN 9.74 
109 T CA 67.830 
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109 T CB 68.84 
110 Q N 118.96 
110 Q HN 7.93 
110 Q CA 59.66 
110 Q CB 29.36 
111 A N 126.30 
111 A HN 7.87 
111 A CA 55.54 
111 A CB 17.98 
112 L N 117.24 
112 L HN 7.95 
112 L CA 55.80 
112 L CB 44.80 
113 V N 106.64 
113 V HN 7.73 
113 V CA 46.87 
114 V N 108.44 
114 V HN 7.45 
114 V CA 59.63 
114 V CB 31.58 
115 E N 122.92 
115 E HN 8.81 
115 E CA 58.25 
115 E CB 31.20 
116 L N 126.04 
116 L HN 9.13 
117 D CA 54.87 
117 D CB 40.47 
118 L N 130.73 
118 L HN 8.41 
118 L CA 54.16 
118 L CB 42.83 
119 S N 121.35 
119 S HN 9.09 
119 G CA 46.54 
123 L N 118.30 
123 L HN 7.36 
123 L CA 56.08 
123 L CB 44.76 
124 G N 106.70 
124 G HN 7.27 
124 G CA 46.09 
125 L N 125.41 
125 L HN 8.50 
125 L CA 56.33 
125 L CB 42.58 
126 R N 126.09 
126 R HN 9.00 
126 R CA 52.74 
126 R CB 35.27 
127 S N 116.57 
127 S HN 8.54 
127 S CA 58.15 
127 S CB 65.23 
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128 R N 120.92 
128 R HN 8.51 
128 R CA 57.22 
128 R CB 33.13 
129 R N 120.57 
129 R HN 7.99 
129 R CA 56.67 
129 R CB 29.95 
130 F CA 57.39 
130 F CB 43.66 
130 A N 121.31 
130 A HN 8.88 
131 A CA 53.45 
131 A CB 22.83 
132 I N 123.34 
132 I HN 9.59 
132 I CA 59.68 
132 I CB 43.39 
133 L N 129.80 
133 L HN 9.01 
133 L CA 54.27 
133 L CB 46.10 
134 V N 130.71 
134 V HN 9.56 
134 V CA 61.32 
134 V CB 33.62 
135 D N 129.50 
135 D HN 9.43 
135 D CA 53.36 
135 D CB 43.87 
136 D N 131.05 
136 D HN 9.40 
136 D CA 56.09 
136 D CB 39.43 
137 L N 107.19 
137 L HN 8.72 
137 L CA 58.67 
137 L CB 40.70 
138 K N 120.25 
138 K HN 7.79 
138 K CA 55.08 
138 K CB 33.66 
139 V N 126.32 
139 V HN 9.12 
139 V CA 195.47 
139 V CB 31.92 
140 K N 131.06 
140 K HN 9.42 
140 K CA 45.63 
141 V N 117.56 
141 V HN 7.57 
141 V CA 62.20 
141 V CB 37.21 
142 A N 131.211 
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142 A HN 9.20 
142 A CA 51.88 
142 A CB 20.33 
143 N N 127.60 
143 N HN 8.70 
143 N CA 52.42 
143 N CB 38.56 
144 V N 125.81 
144 V HN 8.50 
144 V CA 61.94 
144 V CB 33.57 
145 E N 127.70 
145 E HN 9.00 
146 E CA 58.19 
146 E CB 29.95 
147 G N 112.42 
147 G HN 8.60 
147 G CA 48.16 
148 G CA 42.65 
149 A N 126.76 
149 A HN 8.24 
149 A CA 53.51 
149 A CB 19.91 
150 F N 120.08 
150 F HN 8.56 
150 F CA 56.05 
150 F CB 40.82 
151 T N 121.09 
151 T HN 10.60 
151 T CA 63.07 
151 T CB 71.73 
152 I N 119.10 
152 I HN 8.71 
152 I CA 61.94 
152 I CB 41.79 
153 S N 113.38 
153 S HN 7.23 
153 S CA 58.41 
153 S CB 63.02 
154 G N 109.20 
154 G HN 8.46 
154 G CA 45.27 
155 A N 121.13 
155 A HN 7.32 
155 A CA 55.31 
155 A CB 19.52 
156 D N 117.31 
156 D HN 8.73 
156 D CA 57.75 
156 D CB 39.88 
157 E N 119.18 
157 E HN 7.59 
157 E CA 59.15 
157 E CB 29.64 
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158 I N 119.64 
158 I HN 7.16 
158 I CA 61.63 
158 I CB 35.82 
159 L N 121.13 
159 L HN 8.36 
159 L CA 58.47 
159 L CB 42.70 
160 K N 115.37 
160 K HN 7.22 
160 K CA 58.42 
160 K CB 33.37 
161 A N 122.06 
161 A HN 7.77 
161 A CA 52.50 
161 A CB 21.83 
162 V N 120.76 
162 V HN 7.18 
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